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Summary 
 
Introduction: Tumours of the posterior fossa of the cranium are associated with significant 
impairments, morbidity and mortality. Limited evidence is available in the adult population, 
of the potential impact a surgical intervention can have on function, in this tumour type. The 
rehabilitation practices utilised to treat the associated impairments have also received 
limited investigation.  
Aims/Objectives: The primary aim of this research study was to characterise the impact of 
surgery on balance, gait, upper limb dexterity and dizziness in patients with posterior fossa 
tumours. Secondary aims of the study were to profile the demographic and tumour 
characteristics of the study participants. 
Methods: This was a prospective cohort study, which recruited thirteen participants over an 
eighteen month period. A comprehensive testing battery was completed over four time-
points, of six months duration, to categorise the impact of surgery. A systematic review of 
rehabilitation practices in the management of impairments, associated with posterior fossa 
tumours, was also completed. 
Results: Thirteen participants, of mean age 48.8 ± 15.7, were recruited to the study. An 
improvement in the primary outcome, equilibrium and balance, was observed post-
operatively, while surgical impact on gait speed, upper limb dexterity and dizziness resulted 
in negative consequences. Significant morbidity and mortality was associated with surgery 
in this population, impacting on data collection and analysis. 
Conclusions and Implications: Surgical intervention for the presence of a tumour in the 
posterior fossa, resulted in a decrease in gait speed and upper limb dexterity, an increase in 
dizziness and improvement in balance, post-operatively. The most frequently occurring 
tumour type was metastases, indicating the high risk of mortality associated with a tumour 
of this region of the brain. The testing battery used in this research project provides the 
foundation for comprehensive assessment and treatment of this population of patients, in 
future care. 
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Chapter 1: Introduction 
1.1 Purpose of the Thesis 
The purpose of this thesis was to quantify and detect changes in balance, gait, upper limb 
dexterity and dizziness in individuals with tumours of the posterior fossa, before and after a 
surgical intervention.  
The posterior cranial fossa is a bony cavern at the rear of the skull that cradles the 
cerebellum, brainstem and fourth ventricle (Chadha et al., 2015). Tumours of this region of 
the brain remain very rare in adults but occur with increased frequency in the paediatric 
population. Almost 50% of paediatric brain tumours occur in the posterior fossa (Rasalkar et 
al., 2013), with only 15-20% of all adult brain tumours occurring in the posterior fossa 
(Lindsay and Bone, 2004). Although there is a discrepancy in incidence rates of posterior 
fossa tumours between adults and children, clinical presentation between adults and 
children is considered to be essentially similar (Levin, 2002).   
Expansion of a tumour in the posterior fossa can occur at the expense of the normal 
cerebral tissues, and may result in brain stem or cerebellar dysfunction, blockage of the 
fourth ventricle and hydrocephalus (McMillan et al., 2009). Damage to the cerebellum has 
been revealed to cause a myriad of physical symptoms such as gait ataxia (Palliyath et al., 
1998, Ilg et al., 2007), postural disorders (Marquer et al., 2014), balance deficits (Schoch et 
al., 2010), alterations in upper limb dexterity (Ada et al., 2009) and more recently, impaired 
cognition (Koziol et al., 2014). The brainstem plays a significant role in postural control and 
locomotion due to the presence of the vestibular, reticular and red nuclei, while also 
influencing arousal and awareness (Shumway-Cook and Woollacott, 2007).  
The aim of management of a tumour in this region of the brain is ultimately to reduce the 
compressive impact of the tumour, relieve intra-cranial pressure and ultimately prevent 
progressing, neurological decline (Bullock et al., 2006).  Several potential surgical 
procedures can be utilised to manage a tumour occurring in this region. Resection of 
posterior fossa tumours traditionally resulted in permanent bone removal, with a sub-
occipital craniectomy, which improved tumour exposure but resulted in a higher associated 
surgical risk (Legnani et al., 2013). A craniotomy results in reinsertion of the bone flap post-
surgically, allowing more protection of the cerebral tissues (Gnanalingham et al., 2002). 
17 
 
Once access to the tumour is obtained, a sample of the tissue can be collected by biopsy or 
a more aggressive approach involving resection of the tumour, either partially (sub-total) or 
fully (gross-total excision) (Valdes-Gorcia et al., 1998). Surgical techniques undertaken as a 
result of a lesion in this area of the brain are not solely concerned with identification and 
removal of the tumour. Given the proximity to the fourth ventricle, surgical procedures are 
often undertaken to manage hydrocephalus. Use of extra-ventricular drainage systems can 
be employed as temporary measures but ventriculostomy or permanent shunting may be 
required in certain cases to manage hydrocephalus in individuals with posterior fossa 
tumours (Mangubat et al., 2009).  
The complex nature of the associated tissues, the evolving nature of the tumour and the 
potential for neurological impairments, poses a significant challenge to the multidisciplinary 
team, involved in care. The role of physiotherapy in the management of neuro-oncology 
patients is essential to maximise function, in conjunction with medical or surgical 
intervention. However, the available literature focusing on rehabilitation, specifically in 
patients with the diagnosis of a posterior fossa tumour, is limited.  
1.2 Justification for the Thesis  
While the incidence of primary and secondary brain tumours, has increased over the last 
several years (Deorah et al., 2006), tumours of the posterior fossa remain rare. The rarity of 
the condition is reflected in the lack and quality of available research in adult patients, with 
involvement of this area of the brain. While good quality evidence is available (Martin et al., 
2009), focus has been placed on management of impairments as a consequence of varying 
pathologies. The complex role of the anatomical structures in this region of the brain, in the 
involvement of movement generation, movement timing and sequencing provides a 
challenge for therapists in their management of this complex cohort. No specific research 
has previously focused on impairments of balance, gait, upper limb dexterity and dizziness 
solely in an adult posterior fossa tumour population. This novel piece of research has the 
potential to supplement the existing knowledge base and assist therapists with future 
clinical decisions, involving this cohort of patients. 
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1.3 Structure of the Thesis 
The thesis is divided into seven chapters, including the current chapter. Chapter two 
contains a literature review of cancer and brain tumour epidemiology, the anatomy of the 
posterior fossa and medical and surgical techniques employed in their management. 
Chapter three contains a general overview of rehabilitation in brain tumour populations and 
a systematic review of rehabilitation practices in the management of patients with posterior 
fossa tumours. The review focuses on the impairments associated with a tumour of the 
posterior fossa and potential rehabilitation strategies employed to treat subsequent 
impairments. Chapter four outlines the methodology of a prospective cohort study which 
investigated the impact of a neurosurgical intervention on balance, gait, upper limb 
dexterity and dizziness in a cohort of patients with posterior fossa tumours. Chapter five 
details and outlines the results of the cohort study, while chapter six contains the 
discussion, outlining the potential clinical implications of the study. Chapter seven contains 
the study conclusion.  
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Chapter 2: Anatomy and Medical Management Literature Review  
2.1 Introduction 
This chapter of the thesis aims to provide context for the proposed study by providing an 
overview of the epidemiology of cancer, in particular cancer of the central nervous system 
(CNS). In addition, the anatomical function of the structures located within the posterior 
fossa will be described, as well as the impact that a tumour in this region and the associated 
medical and surgical interventions, may have on normal brain function. Chapter one of this 
thesis, has provided an introduction to these concepts and this chapter aims to provide a 
more in-depth review of the relevant literature.  
2.2 Epidemiology of Cancer  
2.2.1 Cancer Incidence  
According to the International Agency for Research on Cancer (IARC), 14.1 million new cases 
of cancer diagnosis were made in 2012 worldwide (IARC Biennial Report, 2012-2013). This is 
a 10% increase in cancer incidence, when compared with 2008 figures (Ferlay et al., 2010). 
Cancer is the second leading cause of death in high income countries and the third leading 
cause of death in medium and low income countries. By 2030, the global burden is expected 
to grow to 21.7 million new cancer cases and 13 million cancer deaths, due to the growth 
and aging of the population (Bray et al., 2012). In 2008, the European Union had 2.45 million 
new cancer diagnoses (Luengo-Fernandez et al., 2013). More recent European data 
demonstrated 3.4 million new cancer cases, excluding non-melanoma skin cancers, in 2012 
(Ferlay et al., 2013). Irish data on cancer incidence, as compiled by the National Cancer 
Registry, displayed an average of 18,500 invasive (excluding non-melanoma skin) cancers, 
were diagnosed annually between 2008 and 2010, equivalent to an incidence rate of 423 
cases per 100,000 per year. Based on increases in population and an aging population, it is 
predicted that the incidence of cancer is set to increase by 81% for females and 108% for 
males in Ireland between the period of 2010 to 2040 (National Cancer Registry, Cancer 
Projections for Ireland 2015-2040, 2014). This projection anticipates an increase in all cancer 
types, for both sexes, with the exception of leukaemia in males in Ireland, by 2040. 
The incidence of developing a primary brain tumour in 2004 was identified as 6.6 per 
100,000, with the incidence of metastatic brain tumour estimated to vary between 8.3 per 
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100,000 to 11 per 100,000 (Barnholtz-Sloan et al., 2004) . The worldwide incidence of 
developing a primary malignant brain or CNS tumour in 2012 was 3.4 per 100,000 (IARC 
Biennial Report, 2012-2013). CNS cancer was the 15th most commonly occurring cancer in 
Ireland (Cancer in Ireland 2013: Annual Report of the National Cancer Registry, 2013).  
2.2.2 Cancer Mortality 
The American Cancer Society identified cancer as a cause of 7.6 million deaths worldwide in 
2008. Recent trends have shown that fluctuations are occurring in the mortality rates 
associated with varying cancer types. In the USA, between 1998 and 2007, a downward 
trend in mortality rates was noted for seven of 15 of the most frequently occurring cancers. 
These cancers included brain tumours, stomach, colon and kidney cancer (Kohler et al., 
2011). Based on data from the 28 member states of the European Union, cancer resulted in 
the death of 1.281 million people, equating to more than one quarter of all deaths (26.3%), 
in 2011 (Eurostat, 2014). This data also highlighted Ireland as one of only three countries, 
with the Netherlands and Slovenia, in 2011, with a greater than 30% mortality rate 
associated with a cancer diagnosis. Age related discrepancies in cancer mortality have also 
been highlighted in the data, with 40% associated cancer mortality in those under the age of 
65 and less than 25% associated mortality in the over 65 age category (Eurostat, 2014). 
Irish data, looking at cancer mortality trends from 1950 to 2002, identified brain and CNS 
cancer as the twelfth most common cause of cancer death in Ireland, for the period 1994-
2001 (O’Lorcain et al., 2006). Survival prospects, based on EuroCare 3 data, associated with 
a CNS cancer diagnosis, are considered relatively poor, with a mean 5 year relative survival 
of 18% in both sexes, for the time-period of 1990-1994 (Sant et al., 2003). EuroCare 5 data 
(Sant et al., 2012), demonstrated a 5 year relative survival of 85%, for a benign CNS tumour 
diagnosis and 19.9% for a malignant CNS diagnosis. Differences between the datasets are 
evident due to the inclusion of benign tumour cases in the latter study. Data for the UK and 
Ireland revealed a 40% higher excess risk of death with a CNS tumour diagnosis, when 
compared with Northern European participants. 
2.2.3 Cancer Expenditure and Costings 
While the exact global cost of cancer treatment and management is unknown, it is 
estimated to cost hundreds of billions of dollars annually (American Cancer Society, 2012). 
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Prediction of true and accurate cancer expenditure incorporates both direct and indirect 
cancer expenses. Direct expenditure relates to the direct medical treatment of cancer 
sufferers and includes hospital admissions, rehabilitation and cancer drugs (Jayadevappa et 
al., 2005). Indirect expenditure predicts the global cost of secondary costs relating to cancer 
such as loss of work related productivity, increases in mortality and premature death 
(Brown et al., 2001). In a review of United States data, the annual cost of cancer care in 
America in 2012 was estimated to be $124.57 billion, with an anticipated increase in costs to 
$157.77 billion by 2020 (Mariotto et al., 2011). This represents a 27% increase in the 
provision of routine cancer care to the American population, by the year 2020. In Europe, 
based on 2009 statistics, the total economic cost of cancer was in excess of €126 billion. On 
comparison of the cancer related funding per citizen, between the USA and Europe, the USA 
spent $255 (€196) per person as compared with €102 per European citizen in 2008. The Irish 
per head of population spending on cancer was €139, which equates to 136% of the 
European average (Luengo-Fernandez et al., 2013). This incorporates the direct cost of 
healthcare and associated productivity losses due to morbidity and mortality (Luengo-
Fernandez et al., 2013). 
One quarter of the global burden of cancer is observed within Europe, while Europe 
contains only one ninth of the world’s population (United Nations, 2010).  However, it is not 
just the healthcare system that carries the burden of cancer management. In a report by the 
NCRI (Financial Impact of a Cancer Diagnosis, 2010) patients have been shown to experience 
a large degree of personal financial stresses due to changes in financial earnings, increased 
health related expenditure and inability to return to gainful employment impacting on 
future earnings. While exact figures are unavailable in the report, it provides insight into the 
cost of cancer at a personal level, in comparison to societal and epidemiological cost 
analysis.  
Expenditure related to cancer type varied based on the location of the cancer and the stage 
of cancer progression. Brain, pancreas, ovary and oesophagus were identified as the cancer 
locations with the highest annual cost to manage in the first year of diagnosis (Mariotto et 
al., 2011). Treatment of brain tumours in the US in 2010 cost the American government $4.5 
billion, with an estimated increase in the resources required to administer cancer care by 
2020, rising to $6.8 billion. The projected increase in costs accommodates inflation and 
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changing trends in cancer incidence, prevalence and mortality over the ten year period 
(Mariotto et al., 2011).  
The destructive capacity of cancer on society and individuals has been outlined. When 
cancer occurs within the CNS there are several additional factors that also need to be 
considered such as cognition, movement and higher executive functioning (Levisohn et al., 
2000). The destructive nature of brain cancer is even more apparent in complex areas of the 
brain, such as those located within the posterior cranial fossa.   
2.3 Anatomy of the Posterior Cranial Fossa  
The human skull consists of three distinct anatomical regions; the anterior, middle and 
posterior cranial fossae. The posterior cranial fossa is a bony cavern located at the posterior 
aspect of the skull. This region of the skull provides a bony cradle to protect complex brain 
structures including the cerebellum, brainstem and fourth ventricle (Levin, 2002).  
 
Figure 2a The posterior fossa of the skull  
Ten of the twelve pairs of cranial nerves have a portion located within the posterior fossa 
(PF) (Matsushima et al., 1982). On sagittal MRI images the boundaries of the posterior fossa 
are made up superiorly of the tentorium, the anterior boundary, the clivus and the inferior 
boundary, the line joining the opisthion and basion (Chadha et al., 2015). The brain 
structures located superior to the tentorium, a sheath of dura, are classified as supra-
tentorial and the structures inferior are classified as infra-tentorial. The complexity of the 
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brain structures located in the posterior fossa indicates the capacity for potential 
dysfunction with involvement of this area of the brain. The presence of a mass lesion within 
the infra-tentorium of the brain has been shown to be associated with compression and 
distortion of these complex structures. The compact nature of the PF results in an inability 
to accommodate increases in pressure, that could be caused by haemorrhages (Bullock et 
al., 2006), tumours (McMillan et al., 2009), hydrocephalus (El Ahmadieh et al., 2013) or 
mass effect (Jauss et al., 1999). Changes in volume or pressure within the supra-tentorial 
region of the brain also have the potential to increase pressure on the neural structures of 
the PF due to its rigid structure (Chadha et al., 2015). 
2.4 Anatomy of the Cerebellum  
The cerebellum constitutes approximately one-tenth of the cerebral volume and is 
connected directly and indirectly to a variety of cerebral structures including the brainstem, 
the spine and diverse cerebral subcortical and cortical regions (Roostaei et al., 2014). Within 
the posterior fossa, the cerebellum is located posterior to the brainstem and the fourth 
ventricle and is rostrally separated from the cerebrum by an extension of the dura matter 
called the tentorium cerebelli (Crossman and Neary, 2005). It is connected directly to the 
brainstem by three pairs of fibrous peduncles, known as the superior, middle and inferior 
peduncles, through which pass all afferent and efferent connections with the cerebrum. 
Gross makeup of the cerebellum is that of two hemispheres separated by the central 
vermis.  Anatomically, the cerebellum consists of three lobes that are subdivided by two 
transverse fissures. The primary fissure divides the anterior and posterior lobe and the 
postero-lateral fissure separates the posterior and flocculonodular lobe (Roostaei et al., 
2014).   
Figure 2b Structure of the cerebellum  
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Anatomical studies have shown that approximately 80% of all the brains neurones, in 
humans are located in the cerebellum (Herculano-Houzel, 2010), which highlights its 
complex computing capabilities. Four main types of neurones are located within the 
cerebellar cortex: granule cells, purkinje cells and the inhibitory Golgi cells and 
stellate/basket cells (Voogd and Glickstein, 1998), and are located within distinct histological 
layers in the cerebellar cortex. The outermost molecular layer is composed of the inhibitory 
stellate and basket cells and the dendritic arborisations of the purkinje cells that extend 
from the intermediate unicellular purkinje cell layer (Kirsch et al., 2012).  The innermost 
layer of the cerebellar cortex, the granular layer, contains mossy fibres, granule cells, uni-
polar brush cells and inhibitory golgi cells (Kirsch et al., 2012). Granule cells which are small 
round cells found within the granular layer of the cerebellar cortex, are the most frequently 
occurring cell of this region of the cerebellum and are believed to play a role in the 
modulation of motor output (Pinzon-Morales and Hirata, 2015).  
The main afferent projections to the cerebellum arise from the spinal cord, inferior olivary 
nucleus, vestibular nuclei and the pons. The axons terminate in the cerebellar cortex and are 
excitatory in nature. The fibres originating in the inferior olivary nucleus give rise to climbing 
fibres, while all other afferents form mossy fibres. Mossy fibres terminate in the granular 
layer in synapse with the granule cells. In turn, the axons of the granule cells project to the 
superficial molecular layer producing two parallel fibres, which traverse the dendrites of the 
purkinje cells, which also extend into the molecular layer. The parallel fibres provide 
excitatory input to these dendrites. Climbing fibres also provide excitatory input to the 
purkinje cells. Both fibre types extend to the deep cerebellar nuclei that regulate cerebellar 
output (Crossman and Neary, 2005). 
Four pairs of cerebellar nuclei are located within the white matter of the cerebellum; the 
fastigial, globose, emboliform and dentate nuclei. The dentate nucleus, the largest of the 
nuclei, was historically believed to project solely to the primary motor cortex of the 
cerebrum, however, recent studies have found that other portions of the nucleus also 
innervate occulomotor, prefrontal and posterior parietal areas (Dum and Strick, 2003).   
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2.5 Anatomy of the Fourth Ventricle  
The fourth ventricle is a broad, tent-shaped midline cavity, located between the cerebellum 
and the brainstem (Rhoton, 2000). The fourth ventricle, the lateral ventricle, the third 
ventricle and the cerebral aqueduct comprises the ventricular system (Crossman and Neary, 
2005). It is located ventral to the cerebellum, dorsal to the pons and medulla and medial to 
the cerebellar peduncles (Rhoton, 2000). Several of the cranial nerves are located within the 
floor of the fourth ventricle. The main function of the fourth ventricle is in the production 
and transport of cerebrospinal fluid (CSF). Communication via the fourth ventricle with the 
subarachnoid space, allows for the flow of CSF from the ventricular system to provide a 
protective cushioning of CSF around the brain (Crossman and Neary, 2005). The complex 
regulation of CSF flow within the brain can become compromised due to the presence of 
mass lesions, including tumours (Fukuda et al., 2014).  
Within the posterior fossa, tumours and the associated oedema, can obstruct the fourth 
ventricle (Schmid and Seiler, 1986), resulting in hydrocephalus due to obstruction of the CSF 
pathways or its absorption (Rangel-Castilla et al., 2008). As a result, uncompensated 
increases in intra-cranial volume can result in elevated intra-cranial pressure (ICP), with the 
potential risk of brain herniation (El Ahmadieh et al., 2013). Hydrocephalus has been 
defined as “an active distension of the ventricular system of the brain resulting from 
inadequate passage of CSF from its point of production within the cerebral ventricles, to its 
point of absorption into the systemic circulation" (Rekate, 2008). Hydrocephalus resulting 
from the presence of a tumour or alternative mass lesion is referred to as obstructive 
hydrocephalus. Management of this form of hydrocephalus requires treatment of the 
underlying mass lesion, with the potential of supplementary CSF surgical management 
techniques such as shunting, being required (Rangel-Castilla et al., 2008). 
2.6 Anatomy of the Brainstem  
The brainstem is composed of the medulla oblongata, pons and midbrain. It is directly 
connected to the cerebellum, is continuous caudally with the spinal cord and rostorally the 
midbrain is continuous with the diencephalon of the forebrain (Crossman and Neary, 2005). 
Ascending and descending pathways involved in the transmission of sensory and motor 
signals within the CNS are located within the brainstem (Shumway-Cook and Woollacott, 
2007).  One of the main descending pathways is the motor pathway, composed of the 
26 
 
corticospinal and corticobulbar tracts which control voluntary skeletal muscle activity of the 
body and face. The somato-sensory afferent pathways of the brainstem conduct sensations 
of pain, temperature, proprioception and touch and are continual with the spinal cord in the 
medulla (Angeles Fernandez-Gil et al., 2010). Cranial nerve nuclei three to twelve are 
located within the brainstem and are involved in significant body functions including sleep, 
arousal, sensation and swallowing (Crossman and Neary, 2005). 
2.7 Pathophysiology of Posterior Fossa Tumours 
Several subtypes of brain tumour can occur within the posterior fossa but similarly to 
cortical brain tumours, all rely heavily on the involvement of blood vessels for survival and 
growth. Blood supply to the tumour can be provided by the pre-existing vasculature of the 
invaded cerebral tissue and also by the process of angiogenesis (Vaupel et al., 1989).  
Angiogenesis is the process of new vessel development and tumour growth is believed to be 
dependent on this process (Wu, 1996). Normal brain vasculature is highly specialised and 
the blood brain barrier (BBB) restricts movement between the intracerebral and 
extracerebral circulatory systems (Jain et al., 2007). Pathology, secondary to the presence of 
a brain tumour, leads to increased vascular permeability of the BBB, causing both structural 
and functional compromise of the BBB (Jain et al., 2007). Vascular endothelial growth factor 
A (VEGFA), a platelet derived growth factor, is highly expressed by tumour cells and 
contributes to the compromise of the BBB by inducing permeability and angiogenesis. This 
permeability of the BBB can result in the formation of vasogenic oedema, due to altered 
restriction on movement across the barrier. This process is frequently observed in brain 
tumours. Formation of vasogenic oedema is strongly associated with high grade, aggressive 
tumours but also occurs in more benign histologies, such as meningiomas (Papadopoulos et 
al., 2004). 
2.8 Posterior Fossa Tumours  
2.8.1 Metastases 
In the adult population, brain metastases are the most frequently occurring intracranial 
tumour as well as the most frequently occurring posterior fossa tumour. Autopsy studies 
have identified, 20-40% of individuals who develop metastatic disease will have a lesion 
metastasise to the brain (Weil et al., 2005). Within the brain, 80% of the metastatic lesions 
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occur within the cerebral hemispheres, 15% in the cerebellum and 5% within the brainstem 
(Buckner et al., 2007).  The most frequently diagnosed primary tumour sites that 
metastasise to the brain are lung and breast cancer (Lassman and DeAngelis, 2003).  
Irish data published in the National Cancer Control Programme (NCCP) Annual Report 2012, 
highlighted 77 adult cases of brain metastases requiring surgical intervention across the two 
neurosurgical centres in the Republic of Ireland - Beaumont Hospital and Cork University 
Hospital, in 2012. This equates to 13% of the gross number of surgical interventions for 
brain tumour conducted in Ireland in 2012. The report outlined 25 of the cases had a 
primary originating in the lung (25/77; 32%) and 16 primaries originating in the breast 
(16/77; 21%), mirroring international trends. 
2.8.2 Haemangioblastoma 
CNS haemangioblastomas, are benign vascular tumours occurring most frequently in adults, 
accounting for 2% of intracranial tumours and 7% - 10% of posterior fossa tumours (Wan et 
al., 2011). This tumour type may have of solid or cystic structure, which plays a role in 
determining the activity of the tumour (Tomasello and La Torre, 2014). 
Haemangioblastomas can occur as a solitary lesion, however approximately 20%-30% of 
tumour occurrences are associated with Von Hippel-Lindau (VHL) syndrome (Neumann et 
al., 1989). VHL disease is a familial syndrome, associated with the presence of vascular 
lesions in various organs, including haemangioblastomas of the retina and CNS, renal cell 
carcinomas and cysts, pancreatic tumours and cysts, endolymphatic sac tumours and 
phaeochromocytomas (Richard et al., 2004). VHL disease is believed to account for 
approximately one third of patients with a CNS haemangioblastoma (Maher et al., 2011).  
In 2012, the NCCP annual report highlighted ten adult cases of intra-cerebral 
haemangioblastoma requiring surgical intervention in 2012. This indicates 1.5% of the total 
number of brain surgeries in the Irish republic in 2012, being due to the presence of a 
haemangioblastoma.  
2.8.3 Meningiomas  
Meningiomas are benign neoplastic lesions which account for approximately 20% of all 
intracranial tumours (Velho et al., 2012), with approximately 9-10% developing in the 
posterior cranial fossa (Roberti et al., 2001). Within the posterior fossa there are several 
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locations associated with meningioma occurrence including cerebellar convexity, tentorial, 
cerebellopontine angle, jugular foramen, petroclival, peritorcula, and foramen magnum 
(Jung et al., 2014). This tumour type arises from the arachnoid granulations and is closely 
related to the venous sinuses, with the tendency to compress brain tissue rather than 
invade it (Lindsay and Bone, 2004). 
The 2012 NCCP Annual Report summarised 86 surgical interventions conducted between 
Beaumont Hospital and Cork University Hospital, were due to the presence of a cerebral 
meningioma. This equates to 14% of all cerebral surgical interventions in 2012, in the 
Republic of Ireland.  
2.8.4 Paediatric posterior fossa tumours  
Significant variations exist in the tumour profile of lesions occurring in the posterior fossae 
of children when compared with that of adults. Medullablastoma is a commonly occurring 
paediatric brain tumour that arises from cerebellar tissue and accounts for approximately 
25% of all childhood brain tumours (Kumar et al., 2015). They are classified as primitive 
neuroectodermal tumours (PNET) and account for only 1% of all adult CNS tumours 
(Brandes and Franceschi, 2014). In paediatric cases, the tumour most commonly occurs in 
the vermis of the cerebellum but tends to originate in the cerebellar hemispheres of adults. 
Variations also exist in the mean survival rates between age groups, with the 15 year mean 
survival rate in children being 53% and in adults 43% (Smoll, 2012). Astrocytomas arising 
within the posterior fossa also occur more frequently in paediatric cases, with an associated 
expected benign course following surgical resection and a 10-year survival rate of more than 
95% (Burkhard et al., 2003). In an Irish series consisting of 79 paediatric posterior fossa 
tumour patients, 41% of the population were diagnosed with pilocytic astrocytomas and 
32% with PNET (O'Brien et al., 2001).  In an international review of the incidence and 
survival of individuals diagnosed with an astrocytoma over a fourteen year period, the age 
profile identified 38% of the study population were paediatric cases, 22% adolescents and 
40% adults (Burkhard et al., 2003). The cerebellum was the most frequent site of growth in 
children (67%), with adults displaying no significant variations between supra and infra-
tentorial location for the occurrence of astrocytomas. 
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2.9 Management techniques of posterior fossa tumours   
Management of lesions in the posterior fossa requires timely intervention due to the 
compact nature of this area of the brain and the associated risk of brainstem compression 
(Bullock et al., 2006). Raised intracranial pressure (ICP) can be of primary or secondary 
origin. Tumours, traumatic bleeds, non-traumatic haemorrhage and hydrocephalus are 
classified as primary causes of raised ICP with hypoxia, hypertension and seizures classified 
as secondary causes (Rangel-Castilla et al., 2008). In a cohort of posterior fossa trauma 
patients, reduction of intracranial pressure and the potentially associated mass effect on the 
fourth ventricle was identified as the primary goal of management (Nixon et al., 2014). 
2.9.1 Steroids   
Clinical use of steroids in individuals with primary or secondary tumours of the central 
nervous system is well documented, for their role in management of peri-tumoral oedema. 
Research has shown that between 70–100% of patients with intrinsic brain tumours will 
have steroids as an independent modality or in conjunction with cytotoxic therapy during 
the course of their treatment (Hempen et al., 2002). Brain oedema is believed to be caused 
by an expansion of brain volume due to an increase in water and sodium content (Kaal and 
Vecht, 2004). Vasogenic oedema is the most commonly occurring type of cerebral oedema 
in this population and results due to disruption of the BBB which allows fluids to leak from 
the blood into the brain parenchyma (Dubois et al., 2014). Research has shown oedema to 
accumulate around brain tumours at a rate of 14 to 78 ml/day (Kaal and Vecht, 2004). The 
role of corticosteroids has been shown to influence this alteration in permeability by 
influencing the rate of permeability across the membrane, with noted radiological changes 
in oedema levels (Andersen et al., 1994).  
Dexamethasone is the most commonly employed corticosteroid agent in the management 
of tumour related cerebral oedema (Ryan et al., 2012). It is approximately six times more 
potent than prednisone and takes full effect within the body between 24 to 72 hours (Ryan 
et al., 2012). It functions by blocking inflammatory pathways, by acting on glucocorticoid 
receptors which reduce vessel permeability of tumour capillaries and increase extracellular 
fluid clearance (Fan et al., 2014). While it is the steroid of choice in the management of this 
population, it is associated with both positive and negative side effects. In a retrospective 
review of dexamethasone dosages and side effects associated with its administration, 
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Hempen (Hempen et al., 2002) investigated its role in the management of neurological 
consequences of primary and secondary brain tumours and its role in the management of 
associated treatment sequelae. Dexamethasone was found to effectively reduce the 
associated neurological side effects of primary and secondary brain tumours and the 
symptoms of radiation therapy. Dexamethasone also plays an essential role in the reduction 
of mass effect, associated with peri-tumoral oedema (Roth et al., 2010). As previously 
outlined, the anatomy of the posterior fossa restricts volume increases with the associated 
risk of compression on the cerebellum and brainstem, with increasing oedema. Mass effect 
in this area of the brain could result in herniation through the foramen magnum with 
associated death (Gurol and St Louis., 2008). Thus the role of steroids in individuals with a 
posterior fossa tumour could have a life-saving role. Negative consequences associated with 
steroid use includes steroid induced diabetes (Roth et al., 2010), myopathy (Owczarek et al., 
2005) and psychiatric consequences (Ross and Cetas, 2012). While the increased risk of 
fracture in the general medical population is believed to be between 50 – 100% with oral 
corticosteroid use, the associated impact with dexamethasone administration in brain 
tumour patients has not been established (Ryan et al., 2012).   
2.9.2 Radiotherapy  
Radiation therapy is a treatment approach utilised in the management of individuals with 
high grade tumours. Radiation energy works by producing ions in the cells of the tissue 
which it passes through and subsequently disrupts the molecular structure of the cells. The 
formation of free radicals leads to the breakdown of tissue, including tumour cells (Kirthi 
Koushik et al., 2013). Radiation therapy can be used as an independent treatment modality 
or in conjunction with surgery and/or chemotherapy, referred to as adjuvant therapy.  
Optimal timing for the commencement of treatment is believed to be two to three weeks 
post-operatively, to allow fibroblastic proliferation and healing of the surgical wound. A 
delay of greater than eight weeks in commencement of radiation can significantly reduce its 
effectiveness due to the tumour cells ability to repopulate within this timeframe (Kirthi 
Koushik et al., 2013).  
Radiation therapy often employed in the management of brain tumours, has been shown to 
cause several side effects including headache, drowsiness, fever, vomiting and worsening 
neurological side effects (Soussain et al., 2009). While these symptoms may occur acutely 
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during delivery of the radiation therapy, delayed deficits associated with the development 
of radiation necrosis can also be observed. Risk of development of radiation induced 
necrosis is highest in the first two years but the threat of development of this complication 
can persist for several years, even decades (Ruben et al., 2006). Radiation necrosis has the 
ability to produce similar side effects and deficits to that of tumour tissue and poses 
difficulty for surgeons in differentiating the tissue type, as these tissues can appear similar 
on MRI scan and in clinical presentation. Irradiated patients have also been shown to have a 
seven fold increased risk of developing a secondary tumour within the margins of the 
radiation treatment zone. Meningiomas are the most frequently occurring post radiation 
tumour, accounting for 70% of radiation induced tumours (Kleinschmidt-Demasters et al., 
2006). 
2.9.3 Chemotherapy 
The role of chemotherapy in the treatment of brain tumours is limited to chemotherapeutic 
agents that have the ability to infiltrate the BBB.  As previously discussed, higher grade brain 
tumours result in the destruction of cells involved in the maintenance of the integrity of the 
BBB, highlighting the role of chemotherapy in the management of high grade brain tumours. 
Chemotherapy can be administered as an independent treatment modality, however it is 
routinely administered post-surgical excision or in conjunction with radiotherapy as a 
concomitant treatment approach (Salmaggi et al., 2011). Temozolomide, a second-
generation alkylating oral chemotherapeutic agent, has demonstrated the ability to cross 
the BBB and achieve CSF concentrations of approximately 30% of plasma concentrations in 
animal and human models (Ebert et al., 2003). In a pioneering study that investigated the 
combined treatment approach of radiotherapy and Temozolomide, in newly diagnosed 
Glioblastoma Multiforme (GBM) patients, a median increase in survival of 2.5 months or a 
relative reduction in the risk of death of 37 %, was identified (Stupp et al., 2005). This 
regimen, The Stupp Protocol, is now an internationally administered treatment approach in 
the management of high grade gliomas.  
While the role of chemotherapy in high grade primary brain tumours such as GBM has been 
established, its role in the management of posterior fossa tumours may be limited, as GBM 
tumours have been shown to be much less likely to occur in the posterior fossa when 
compared with the cerebrum (Chakrabarti et al., 2005).  
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2.9.4 Surgery  
The most effective treatment option in the management of elevated ICP is the surgical 
removal of the underlying space occupying lesion (El Ahmadieh et al., 2013). Two frequently 
utilised surgical procedures to expose and access a posterior fossa lesion include a 
craniectomy (complete removal of the bone) or craniotomy (bone flap fixation) (Legnani et 
al., 2013). Historically, craniectomy was the most frequently utilised surgical technique 
giving excellent exposure, however, it resulted in the cerebellum and dura being protected 
by muscle and scalp alone (Bucy, 1966). Craniotomy, due to the replacement of the bone-
flap post surgery, has been shown to provide increased protection of the posterior fossa, 
with a reduced complication rate (Gnanalingham et al., 2002).  Legnani et al (2013) 
retrospectively analysed 152 consecutive patients admitted to a neurosurgical centre, over a 
three year period, who underwent a craniotomy or craniectomy procedure, due to the 
presence of a posterior fossa tumour. One hundred patients underwent a craniotomy (66%), 
while 52 patients underwent a craniectomy (34%). Results of post-operative complication 
rates, related to the surgical technique, was 7% for the craniotomy group and 32.6 % for the 
craniectomy group (<0.0001), indicating a statistically significant reduced rate of surgical 
complication, related to craniotomy when compared with craniectomy. The post-operative 
complications identified in the whole sample included pseudomeningocele (an abnormal 
collection of CSF), CSF leak, wound infection and hydrocephalus. The integrity of the dura 
mater was identified as a key component in determining the success of the surgery, as 50% 
of the patients who did not have a complete dural closure post-operatively, developed 
issues with CSF flow and development of fluid collections. Other researchers have identified 
similar surgical complications in those undergoing surgery of the posterior fossa (Dubey et 
al., 2009) with CSF leaks, meningitis, wound infection, hydrocephalus and cerebellar 
haematoma being identified as the associated risks. 
While several surgical complications can be associated with a neurosurgical intervention to 
this aspect of the brain, even successful surgery carries significant risk. The characteristics of 
the tumour, exact location of the surgery and skill of the surgeon, all influence the outcome 
of the patient.  The compact nature of the posterior fossa and the complexity of the 
cerebellum in the control and regulation of movement, places risk on the patient in relation 
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to the execution and modulation of skilled movements as demonstrated in gait and upper 
limb activities.    
2.10 Clinical Presentation  
Clinical deficits associated with the presence of a brain tumour are resultant from the focal 
disruption of the lesion itself, associated increase in intra-cranial pressure and surgical 
techniques employed in managing the tumour. This is particularly relevant in the posterior 
fossa, due to the limited capacity for tissue adaption due to restricted space and the rigidity 
of the cranium. The presence of the cerebellum, brainstem and fourth ventricle within the 
posterior fossa, give rise to associated dysfunction when compromised. Ataxia is a very 
common feature observed in individuals with dysfunction of the posterior fossa. 
Involvement of the cerebellum or its input and output pathways, can result in ataxia of 
voluntary limb movement or gait, which can lead to high amplitude tremors associated with 
ataxic movement (Bastian, 1997). Cerebellar gait ataxia has typical features including 
increased step width, variability of foot placement, irregular foot trajectories resulting in a 
stumbling walking path with very high movement variability and, an associated increased 
falls risk (Ilg and Timmann, 2013). Postural instability with associated antero-posterior (AP) 
sway, postural tremor and increased intersegmental movements of the head, trunk and 
legs, contributes to the characteristic patterns identifiable in this population of patients 
(Morton and Bastian, 2007). Increased reaction time and an associated reduced speed in 
execution of tasks, is also characteristic of this population. Deficits of multi-joint 
movements, called dyssynergia, manifests in movements with associated prolonged 
duration, decreased maximal velocity and an increase in spatial variability, resulting in 
variability between trials (Marsden and Harris, 2011). Emerging evidence has also 
highlighted the role of the cerebellum in working memory, implicit and explicit learning and 
language, indicating the potential for higher level deficits with the capacity to influence 
rehabilitation and new skill acquisition (Desmond and Fiez, 1998). In conjunction with the 
cerebellum, the brainstem also has the capacity to impact on motor control due to its role 
as a junction for several of the main ascending and descending pathways of the brain 
(Angeles Fernandez-Gil et al., 2010). 
While the anatomical structures of the posterior fossa are heavily involved in movement 
and control of movement sequencing within the body, minor shifts in volume within this 
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area, can result in mortality due to altered CSF flow, compression of eloquent tissues and 
distortion of brainstem structures. In the clinical and rehabilitation setting, the patient with 
a posterior fossa tumour may never be well enough to engage in treatment for their 
movement deficits, due to the risk of  mortality associated with tumours of this region of 
the brain (Jung et al., 2014). 
2.11 Conclusion  
This chapter of the thesis has reviewed the global and national data on cancer and brain 
tumours, outlined anatomy of the posterior fossa and its cerebral components and 
reviewed medical and surgical management techniques utilised in the treatment of this 
tumour type. In chapter three of the thesis, rehabilitation in cancer, with particular 
emphasis on rehabilitation of patients with deficits secondary to posterior fossa lesions, will 
be explored. 
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Chapter 3: Rehabilitation in the Management of Brain Tumour Patients  
3.1 Introduction  
Chapter three of this thesis aims to provide a comprehensive overview of the role of 
rehabilitation in the management of cancer patients, with particular focus on the role of 
rehabilitation in those with brain tumours. This chapter also provides a detailed outline of a 
systematic review that was completed over a two year period, as part of the Master’s 
programme, systematically reviewing the entire catalogue of available literature on 
rehabilitation practices in the management of individuals with tumours of the posterior 
fossa.  
3.2 Brain Tumours  
Tumours of the cerebrum are complex and diverse pathological anomalies that include 
primary neoplasms, that arise from normal cellular constituents and embryologically 
displaced tissues and brain metastases, which derive from a distantly located malignant 
cancer site (Giordana and Clara, 2006). Given the increasing incidence of brain tumours (BT), 
the complexity of their management , the chronic and progressive nature of symptoms and 
an ageing population, increasing attention needs to be focussed on this patient cohort to 
optimise management (Gamble et al., 2011). Historically, diagnosis of a brain tumour was 
generally associated with a terminal outcome, however, continuing advances in cancer 
therapies and increased survival, has resulted in cancer management adopting a profile of 
chronic disease (von Eschenbach, 2004). Brain tumour patients are now living longer with 
deficits associated with the tumour and the cancer treatments employed in its management 
(Loescher et al., 1989).  
In a review of surgical approaches in the management of a single brain metastases, 
complication rates associated with an “en bloc” versus “piecemeal” excision approach was 
investigated (Patel et al., 2015). A higher rate of associated side-effects was noted in the 
“piecemeal” excision approach (19%), however, both surgical approaches resulted in a 
variety of side-effects including neurological deficits, deep vein thrombosis, infections and 
haemorrhages. Radiation therapy, often employed in the management of brain tumours, 
has been shown to cause several side effects including headache, drowsiness, fever, 
vomiting and worsening neurological side effects (Soussain et al., 2009). Given the 
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symptoms associated with a brain tumour and the potential for development of treatment 
associated side-effects, a shift towards comprehensive rehabilitation practices to manage 
this population has occurred over the previous 40 years.  
3.3 Introduction to Rehabilitation  
Rehabilitation has been defined as “a problem-solving educational process aimed at 
reducing disability and handicap experienced by someone as a result of disease or injury” 
(Wade, 1992). The role of rehabilitation as a vital component of treatment, to assist 
functional recovery within certain neurological populations is well established (Taylor et al., 
2014, Rose, 1999). In neuro-oncology patients, the neurological deficits combined with 
uncertainty and fear of a cancer diagnosis, creates a more challenging presentation to 
manage.   
3.4 Cancer Rehabilitation  
Cancer rehabilitation is considered to be a relatively new sub-speciality within the 
rehabilitation field, which should be incorporated into routine care of all cancer patients 
(Ganz, 1990). The earliest research available that explored rehabilitating cancer patients was 
undertaken by rehabilitation specialists, who hypothesised that the application of pre-
existing rehabilitation principles to cancer sufferers should provide similar benefits as non-
cancer patients, with similar deficits (Dietz, 1969, Rusk, 1964). Considered the forefathers of 
oncology rehabilitation, their pioneering research encouraged subsequent researchers to 
explore the potential positive impact rehabilitation could have on the outcomes of this 
population of patients. An early definition of cancer rehabilitation put forward by Dietz 
(1981), introduced this rehabilitation concept under four subheadings including; 
preventative, restorative, supportive and palliative. These four subheadings aimed to 
provide the appropriate level of rehabilitation input required by patients at the varying 
stages of the disease process. The terminology defining cancer rehabilitation has continued 
to evolve since Dietz original work. Dudas (1984) defined cancer rehabilitation as “a dynamic 
process directed toward the goal of enabling persons to function at maximum levels, in all 
life spheres, within the limits imposed by the disease”, while Mayer and Connor (1989) 
recognised the importance of rehabilitating “individuals within their environments”, to 
maximise rehabilitation gains.  Modern definitions have aimed to adopt a rehabilitation 
37 
 
philosophy that is holistic in approach and incorporates the diverse skill and knowledge of 
the multidisciplinary team (Cheville, 2005).  
 Comparable improvements in rehabilitation outcomes have been noted between varying 
oncology populations. In a retrospective review of 159 inpatients in a rehabilitation facility, 
comparable functional gains were made across diverse oncology populations, including 
diagnosis of primary brain tumour, breast cancer, spinal tumour and a category called 
“other”, which incorporated any other cancer patient who met the desired inclusion criteria 
and had to be grouped into a subgroup, for analysis (Marciniak et al., 1996). This study also 
revealed that the presence of metastatic disease or concurrent radiation therapy, during the 
course of rehabilitation, did not negatively impact on the degree of functional improvement. 
Another study (Cole et al., 2000) looked at the functional gains across nine cancer subgroups 
and found results comparable with that of Marciniak et al (1996). These results highlight the 
potential for all cancer patients, with cancer associated deficits, to benefit from a period of 
rehabilitation, regardless of tumour location or subtype, including brain tumours of primary 
or secondary origin.    
3.5 Brain Tumour Rehabilitation  
Although increasing advances in the management of brain tumour patients are occurring 
every year, a survey conducted in the United States revealed that 50% of rehabilitation 
hospitals treat a maximum of ten brain tumour patients per year (Boake and Meyers, 1993). 
Throughout the literature, comparisons have been drawn between rehabilitation of brain 
tumour patients and other neurological conditions. Researchers have shown that brain 
tumour patients possess the potential for comparable functional gains and outcomes (Tay et 
al., 2009). Within this population, coping with the psychological impact, reduced income 
and socioeconomic implications, increased demand for health care, social and vocational 
services, and caregiver burden (Tang et al., 2008), as well as considering decisions regarding 
cancer therapies, all place extra stresses on the BT patient (Cheville, 2001). Cognitive 
impairment has been highlighted as one of the most frequently occurring deficits in this 
population, with limb weakness, the second most frequently occurring consequences of a 
brain tumour (Marciniak et al., 1996, Mukand et al., 2001). O Dell et al (1998) 
retrospectively reviewed all brain tumour patients admitted to a rehabilitation centre over a 
30 month time period. Forty patients, with varying tumour type, were included and 
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matched with Traumatic Brain Injury (TBI) patients of similar age, Functional Independence 
Measure score (FIM) and gender. The researchers found that within the brain tumour 
group, more favourable outcome was directly linked to diagnosis of a meningioma or a left 
sided lesion, without receiving concomitant radiation therapy. When compared to TBI 
patients, FIM scores were statistically significant for two of the subsections of the form but 
these benefits were not significant when variances in length of stay were adjusted for. The 
literature has shown that with similar deficits, brain tumour participants tend to be 
discharged home quicker than TBI participants. This is believed to be linked to the potential 
terminal diagnosis that these patients may have, which encourages optimally facilitated 
discharges. In a similar study (Huang et al., 2000), a group of brain tumour patients and TBI 
patients were matched on the basis of age and side of lesion. This study revealed similar 
results in FIM scores, at admission and discharge and overall function was comparable 
between the groups. This study also demonstrated a reduced length of stay in the brain 
tumour population. Comparison of outcome with stroke has also been investigated (Huang 
et al., 1998). This study found similar levels of improvement between the two groups on the 
overall FIM score and when subdivided into certain components including the mobility, 
Activities of Daily Living (ADLs) and cognition elements of the measure. A significant 
difference was noted on comparison of the length of stay, both in the acute setting and in 
rehabilitation environments. This finding is similar to that already noted in the comparisons 
between TBI and BT outcomes. Similar treatment approaches in the management of TBI and 
BT patients have shown maintained benefits in BT patients for an average of eight months 
(Sherer et al., 1997). Focus on the physical consequences of brain tumours remains of 
paramount importance to the recovery of this population, however, associated  concerns 
and anxieties (relationship, employment, tumour recurrence) cannot be underemphasized 
(Ownsworth et al., 2009). 
3.6 Multidisciplinary (MDT) role in neuro-oncology rehabilitation  
The complexity of rehabilitation needs in neuro-oncology patients has highlighted the 
importance of collaborative and cohesive multi-disciplinary approaches to management. 
The World Health Organisation (WHO) defines MDT rehab as “coordinated delivery of 
multidimensional rehabilitation intervention provided by two or more disciplines, in 
conjunction with medical professionals, which aims to improve patient symptoms, and 
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maximise functional independence and participation (social integration) using a holistic 
biopsychosocial model of care, as defined by the International Classification of Functioning, 
Disability and Health (ICF)” (Stucki et al., 2003). A lack of research is available investigating 
the role of the MDT in brain tumour management when compared with alternative 
neurological populations (Khan et al., 2007, Turner-Stokes et al., 2005, Stucki et al., 2003, 
Monaghan et al., 2005). As previously outlined, this population of patients demonstrate a 
complex range of bio-psychosocial difficulties that would benefit from an MDT approach to 
management and care. While the importance of the role of the medical and surgical MDT 
has long been established in brain tumour care pathways (Landonio, 2005), the role of allied 
health care professionals in management of this population has had limited investigation. In 
a recent Cochrane Review of the literature, Khan et al (2013) investigated multidisciplinary 
rehabilitation practices post treatment, for a primary brain tumour. No randomised or case 
controlled trials were identified by a systematic review of the literature and this Cochrane 
collaboration is based on the results of twelve observational studies. The quality of the 
available evidence limited the conclusions that could be extrapolated but the authors 
concluded that the poor quality of available evidence does not distract from the need for 
multidisciplinary involvement but further high quality research is required to identify the 
merits of this intervention.  Although the quality of included evidence was poor the 
investment of resources in conducting a Cochrane review on this topic, highlights the 
increasing awareness and need of quality evidence in this field.   
3.7 Rehabilitation of posterior fossa tumour patients  
The role of rehabilitation in the management of cancer patients has been clearly 
demonstrated to date.  Research has highlighted the benefits to be gained from 
rehabilitation regardless of the location of the cancer or the WHO grade (Louis et al., 2007). 
The WHO classification system is the internationally accepted system of brain tumour 
classification, based on the tumour’s histological components. Unfortunately, extreme care 
must be considered when dealing with tumours of the central nervous system due to the 
complex and delicate nature of the involved brain tissue. Several factors including the space 
occupying lesion (Nakaya et al., 2010), associated vasogenic oedema (Gurol and St Louis, 
2008), surgical compromise (Jahangiri et al., 2012) and hydrocephalus (Goel, 2002) can 
compromise the tissues of the brain and spinal cord. The posterior cranial fossa is an area of 
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the skull that is located between the foramen magnum and tentorium cerebelli and houses 
the highly complex cerebellum, brainstem and fourth ventricle (Levin, 2002). The rigid 
nature of the cranium means the presence or expansion of a mass in this area of the brain 
can potentially cause compromise to the brainstem and cerebellum with the possibility of 
fourth ventricle blockage causing hydrocephalus (Levin, 2002). Dysfunction of the 
cerebellum can result in reduced co-ordination, manual dexterity compromise as well as gait 
and balance dysfunction. An ataxic gait pattern is often characteristic of cerebellar 
compromise and features include reduced gait speed and cadence (Palliyath et al., 1998), 
increased step width (Ilg et al., 2007) and abnormal inter-joint coordination (Morton and 
Bastian, 2003). A close interaction has been revealed between altered balance and ataxia in 
individuals with cerebellar compromise (Marquer et al., 2014). The brainstem contains 
several nuclei involved in essential processes including the vestibular, red and reticular 
nuclei, which play a role in postural control, locomotion, arousal and awareness (Shumway-
Cook and Woollacott, 2007). The floor of the fourth ventricle is formed by the brainstem 
and its lateral wall and roof formed by the cerebellum, indicating dysfunction to one of 
these structures can cause a negative impact on all (Su and Young, 2011).  
As previously identified, there has been increasing attention towards the rehabilitation of 
brain tumour sufferers, however there is a significant dearth in the volume of research that 
has specifically investigated the rehabilitation of individuals with a tumour occurring in the 
posterior fossa. Nine studies were included in a systematic review that reviewed 
rehabilitation in the management of individuals with cerebellar dysfunction (Martin et al., 
2009). This review included a cohort with varying primary diagnosis, including Multiple 
Sclerosis (MS), Traumatic Brain Injury (TBI), BTs and hereditary ataxia. To treat the 
commonly occurring deficits noted in individuals with cerebellar compromise, balance and 
gait training (Marsden and Harris, 2011), Frenkel’s exercise (Armutlu et al., 2001), vestibular 
habituation exercises (Brown et al., 2006) and proprioceptive neuromuscular facilitation 
(Perlmutter and Gregory, 2003) were identified as the commonly adopted rehabilitation 
approaches utilised. Reproduction of the programmes would remain difficult due to poorly 
documented specifics of exercise prescription and progression.  
Despite the availability of research investigating rehabilitation of the symptoms associated 
with involvement of the posterior fossa, a review has not previously been undertaken that 
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has investigated the role of rehabilitation in individuals with the sole diagnosis of a tumour 
of the posterior fossa.  
3.8 Systematic Review  
3.8.1 Introduction  
A systematic review was undertaken with the aim of investigating the rehabilitation 
techniques employed by rehabilitation therapists (Physiotherapist or Occupational 
Therapist), in the management of impairments, activity limitations or deficits in 
participation, in individuals with tumours of the posterior fossa. The following section 
details the methodology, analysis and results of the systematic review. The findings of the 
systematic review are also discussed in relation to the current and future status of 
rehabilitation, in this population of patients.  
3.8.2 Methodology 
To ensure this systematic review was conducted in a comprehensive and systematic fashion, 
the MOOSE (Meta-analysis Of Observational Studies in Epidemiology) standardised 
reporting guidelines were followed to conduct and report the findings (Stroup et al., 2000). 
In June 2013, a comprehensive search of the literature was conducted and included the 
search engines Pubmed, The Cochrane Library, Embase, Ebsco Host and Sciverse. A 
comprehensive search string was established that included the search terms, “cerebellar 
neoplasm”, “posterior fossa tumour”,  “brainstem neoplasm”, “infra-tentorial neoplasm”,  
“tumour”, “balance”, “gait”, “physical therapy” and “neurologic gait disorders”. A copy of 
the full search string is included as appendix one and two. The reference lists for all the 
identified articles were searched for any further potential articles for inclusion. The search 
did not restrict article inclusion based on year of publication or non-English language 
publication. To ensure the systematic review remained current, the original search-string 
was reanalysed in April 2015, adhering to the same search criteria, to ensure any newly 
available research on the topic of rehabilitation in posterior fossa patients, was identified 
and included in this systematic review. No new appropriate studies were identified on the 
supplementary searching, for inclusion in the review.  
A set of inclusion criteria was established to identify relevant and eligible articles for 
inclusion. The inclusion criteria included: (1) All study designs (2) The study population was 
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that of an adult or paediatric population who had undergone a surgical intervention, due to 
the presence of a tumour in the cerebellum, brainstem or fourth ventricle (posterior fossa). 
Inclusion of paediatric participants in the systematic review is in contrast with the age 
related inclusion criteria of the prospective study. Inclusion of paediatric studies in the 
systematic review ensured all potential rehabilitation and treatment approaches pertaining 
to the posterior fossa were included in the review, ensuring a comprehensive and complete 
review of rehabilitation for the posterior fossa. (3) Studies that had utilised a rehabilitation 
programme conducted by a physiotherapist or occupational therapist, for the treatment of 
balance, gait, upper limb dexterity or dizziness deficits. Outcomes of interest were those at 
the level of impairment, activity limitation or participation restriction. (4) Posterior fossa 
tumours that did not originally originate in the internal auditory meatus. This is a common 
site of origin of vestibular schwannomas and their management and clinical course differs 
significantly, to tumours originating within the posterior fossa itself. Previous literature has 
classified posterior fossa tumours in a similar fashion (Karakaya et al., 2000). 
On identification of potentially suitable articles for inclusion, the researcher read the titles 
and/or abstracts of the identified references to determine those which met the inclusion 
criteria. All references of studies deemed irrelevant were eliminated. Studies that were 
considered to be relevant, based on this process, were read in duplicate by two 
independent reviewers (KM and RG). Any disagreement that was encountered was 
managed by consensus. A process of data extraction was undertaken, that gathered 
information from the appropriate studies including study type and setting, patient 
demographics including age and sex, clinical characteristics including tumour location, 
timeframe since surgery, rehabilitation interventions based on the FITT (frequency, 
intensity, time and type) principles, outcome measures utilised in the studies, number of 
interventions and follow-up period.  
On completion of a systematic search of the literature, the only identified studies that 
complied with the inclusion criteria were case series, and as a result was the only study type 
included in this systematic review. To ensure best epidemiological practice, the CARE (case 
reports) checklist was used to critically appraise the selected articles for inclusion in the 
systematic review (Gagnier et al., 2013). A copy of this checklist, used to evaluate the quality 
of each study in the systematic review is available as appendix three to seven inclusive. Two 
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investigators (KM and RG) independently assessed and appraised the methodological quality 
of each included study. During the process two areas of disagreement occurred, when 
conducting the literature appraisal. The identified discrepancies occurred in relation to one 
article (Ada et al., 2009). The identified discrepancies pertained to the inclusion of relevant 
milestones within the article and reference to prognostic characteristics, where applicable 
within the article. These discrepancies were resolved by discussion.  
The study design of each of the included studies in this systematic review was case studies. 
Due to the clinical and methodological heterogeneity of the five included studies, a 
narrative review of the results is presented, due to an inability to conduct a meta-analysis. 
To ensure optimum standards in the conducting and presentation of the review, the 
Cochrane Handbook guidelines were followed (Higgins and Green, 2011). The narrative 
review of the results includes the number of participants within each study, duration of 
intervention, rehabilitation techniques utilised in the treatment of the participants, 
outcome measures used and follow-up timeframe. An assessment of the methodological 
quality of each study has been reported within the review, as well as a discussion of the 
limitations.  
3.8.3 Results   
A Prisma flow diagram is included as appendix eight, to give an accurate graphical 
presentation of the search strategy conducted in the identification of appropriate studies, 
for inclusion in the systematic review. The flow diagram of updated results obtained with 
the updated search in April 2015 is available as appendix nine. No supplementary, 
appropriate articles were identified on the updated search, for inclusion in the systematic 
review. 
 The search yielded 3,482 articles from five databases including Pubmed, The Cochrane 
Library, Embase, Ebsco Host and Sciverse. An additional five articles were identified for 
potential inclusion by hand searching reference lists. With removal of duplicates 3,276 
articles were available for consideration for inclusion. The titles or abstract was reviewed of 
the 3,276 articles to determine suitability and as a result 3,254 articles were subsequently 
excluded. The full text of the remaining 22 articles was read and as a result only five full text 
articles achieved the desired inclusion criteria and as a result were included in the 
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systematic review. Reasons for exclusion were tumours not specifically located in the 
posterior fossa and participants not receiving a period of rehabilitation.  
3.8.3.1 Study Characteristics  
A table depicting the characteristics of the five included studies is available as appendix ten. 
The study locations varied across the studies. Two studies were conducted in the United 
States (Gill-Body et al., 1997, Cremer, 1998), one in Australia (Ada et al., 2009), one in 
Canada (Betker et al., 2006) and one in Turkey (Karakaya et al., 2000). The size of the patient 
cohort ranged from a single participant (Ada et al., 2009) to 20 participants (Karakaya et al., 
2000), diagnosed with a tumour of the posterior fossa. The age profile of the study subjects 
also varied across the studies. A total of 52 participants were included in the studies but of 
these individuals only 24 met the inclusion criteria of being diagnosed with a tumour of the 
posterior fossa. Participants that did not meet inclusion criteria had varying diagnosis 
including cerebellopontine angle tumour (Karakaya et al., 2000), cerebrotendinous 
xanthomatosis (Gill-Body et al., 1997), stroke (Betker et al., 2006) and TBI (Betker et al., 
2006). Of the included studies, all lacked the inclusion of a comparison group. 
3.8.3.2 Study Quality  
The overall quality of the included studies, within the systematic review was poor. As only 
case studies were identified as satisfying the inclusion criteria, an immediate low level of 
epidemiological quality was assumed. In terms of the internal validity of the studies, 
infrequent reporting methods were used to obtain informed consent and a lack of 
consistency in the reporting of adverse outcomes and diagnostic challenges were evident in 
the majority of studies. A period of follow-up was documented as occurring in only one of 
the studies (Ada et al., 2009). A follow-up timeframe of two weeks was used in the study but 
this short observation period, while superior to no follow-up, prevented robust conclusions 
about the long term effectiveness of the rehabilitation techniques utilised in the 
management of deficits, as a result of a tumour of the posterior fossa.  
3.8.3.3 Rehabilitation Techniques  
Within the five included studies in the systematic review, all rehabilitation programmes 
were delivered by a physiotherapist/physical therapist. While the inclusion criteria 
considered rehabilitation programmes delivered by either the discipline of physiotherapy or 
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occupational therapy, no studies were identified in which a programme of occupational 
therapy was delivered to this cohort of patients, to treat the deficits associated with 
posterior fossa tumours.  
Within the included studies the rehabilitation programmes and the associated interventions 
were aimed at treating a range of impairments and activity limitations. A large degree of 
variation existed with regards to the rehabilitation programmes and variances in frequency, 
intensity, type and time-frames were common throughout the five studies.  
Ada et al (2009) investigated the ability to train upper limb dexterity in a five year old child, 
who had undergone a neurosurgical procedure for the excision of a large midline cerebellar 
tumour, three and an half years prior to being recruited for the study. At time of enrolment 
in the study, the participant had no upper limb weakness but experienced residual bilateral 
upper limb ataxia, the right being more severely affected. As a result the right upper limb 
was chosen as the limb of choice for involvement and investigation in the study. The 
treatment technique was a computer based programme using an electro-goniometer 
attached to the participants forearm to monitor elbow flexion and extension as she tracked 
movements of a pseudo-random target on the computer. The targets moved irregularly on 
the screen and at varying frequencies giving an element of unpredictability to the task. 
Twelve sessions of this treatment were provided in the participant’s home by a parent, who 
was also a physiotherapist. A maximum of ten, thirty second trials were completed during 
each treatment session, using varying frequencies. To optimise compliance of the 
participant, a standardised number of sweets were used as reinforcers, to encourage 
engagement with the programme, when she was not eager to engage. All sessions were 
conducted in the participant’s home in the late afternoon.  
Betker et al (2006) also used technology to deliver a rehabilitation programme focusing on 
the use of video games in the balance training of three participants. Each of the participants 
had a varying primary diagnosis including a twenty year old post cerebellar tumour excision, 
a 58 year old post a single right sided stroke and a 41 year old post closed TBI. Only the 
participant with cerebellar tumour will be discussed.  The video game focused on controlling 
centre of pressure through a virtual reality platform. Three games were developed to fulfil 
this aim, “Under pressure”, “Memory Match” and “Tic-Tac Toe”. All three games 
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encouraged anteroposterior and mediolateral movement with changes to the centre of 
pressure influencing ability to complete the virtual reality task. A previous pilot study that 
evaluated the merits of the video games provided positive feedback in relation to 
enjoyment, difficulty levels and usability (Betker et al., 2006).  The games provided varying 
challenges of speed, direction and range of movement, creating variable intensity based on 
the participant’s needs and abilities. Auditory and visual positive reinforcers were available 
in the system. The programme of rehabilitation provided to the participant consisted of 
eight, 45 minute sessions, delivered over a three week period.  
Gill-Body et al (1997) utilised a conventional programme of rehabilitation that focused on 
improving balance and mobility, to ultimately have a positive impact on functional ability. 
Two participants were included in the study. Participant one was a thirty six year old female, 
diagnosed with a recurrence of a midline cerebellar pilocytic astrocytoma. She underwent 
an initial excision of the tumour six years previously, with further surgery required due to 
recurrence of the same tumour. No change in the histology of the tumour was noted, 
however, she did require a month of radiation therapy. The associated balance and gait 
deficits that she experienced were only evident after the second follow-up surgery. The 
second patient was a forty eight year old male diagnosed with cerebrotendinous 
xanthomatosis (CTX), a rare autosomal recessive disorder of lipid metabolism but will not be 
discussed. The main deficits identified by the cerebellar tumour participant were dizziness, 
unsteadiness when mobilising, impaired upper limb coordination, left sided weakness and 
reduced balance. The treatment approach adopted included a gait and balance 
rehabilitation programme that incorporated gaze stabilisation exercises, to maximise 
stability by improving the patient’s ability to effectively utilise visual, vestibular and 
somatosensory inputs to compensate for the cerebellar deficits. Rehabilitation sessions 
were provided weekly, for six weeks and lasted between thirty and forty five minutes. 
Reassessment and progression of the programme was evaluated during these sessions. A 
home exercise programme was provided encouraging completion at least once a day. An 
exercise diary was compiled throughout the programme to monitor compliance.  
Karakaya et al (2000) implemented a programme of ten sessions of rehabilitation that was 
provided over a two week period, with patients receiving sessions five days a week. Forty 
participants were enrolled in the study, twenty individuals with tumours occurring in the 
47 
 
posterior fossa and twenty individuals with tumours migrating into the cerebello-pontine 
(CP) angle. This area of the posterior fossa is formed from the borders of the cerebellum and 
pons (Crossman and Neary, 2005) and tumours that invade this aspect of the posterior fossa 
tend to originate in the internal auditory meatus and invade the CP angle as they increase in 
size. This is the frequent growth pattern seen in vestibular schwannomas. Presentation and 
management of this tumour type differs significantly with tumours of the cerebellum, fourth 
ventricle or brainstem and as a result were not included in this systematic review. The 
participants of this study received individualised programmes based on presentation, 
making it difficult to appraise benefit due to the variance across participants.  
The paper by Cremer (1998), provided a narrative review of the experience of a fifteen year 
old male diagnosed with a medullablastoma requiring surgery, chemotherapy and 
radiotherapy. While the paper outlined that the subject received physiotherapy and 
occupational therapy during his hospital stay, no details of the utilised programmes were 
included in the study. The lack of detail prevented the ability to draw conclusions regarding 
the rehabilitation strategies that may have been used or the potential benefit associated 
with the chosen techniques.  
Four of the five included studies outlined details of the specific programmes provided to the 
patients (Ada et al., 2009, Betker et al., 2006, Gill-Body et al., 1997, Karakaya et al., 2000). 
Two studies lacked significant detail making reproducibility of the interventions difficult 
(Cremer, 1998, Karakaya et al., 2000).   
3.8.3.4 Outcome Measures  
Outcome measures are measurement tools used to document change over time in 
individuals to assist with programme evaluation, case management, quality improvements, 
cost containment and research (Wedge et al., 2012). Comprehensive use of appropriate, 
valid and reliable outcome measures, assists with ensuring high quality research is 
conducted. Within the studies in this review, four of the studies used outcome measures to 
track and monitor change (Ada et al., 2009, Betker et al., 2006, Gill-Body et al., 1997, 
Karakaya et al., 2000). The measures used in the studies were specific to the aims of the 
studies.  
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Ada et al (2009) used the finger nose test (Gagnon et al., 2004) as a measure of elbow 
dexterity and the 9 hole peg test (NHPT) to look at upper limb dexterity (Mathiowetz et al., 
1986). Psychometric properties of the measures were not included. While the researchers 
identified a small change in the speed and accuracy of upper limb movement in the 
participant post a two week period of intervention, the changes were only maintained for 
two weeks duration post the withdrawal of therapy. Betker et al (2006) evaluated 
parameters extracted from their computerized system including number of falls, range of 
centre of pressure excursion and centre of pressure of path length.  The researchers were 
able to capture these parameters using incorporated sensors within the system. While the 
outcome measures are restricted to that measurable using this gaming software, reference 
is made to comparisons between this balance measurement technique and the sensory 
organization test, which is a component of the Equitest system, considered the gold 
standard in balance measurement (Mancini and Horak, 2010). The Berg Balance Scale (Berg 
et al., 1992), six minute walking test (Schmidt et al., 2013) and the Timed Up and Go (TUG) 
(Schoene et al., 2013), were conventional measures used.  The researchers noted a 
reduction in the rate of falls in two of the three study participants. Of these two patients, 
only one was diagnosed with a posterior fossa tumour. Outcome measurement was 
restricted to the berg balance scale as “difficulties” were cited as limiting the use of the 
mobility measures. No further explanation was provided on the factors limiting use of these 
measures. A reduction in falls rate is cited but no Berg Balance re-test data was available. 
Gill-Body (1997) used a battery of outcome measures in the assessment of balance and 
mobility function in a single posterior fossa tumour participant. Prior to inclusion in the 
study the participants received a comprehensive medical examination to ensure suitability 
for inclusion. The outcome measures administered included the dizziness handicap 
inventory (DHI) (Jacobson and Newman, 1990), TUG (Schoene et al., 2013), dynamic 
posturography (Mancini and Horak, 2010) and timed mobility measures (Schmidt et al., 
2013) that incorporated variations in speed, head position and degree of visual input. This 
study also utilised computerised kinematic gait analysis (Olsson et al., 1986). Kinematic gait 
analysis and dynamic posturography are considered the gold standards in balance and gait 
assessment, indicating the high quality of assessment methods used in this study. On 
reassessment at six weeks, improvements were noted in gait, balance and perceived 
dizziness. 
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All the measures tracking the changes resulting from a period of rehabilitation in the 
included studies, outlined improvements at impairment, disability and integration levels. 
Unfortunately only one study in the systematic review included a follow-up period. This 
follow-up period was of two weeks duration (Ada et al., 2009). Lack of adequate follow-up 
combined with lack of controls, limited the ability to draw long term conclusions regarding 
the benefits of rehabilitation or specific rehabilitation approaches in this population.  
3.8.4 Discussion 
3.8.4.1 Statement of principal findings  
This systematic review investigated and documented rehabilitation practices in the 
management of deficits in posterior fossa tumour patients. It is the first review to be 
undertaken to investigate and summarise the rehabilitation practices used in treating these 
individuals. While the narrative overview confirms that positive benefits were derived from 
the participants of the studies who received rehabilitation, due to the lack of control groups 
any conclusions regarding efficacy cannot be made. No conclusions regarding long-term 
benefits to the included rehabilitation technique could be deduced, due to lack of adequate 
long-term follow-up within any of the studies. While the execution of this systematic review 
followed epidemiologic best practice guidelines, the quality of the studies meeting inclusion 
criteria were all case series.  No randomised controlled trial was available for inclusion in the 
review, highlighting the need for further multi centre prospective cohort studies to examine 
the impact of rehabilitation exposure in this population.  
3.8.4.2 Results in the context of the current literature  
Tumours of the posterior fossa are exceedingly rare, particularly within the adult 
population. The rarity of the condition is reflected in the identification of only five studies, 
throughout the entire research catalogue, for inclusion in this systematic review. The 
inclusion criteria limited included studies to individuals with a posterior fossa tumour but 
other research has investigated deficits of the posterior fossa due to a stroke (Bultmann et 
al., 2014), Multiple Sclerosis (Prosperini et al., 2011) and Traumatic Brain Injury (TBI) (de 
Amorim et al., 2014). A systematic review by Martin et al (2009) investigated the 
effectiveness of physiotherapy interventions in the treatment of deficits of cerebellar 
dysfunction. This review did not limit inclusion on the basis of a specific pathology. 
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Participants had varying diagnosis including tumour, TBI, MS and stroke. By basing the 
inclusion parameters on a specific impairment in contrast to a specific pathology, the 
researchers were able to identify one randomised controlled trial, one cross sectional study 
and seven case series for inclusion. Two common studies are included in both systematic 
reviews (Gill-Body et al., 1997, Karakaya et al., 2000). Similar difficulties with potential 
reproducibility of the included rehabilitation programmes were experienced due to limited 
details of the specific programmes. This trend in research publications containing limited 
details of prescribed programmes, limits the usability and benefit that can be derived by 
therapists and service users. Follow-up periods were also limited in this study, however, one 
included study offered a three month follow-up (Folz and Sinaki, 1995), which was 
significantly longer than the longest follow-up of  two weeks offered in this systematic 
review (Ada et al., 2009). A recent systematic review that investigated approaches in the 
management of postural disorders associated with cerebellar ataxia identified nineteen 
studies that focus on rehabilitation (Marquer et al., 2014). Within the included studies only 
one was identified as containing a definite case of cerebellar tumour. The study identified 
with this participant is also contained in this systematic review (Gill-Body et al., 1997). 
Multiple sclerosis and degenerative ataxia were the most frequently included conditions, 
again highlighting the dearth of available research looking at management of posterior fossa 
symptoms caused by a tumour.  
3.8.4.3 Strengths and weaknesses  
This is the first systematic review that has looked at rehabilitation practices in a population 
of patients with a tumour in the posterior fossa. The methodological process that was 
undertaken throughout this review was conducted in a systematic and reproducible fashion. 
A comprehensive search, including five databases and a secondary search of the 
corresponding reference lists, ensured that the bulk of relevant evidence pertaining to the 
topic was identified. The search was completed at two points; initially in June 2013 and 
repeated in April 2015, to ensure the included research was up to date.  While every effort 
was made to comply with epidemiological guidelines when carrying out the searches, the 
quality of the articles that were identified was of very low methodological quality. All the 
studies were case series, with limited follow-up, small participant numbers and lacking 
comparison groups. No randomised controlled trial (RCT) was identified for inclusion. The 
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poor quality of these five studies, limits the ability to draw robust conclusions from this 
systematic review.  
The specificity of the aim and inclusion criteria of this systematic review provided 
substantial barriers to the identification of appropriate research articles. As highlighted 
earlier in the review, the volume of neuro-oncology literature continues to exponentially 
grow (Khan et al., 2013, Trimble et al., 2015) but, in relation to the posterior fossa the 
evidence still remains sparse. This review has provided a summary of the available research 
in relation to rehabilitation of this population. While providing a comprehensive overview of 
the literature based on sound methodological principles, the quality of the systematic 
review itself suffers due to the limited historical evidence in relation to this population.  
3.8.4.4 Clinical and policy implications 
The rehabilitation programmes described within these studies, contained limited details 
about rehabilitation practices/programmes, making reproducibility and practical 
implementation difficult. A lack of adequate follow-up across the five studies also limited 
the ability to formulate conclusions for longer term benefits of the utilised techniques. To 
ensure transferability of rehabilitation principles into everyday practice they need to be 
formulated on solid and theoretically sound prescriptive and exercise principles (Swain, 
2014). Areas in exercise prescription that have been identified as lacking consistency across 
research studies include “type of exercise, frequency, duration, repetitions, sets, intensity, 
progression rules, supervision, individual or group and/or adverse events” (Slade et al., 
2014). To overcome this deficit in rehabilitation literature experts in the field of 
rehabilitation are undertaking an international study to develop consensus on the essential 
elements required in the reporting of exercise prescription and subsequently develop a 
standardised method of reporting (Slade et al., 2014). By standardising the reporting in 
research papers, extrapolation of results will become easier, with more benefits being 
derived for the service user.  
This systematic review has focused solely on a neuro-oncology population. Tumours 
occurring in the posterior fossa can produce a variety of symptoms due to the potential 
involvement of several cerebral structures. Given the complexity of this region of the brain 
and the diversity of tumours based on their histological components (Piccirillo et al., 2014), 
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proceeding with caution is essential to ensure adequate consideration of confounding 
factors associated with having a cancer diagnosis of the central nervous system (Buckner et 
al., 2007). 
3.8.4.5 Areas for further research  
Ensuring good ethical practice is the cornerstone of any research study (Freedman, 1987), 
therefore the deliberate withholding of a potentially beneficial treatment approach would 
breach ethical practice. This ultimately limits the ability to conduct an RCT. This systematic 
review has highlighted the lack of high quality evidence that is available in this population, 
identifying the need for future observational research that focuses on prospective, multi-
centre cohort studies, with an adequate period of follow-up. The complexity of this 
population and the changeable nature of brain tumours require a long-term follow-up, to 
influence a change of practice.  Certain neuro-oncology populations have large volumes of 
high quality research available to assist with clinical decision making (Passier et al., 2012, 
Roberts et al., 2014). The complexity of this patient cohort and the high degree of mortality 
associated with tumours of this region of the brain (Strauss et al., 2013), may be a limiting 
factor in researchers conducting studies that focus on this population. 
Two of the studies included in the systematic review used technology as the basis of the 
rehabilitation programme. Throughout the literature, technology is being incorporated into 
research and practice (Taylor and Griffin, 2014, Laufer et al., 2014, Meldrum et al., 2012), 
and offers diversity from routine conventional programmes. Given the increase in 
technology throughout all aspects of daily living, the incorporation of technology into 
patient management programmes  ensures programmes remains relevant and relatable, for 
patients (DiDonato et al., 2015).  
3.9 Conclusion  
Twenty years ago the concept of cancer rehabilitation was “struggling for definition, 
recognition and direction” (Watson, 1990), but with the increasing numbers of cancer cases 
and the reduction in mortality rates, cancer rehabilitation has become integral in the 
management structure of this population. This systematic review highlighted that 
specifically targeted programmes provided benefits to individuals suffering with symptoms 
as a result of a posterior fossa tumour. However, the conclusions that can be extrapolated 
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from this systematic review must be heeded with caution, due to the variation in 
rehabilitation programmes, lack of comparison groups, limited follow-up periods, small 
patient populations and variability in subject demographics. More research of higher quality 
needs to be conducted in this population to allow for optimum rehabilitation strategies to 
be developed, to maximise functional gains.  
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Chapter 4: Methodology  
4.1 Introduction 
Chapter two of the thesis has outlined the anatomical and surgical consequences associated 
with a tumour of the posterior fossa, while chapter three looked at the role of rehabilitation 
in the management of this population. The literature reviews have highlighted the limit of 
specific research available in relation to this complex adult neuro-oncology population. The 
limit of pre-existing research in this population, limited the resources available on which to 
establish the methodology for this research project. Subsequently this study was designed 
to contribute to a foundation in our understanding and management of this complex 
population. This study aimed to provide scientific information on a complex neuro-oncology 
population, to assist in the clinical management and future research strategies of this neuro-
oncology population.  
4.2 Aim of the Research Study 
The primary aim of the research was to characterise balance, gait, upper limb dexterity and 
dizziness in patients, pre and post posterior fossa tumour surgery. The secondary aim was to 
profile the demographic and tumour characteristics of the study participants. 
In this study the experimental hypothesis was that the subjects with posterior fossa tumours 
would demonstrate reduced balance, reduced gait speed, increased dizziness and reduced 
upper limb dexterity and quality of life post-operatively when compared with their pre-
operative status. The null hypothesis for the research suggested that there would be no 
difference between pre and post- operative outcomes on assessment of balance, gait, 
dizziness, upper limb dexterity and quality of life.  
A hypothesis was established for each of the outcome measures used in the research 
project. For the primary outcome measure, computerized dynamic posturography (CDP), it 
was hypothesized there would be a reduction in measured equilibrium on the sensory 
organisation test (SOT) when comparing pre and post-surgery results. The proposed 
hypothesis for the mobility outcome measures, the 10m walking tests, was that there would 
be a measurable reduction in gait speed between pre and post-surgical testing, for the three 
test conditions. The hypothesis for dizziness, as measured using the dizziness handicap 
inventory was an anticipated increase in self-perceived dizziness, as reported by the 
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participants, pre and post-surgery. The hypothesis for upper limb dexterity, using the nine 
hole peg test was an anticipated reduction in the speed of completion of the test post-
operatively as compared with pre-operatively.  
The objectives of the study were:  
To establish the impact of surgery on balance, mobility, upper limb dexterity and dizziness in 
patients, pre and post-surgery, with a tumour of the posterior fossa. Four varying time-
points, pre-operatively (T1), post-operatively as an inpatient (T2), six week follow-up (T3) 
and six month follow-up (T4) were used for patient assessment and data collection.  
To characterise the demographic profile of patients admitted to Beaumont Hospital for 
posterior fossa tumour surgery  
To characterise the tumour characteristics of patients admitted for posterior fossa tumour 
surgery to Beaumont Hospital 
4.3 Study Design  
This study was a prospective cohort study. The STROBE (Strengthening the Reporting of 
Observational studies in Epidemiology) standardised reporting guidelines were followed to 
standardise the conduct and reporting of this research (von Elm et al., 2007). 
4.4 Participants  
4.4.1 Participant Recruitment 
All patients admitted to the Neurosurgical service in Beaumont Hospital for surgery relating 
to the presence of a posterior fossa tumour were considered as potential subjects for 
inclusion in the research study. Potential participants were identified by monitoring 
neurosurgical admission lists, neurosurgical theatre lists and by liaising with the appropriate 
ward managers and bed managers. Appropriate participants were highlighted to the 
inpatient neurosurgical physiotherapy service. Patients with the appropriate inclusion 
criteria were approached by a member of the neurosurgical physiotherapy team, who acted 
as the gatekeeper. Participants were provided with information leaflets explaining the 
research project and given a cooling off period to consider their involvement in the study. 
Written informed consent was obtained when the subject agreed to participate in the 
research study.  Subjects were informed of their ability to withdraw from involvement in the 
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study at any stage without the need for an explanation.  Patients who refused consent to be 
involved in the research project were advised that refusal would not impact on future care 
and they would receive normal care as per Beaumont Hospital policy. An anonymous record 
of all individuals who refused consent or did not meet inclusion criteria was maintained to 
ensure a complete record of this population of patients over the duration of the study 
period.  Recruitment commenced on the 8th of February 2013. 
4.4.2 Inclusion Criteria 
Participants were considered eligible for inclusion in the study if they were admitted to 
Beaumont Hospital for surgery relating to the presence of a tumour in the posterior fossa. 
Presence of the tumour within the cerebellum, brainstem or floor of the fourth ventricle 
required confirmation on either MRI or CT, by a consultant radiologist. To ensure no residual 
deficits secondary to previous surgeries, participants were only included if they underwent 
first time brain surgery. Any surgical procedure on the brain carried out previously, 
throughout the lifetime of the individual, resulted in their exclusion from the study. If the 
individual had received previous brain radiation, they were also excluded due to the 
potential of developing physical deficits as a result of brain radiation. All participants for 
potential recruitment to the study were aged 18 or older and able to consent to 
involvement in the study independently. Potential participants were also questioned as to 
the presence of, or previous treatment for vestibular symptoms. The individual’s medical 
chart was also consulted to check if there was any evidence of previous medical 
management for a vestibular lesion.  If an individual displayed any difficulty with the 
consent procedure due to altered Glasgow Coma Scale (GCS), they were excluded as 
potential participants. Individuals provided written informed consent for involvement in the 
study. Individuals had to be able to mobilise for inclusion in the study but individuals who 
mobilised with the use of a gait aid were still offered the opportunity to be involved in the 
study. Ability to stand for approximately twenty seconds to allow testing on the Equitest 
(primary outcome measure) was also a criterion for inclusion. Due to the use of written 
questionnaires and outcome measures in English, fluency in written and spoken English was 
required. 
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4.4.3 Exclusion Criteria 
Patients were excluded from consideration for the study if they had a neurosurgical opinion 
and assessment while an inpatient that did not warrant a surgical intervention. Individuals 
unable to provide written, informed consent or unable to comprehend written or spoken 
English were also excluded. Inability to complete the testing battery resulted in exclusion. 
Individuals with a tumour originating from the internal auditory meatus were excluded as 
this is the common site of origin of vestibular schwannomas, which display similarities in 
presenting features but differ in management to the population of interest. The study 
cohort was an adult population, so participants under 18 years of age were excluded.  
4.5 Sample Size    
Beaumont Hospital is the National Neurosurgical centre in Ireland with 2,455 admissions 
and 25,339 bed days utilised by the neurosurgical service in 2013 (Beaumont Hospital 
Annual Report, 2013) . Over a five year period, ranging from 2007 to 2011 inclusive, 114 
patients were admitted to Beaumont and had surgery as an inpatient due to the presence of 
a posterior fossa tumour, with an average annual admission rate of 23. Based on the above 
figures it was assumed that the number of patients potentially meeting inclusion criteria 
would be reflected in these numbers. Recruitment was also dependent on patients 
consenting to being involved. Assuming 50% of the potential participants would decline 
involvement, the study aimed to recruit a minimum of twelve participants over an eighteen 
month period. Pre-existing research data was unavailable on which to formulate a scientific 
calculation. 
4.6 Ethical Considerations 
An application for ethical approval was initially submitted for consideration by Beaumont 
Hospital Medical Research Ethics Committee on 25th of October 2012. On receiving feedback 
from the ethics committee, minor modifications were required to the patient information 
leaflet. On resubmission of the amended patient information leaflet, ethical approval was 
received on 20th of December 2012. A copy of the Ethics approval is available as appendix 
eleven. An amendment form was submitted to the Beaumont Hospital Ethics Committee on 
29th January, relating to a modification in the testing procedure. Addition of the nine hole 
peg test (NHPT), a functional measure of upper limb dexterity was included in the testing 
battery post discussion with a neurosurgeon (SMcN). Approval for inclusion of the NHPT was 
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received on the 8th February 2013 from Beaumont Hospital Ethics Board. A copy of the 
Ethics approval is available as appendix twelve.  
 All potential participants were provided with a copy of the patient information leaflet when 
approached by the gatekeeper, if they indicated an interest in considering involvement in 
the research study. A copy of the information leaflet is available as appendix thirteen. The 
aims and objectives of the research were outlined to the patient at this time and 
participants were informed of the voluntary nature of the study. Participants were also 
advised that refusal to participate would not impact on any future care they would receive 
while a patient in Beaumont Hospital. Verbal consent was obtained to ensure the 
participant was happy to be approached by the principal investigator (PI). The participant 
was provided with a cooling off period of at least one hour to ensure adequate time to 
evaluate their potential involvement in the study. The patient was advised of their ability to 
withdraw from the study at any point, without explanation and it would not impact on their 
future management.  
The PI approached the participant once verbal consent was obtained to do so. Any 
outstanding questions requiring clarification were discussed at this point. The withdrawal 
process from the study was also re-clarified at this point. Signed, informed consent was 
obtained from the subject. One copy was placed in the subject’s medical chart, one copy 
was provided to the subject and one copy was retained by the PI. A copy of the consent 
form is available as appendix fourteen. 
There was no identifiable personal information collected on the data collection form used to 
gather participant information. A unique identification code was assigned to each 
participant and was used to identify participant data. The identification codes and subjects’ 
names were stored on a password protected spread sheet, to which only the PI had access. 
All written documentation was kept in a locked filing cabinet in the physiotherapy 
department to which only the PI had access. Data was stored on a hard drive which was 
password protected. The collection, storage and use of participant data was carried out in 
accordance with the Data Protection Act (1998).  Prior to commencement of the study each 
neurosurgical consultant was contacted by email informing them of the study and was 
provided with a copy of the finalised protocol. A letter was forwarded to each consultant 
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informing them of their patient’s involvement in the study if they consented to 
participation. A copy of the consultant letter is available as appendix fifteen. A letter 
outlining the participant’s involvement was also forwarded to their General Practitioner 
(GP). A copy of the GP letter is available as appendix sixteen.  
A small number of potential risks associated with involvement in the research study were 
identified. A fall was perceived as being a potentially high risk consequence due to the 
challenging nature of the balance testing, involved in the assessments. To minimise the risk 
of a fall, all participants were closely supervised throughout the testing procedure by the PI 
and if any adverse event occurred the testing was ceased and the treating neurosurgical 
team were contacted and advised of the event. Neck pain was also considered a potential 
risk due to the presence of a sub-occipital post-operative wound. As the subjects were 
requested to move their head from side to side during the testing, potential post-operative 
wound discomfort may have been experienced. To minimise this risk, the patient’s cervical 
range of movement was tested prior to conducting the walking tests. The patient was 
instructed to carry out the movements of the head and neck within comfortable limits. If no 
comfortable limits were identified the walking tests involving the horizontal head turns 
were excluded from the testing battery. If increases in neck pain were identified post 
testing, the ward was contacted regarding the administration of pain relieving medication. 
Increase in the levels of dizziness was also identified as a potential risk of inclusion in this 
study. If subjects reported an increase in their levels of dizziness post assessment that did 
not settle, the treating neurosurgical team was contacted. Fatigue was also identified as a 
risk due to the impact of surgery and the number of assessments being conducted. 
Opportunity to rest between each test was provided for each participant and any further 
request for rest periods was provided. No adverse events occurred at any time-point, during 
the testing of participants. 
4.7 Procedure  
When a patient was admitted to one of the neurosurgical wards in Beaumont Hospital and 
met the inclusion criteria, they were approached at this point by the gatekeeper to outline 
the research study. A cooling off period of one hour was provided and they were given the 
information leaflet to assist with decision making regarding consent. If the patient 
consented to being approached by the PI, the study was further discussed prior to decision 
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making. If the patient wished to be involved in the study written informed consent was 
obtained. The individual’s medical chart was assessed to obtain baseline demographic data 
and information relating to their admission history. A copy of the data collection sheet is 
available as appendix 17. Beaumont Hospital PACS system (online radiological system) was 
accessed to confirm a tumour of the posterior fossa on CT or MRI as confirmed by a 
consultant radiologist. A time was then arranged to execute the assessments that was 
agreeable to the participant, in the physiotherapy department.  
The assessments and outcome measures were conducted at four consecutive time-points 
(Tp) during the study. The SOT testing procedure, of the CDP Equitest system, was the 
primary outcome measure used in the study. The composite score of the SOT was the 
primary endpoint utilised in the study. A table of the testing procedure at each time-point is 
available as appendix 18. 
Tp1: Pre-operatively- This was the initial battery of testing that was completed prior to the 
individual undergoing their neurosurgical procedure. The number of days prior to surgery 
that this testing occurred varied between participants due to several factors. Access to 
participants varied due to absence from the wards due to radiological demands and 
consultations with a variety of healthcare professionals.  At this stage of the testing 
procedure the testing protocol consisted of collecting demographic data, completion of the 
SOT component of the Equitest, 10 metre walk tests, the Nine Hole Peg Test (NHPT), Linear 
Analogue Scale Assessment (LASA) and the dizziness handicap inventory (DHI).  
Tp2: Post-operatively as an inpatient- The post-operative testing battery was completed at 
the first opportunity that the participant reported feeling able to engage. Given the nature 
of the presentation, the number of days post-operatively, that this testing was completed 
varied between participants. The testing protocol at this point included the SOT component 
of the Equitest, 10 metre walk tests, NHPT, box scale for pain,  and DHI.   
Tp3: Post-operatively at 6 week review – This stage of the testing was completed to coincide 
with the patient’s six week clinic review with the treating neurosurgeon. The testing 
protocol at this stage of the study included the SOT component of the Equitest, 10m walk 
tests, NHPT, DHI and box scale for pain.  
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Tp4: Post-operatively at six months – This stage of the testing was completed by phone 
follow-up in which subjective measures were completed over the phone with the 
participants. The testing protocol included the LASA, DHI and box scale for pain.  
A copy of the data collection checklists utilised at each Tp, are available as appendix 19, 20, 
21 and 22. 
4.8 Assessments  
4.8.1 Demographics 
Demographic information for each of the participants was collected from the medical chart, 
once written informed consent was obtained. Any missing information from the medical 
chart was supplemented by discussion with the participant. This included information on 
gender, age and mobility status. A comprehensive history of presenting features was 
obtained. This included the presence of nausea, vomiting, dizziness, vertigo, tinnitus and 
oscillopsia. This participant information was collected initially, in conjunction with T1 testing 
protocol and was not repeated during the other testing time-points. A record of the number 
of days each participant was an inpatient in Beaumont Hospital was also collected, at 
discharge. The GCS was also recorded at admission and any change in the same throughout 
the inpatient stay was noted, to monitor clinical deterioration. If the participant required an 
intensive therapy unit (ITU) admission during their inpatient stay this was also captured. All 
testing completed during the course of the research project was executed by the PI (KM), to 
ensure consistency and reduce the risk of bias. The majority of the demographic data was 
collected at T1 but supplementary information was gathered at each of the time-points.  At 
T2, data relating to the surgery and the tumour was collected, at T3 information relating to 
radiation and chemotherapy and at T4 data relating to general well-being and current 
functional status was collected.  
4.8.2 Computerized Dynamic Posturography (CDP) 
Computerised dynamic posturography is a quantitative method of measuring upright 
balance function under a variety of simulated balance conditions (Jacobson et al., 1993), and 
is considered a gold standard objective measure in balance assessment (Mancini and Horak, 
2010). The Equitest system contains three programmes designed to challenge aspects of 
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balance including the motor control test (MCT), sensory organisation test (SOT) and 
adaption test (AT).  
Platform posturography, in the clinical setting was developed to clarify the nature of motor 
coordination problems associated with vestibular impairments and other sensorimotor 
deficits (Di Fabio, 1995). Nashner and Peters (1990) developed the sensory organisation test 
(SOT) based on the hypothesis that “disruption to the gravitational reference (low-
frequency otolith feedback) would create postural instability if visual and somatosensory 
inputs were not available as redundant systems to control balance” (Nashner, 1971, 
Nashner, 1972, Di Fabio, 1995). The SOT in the clinical setting is used to evaluate postural 
sway in six conditions, in which visual and somatosensory cues are absent or altered 
(Herdman, 2007). While considered a gold standard in balance assessment several 
limitations exist. An extensive collaboration of experts in balance and motion identified poor 
sensitivity and specificity of CDP in its ability to identify and quantify postural and balance 
deficits (Kingma et al., 2011). A retrospective review of the SOT and its ability to detect 
balance deficits in a population with central nervous system balance deficits, reported 100% 
sensitivity in identifying balance deficits (Keim, 1993). In a review of the learning effects of 
repeated administration of the SOT in a healthy, young population, Wrisley et al (2007) 
identified a fair to good test-retest reliability of the SOT composite score, from session one 
to two, with an average of 1.7 ± 0.9 days between testing, highlighting a .67 intra-class 
correlation co-efficient (ICC). Within the same study, the investigators identified an eight 
point change in the composite score as a clinically meaningful improvement in equilibrium. 
The researchers identified this score as sufficient to counteract the potential of a learning 
effect, making an eight point change in score attributable to the associated intervention. 
While the diagnostic abilities of CDP and the SOT have been called into question (Baloh et 
al., 1998), the ability of the SOT to track changes of balance function over time have been 
proven, emphasising its ability to monitor the impact of rehabilitation and medical 
interventions (Di Fabio, 1995). 
Postural sway is measured in the SOT by manipulating visual and somatosensory feedback, 
with the aim of evaluating the person’s postural stability (Mirka and Black, 1990).  The SOT 
is administered with a computerized system using a movable dual force-plate and a movable 
visual screen (Equitest) (Ford-Smith et al., 1995). Varying degrees in body sway compared to 
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maximum known limits, measured during the six sensory conditions determines the 
person’s ability to organize and select the appropriate sensory information to maintain 
postural control (Nashner and Peters, 1990). Each condition has three, 20 second trials. In 
condition one, the participants stand still with eyes open. No alteration to sensory 
stimulation is provided in this testing condition. Visual stimuli are removed in condition two 
by instructing the subject to close their eyes. In condition three, visual stimuli are altered by 
moving the visual screen with the subject’s anterior/posterior sway, thus maintaining the 
visual field a constant distance from the subject’s eyes. This is referred to as “sway 
referencing” (Nashner et al., 1982). In condition four, proprioceptive stimuli are distorted by 
rotating the force platform with the subject’s sway, while maintaining a constant angle at 
the ankle joint. Condition five, removes visual input by eye closure and alters proprioceptive 
stimuli, due to sway referencing. In condition six proprioceptive and visual stimuli are both 
altered by moving the platform and sway referencing (Ford-Smith et al., 1995). During 
conditions four, five and six, the vestibular system is believed to be the main sensory control 
system (O'Neill et al., 1998).  
The Equitest system was used to administer the SOT protocol in this research project. The 
equipment consisted of a movable dual force-plate, a movable visual screen and overhead 
safety bar with safety straps. The dual force-plate consisted of two 9 x 18 footplates 
connected by a pin joint. The two footplates have four force transducers mounted 
symmetrically under the footplates on a supporting centre plate and a fifth transducer is 
bracketed to the centre plate directly beneath the pin joint. The force transducers are 
placed so that when a subject stands with ankles centred over the placement strip on the 
dual force-plate, with feet an equal distance laterally from the centre line, his or her centre 
of gravity (COG) is positioned directly above the intersection of the X and Y axis (Ford-Smith 
et al., 1995). 
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 Figure 4a Participant within the Equitest system 
Within the testing battery, the SOT was used to measure the participant’s equilibrium pre-
surgery (T1), post-surgery (T2) and at clinic review (T3).  The testing procedure followed the 
SOT pre-programmed Equitest protocol. The participant was instructed regarding the testing 
procedure prior to commencing testing. The participant’s height was also measured and 
input to the system along with age, to allow comparison with computed normative data. 
Each trial is scored separately with equilibrium scores expressed as a percentage ranging 
from zero to one hundred. Equilibrium scores nearer one hundred indicated reduced 
antero-posterior (AP) excursion. AP excursion is a measure of sway in the antero-posterior 
direction of the participant’s centre of gravity in relation to the ankle position (Nashner et 
al., 1982). The trial was stopped if the subject took a step, opened their eyes, stepped off 
the force platform or grabbed an object to maintain upright stance. Interrupted trials were 
considered a fall and scored zero. A composite score was automatically calculated by the 
equipment based on normative data and was used for statistical analysis. 
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Figure 4b Computerized output of SOT for a study participant.   
The output provides a graphical representation of the score for each trial and the computer 
generated composite score. Graphical representation is also provided for sensory analysis, 
ankle and hip strategy analysis and alignment of the centre of gravity. The red areas 
represent trials where the individual scored lower than age matched normative data. Green 
areas indicate scores that are equal or higher than that of age matched normative data.  
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4.8.3 10m Walk Test   
Individuals with balance or vestibular disorders frequently demonstrate gait disorders, 
report postural instability and fall more frequently than individuals without vestibular 
dysfunction (Marchetti et al., 2008). Typically, clinical features identified in individuals with 
infra-tentorial tumours revealed ataxic gait including widened base, unsteadiness, 
irregularity of steps and veering to one side (Palliyath et al., 1998). Laboratory studies in 
individuals with cerebellar disease revealed that cadence and step length are significantly 
lower, whilst step width, stance phase and outward rotation of feet are significantly 
increased in cerebellar patients compared to normal subjects. As a result of this reduction in 
step length and cadence, a diminution of gait velocity is also observed (Stolze et al., 2002). 
Walking speed has been shown to be a key factor in determining rehabilitation needs and 
discharge location and has the potential to predict future functional decline and fall risk 
(Peters et al., 2013). 
Given that irregularities of gait velocity and cadence have been identified in individuals with 
involvement of the cerebellum (Ilg et al., 2007, Stolze et al., 2002), a simple 10 metre walk 
test was employed to measure these temporal gait parameters, in the participants with 
posterior fossa involvement. Three varying testing conditions involving the 10m walk test 
were used; self-selected walking speed, maximum walking speed and walking with 
horizontal head turns.  
In a study investigating the impact of locomotion speed on gait variability in individuals with 
vestibular and cerebellar deficits, temporal gait variability was identified in both populations 
(Schniepp et al., 2012). In patients with cerebellar ataxia, variability was increased during 
slow (8.4 ± 5.3%, P < .01) and fast (7.9 ± 6.4%, P < .01) walking speed but was normal during 
preferred walking speed. In a review of temporal and spatial gait parameters in individuals 
with and without balance and vestibular disorders, a significant decrease in gait speed for 
several conditions of the Dynamic Gait Index, including horizontal head turns was identified 
(Marchetti et al., 2008).  
The ease of administration of the 10m walk test in the clinical setting has made it a 
commonly chosen measure to monitor gait speed. The psychometric properties of the 
measure have been investigated in several populations. Test retest repeatability has been 
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shown to be excellent at both self-selected and maximal walking speeds, in a healthy adult 
(ICC 0.93, ICC 0.91) (Bohannon, 1997) and chronic stroke (ICC 0.94, ICC 0.97) (Flansbjer et 
al., 2005) population. In the same cohort of chronic stroke participants, Flansbjer et al 
(2005) identified a standard error of measurement of 0.07m/s at a self-selected comfortable 
speed and 0.08 m/s at maximal walking speed. In the clinical environment a variation in 
clinically meaningful, gait speed changes have been identified across differing cohorts. In an 
elderly population, 0.05 m/s was classified as a small meaningful change in gait speed and 
0.13 m/s a substantial change (Perera et al., 2006). The researchers identified similar trends 
in a stroke population with 0.06 m/s classified as a small change and 0.14 m/s classified as 
substantial (Perera et al., 2006). In a chronic TBI population, a change of 0.15 m/s at a self-
selected pace and 0.25 m/s at maximal walking speed was considered clinically meaningful 
(vanLoo et al., 2004).  
Each participant completed 3 consecutive trials for each walking test, for a total of 9 walking 
trials. An average gait speed was then calculated from the three trials. The testing 
procedure used was identical to that outlined in previous studies (Peters et al., 2013). A 
copy of the testing protocol is available as appendix 23. Walking speed was measured using 
a stopwatch, starting the stopwatch as soon as the participant’s lead leg crossed the first 
marker and stopping it when the participant’s lead leg crossed the second marker. The PI 
performed all stopwatch measurements to prevent introducing inter-rater variability. 
Participants were provided the opportunity to take rest breaks as needed throughout the 
testing session but no participant required a break. 
4.8.4 Nine Hole Peg Test  
The Nine Hole peg test (NHPT) is one of the most frequently utilised assessments for the 
measurement of upper limb dexterity (Oxford Grice et al., 2003). It is a timed test in which 
nine pegs are inserted and removed from a pegboard containing nine holes (Poole et al., 
2005).  Age related normative data as well as a standardised testing procedure have been 
established for consistency of testing (Mathiowetz et al., 1985). Inter-rater and test–retest 
reliability of the most widely-used, commercially available version of the Nine Hole Peg Test 
has been established (Oxford Grice et al., 2003) and was found to be very high (right = .984, 
left = .993). The standard error of measurement, in a stroke population of varying time since 
onset was 29 seconds (Chen et al., 2009) and 1.02 seconds for the dominant hand in a 
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Parkinson’s disease population (Earhart et al., 2011). Within the same studies, a minimal 
detectable change of 32.8 seconds in the stroke population (Chen et al., 2009) and 2.6 
seconds for the dominant hand in the Parkinson’s disease population (Earhart et al., 2011), 
was identified. The merits of the NHPT as a quick, easy to administer and reliable measure 
of upper limb dexterity has been established (Mathiowetz et al., 1985, Smith et al., 2000). 
Its predictive role of upper limb deficits of dexterity has been recognised by its inclusion in 
the NIH Toolbox   (Wang et al., 2011). The NIH toolbox initiative was developed to provide 
“a standard set of concise, well validated measures that will be available in English and 
Spanish for longitudinal or epidemiological studies and also for prevention or intervention 
trials of people aged 3–85 years” (Gershon et al., 2010). 
The testing procedure utilised in this study was that outlined by Mathiowetz et al (1985) and 
replicated by Oxford-Grice et al (2003). Each participant was instructed to centre the 
pegboard directly in front of him or her, oriented such that the shallow dish was on the 
participant’s dominant hand side and the peg holes on the non-dominant side. Instructions 
for the test were given as per the standard instructions (Mathiowetz et al., 1985), along with 
a brief demonstration. A copy of the standardized testing procedure is available as appendix 
24.  Participants were given the opportunity for a practice test prior to the actual test, 
commencing with the dominant hand and then the non-dominant hand. The actual testing 
procedure was then completed in the same format with the dominant hand first followed by 
the non-dominant hand.  The tests were timed, with a stopwatch, from the moment the 
participant touched the first peg until the moment the last peg hit the dish. The test was 
then repeated for the non-dominant hand using the same testing method, with the 
pegboard rotated such that the dish was in front of the non-dominant hand. All participants 
were tested using this procedure. In the event that the participant dropped a peg or the trial 
was interrupted in any way, the evaluator cued the participant to stop and a new trial was 
initiated (Oxford Grice et al., 2003). All trials of the NHPT, at all the testing time-points were 
completed by the PI, for consistency.  
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Figure 4c NHPT board  
4.8.5 Dizziness Handicap Inventory  
The Dizziness Handicap Inventory (DHI) (Jacobson and Newman, 1990) is a self-perceived 
measure of disability attributed to vestibular dysfunction (Herdman, 2007). The subjective 
perception of vertigo and dizziness is believed to be influenced by the patient’s personality, 
anxiety with regards to unforeseeable recurrence, associated symptoms and the 
unpredictable evolution of the underlying disease (Duracinsky et al., 2007). The scale 
consists of 25 questions that are classified into physical, functional and emotional subgroups 
with the aim of evaluating the impact of dizziness on the way a patient functions in 
everyday life (Jacobson and Newman, 1990). The scale is scored by providing four points for 
a “yes” response, two points for a “sometimes” response and zero for a response of “no”. 
The scoring sequence ranges from zero to one hundred with zero indicating no perceived 
disability and 100 indicating a maximum perceived disability (Herdman, 2007). Good 
internal consistency reliability was demonstrated when the scale was administered to 106 
consecutive subjects (Jacobson and Newman, 1990) but the construct validity of the scale 
was called into question as only item total correlations have been studied. A factor analysis 
study carried out on a Spanish population of 337 patients identified three factors that 
differed from the original publication including, “vestibular disability”, vestibular handicap” 
and visio-vestibular disability”. The discrepancies identified between the English and Spanish 
version of the scale highlight the potential for error and the inability to ensure validity of the 
measure in alternate languages. The standard error measurement, in a population with 
peripheral and central vestibular pathology, was identified as 6.23, with an 18 point change 
in the scoring required to signify a minimal detectable change in the individual’s self-
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perceived dizziness handicap (Jacobson and Newman, 1990). A copy of the scale is available 
as appendix 25. 
In an article reviewing 74 studies relating to the DHI (Mutlu and Serbetcioglu, 2013) it was 
concluded that self-reported measures provide unique information in the management of 
the dizzy patient. The DHI was reported as the most widely used self-reported measure of 
dizziness and has been translated into fourteen languages making it widely recognised and 
accepted.  
4.8.6 Box scale for pain  
Due to the risk of post-operative pain associated with the participants in this study, a 
measure of pain was included in the testing battery at time-points two, three and four. The 
numeric rating scale (NRS) involved asking participants to rate their pain intensity by 
selecting a number on a scale from 0–10 (11-point scale) by filling in a questionnaire or 
stating verbally a numerical level (Mannion et al., 2007). The box scale is a slight variation , 
where each number (e.g. 0−10) is written in a box and participants are asked: “If a zero (0) 
means ‘no pain’ and a ten (10) means ‘pain as bad as it could be’, on this scale of 0−10, what 
is your level of pain? Put an “X” through that number”(Jensen et al., 1986). 
In a comparison study of the visual analogue scale (VAS), numeric rating scale (NRS) and the 
verbal rating scale(VRS), the NRS was found to provide interval level data and was as 
sensitive as the VAS (Williamson and Hoggart, 2005). The scale is considered easy to 
administer and record. In a study examining the validity of a verbally administered 0-10 NRS, 
the correlation between the VAS and the NRS was found to be strong and statistically 
significant in a mixed oncology population (r = 0.847, p < 0.001) (Paice and Cohen, 1997). In 
a population of post-surgical patients of varying pathology, 35% reduction on the numeric 
pain rating scale indicated minimal relief, 67% moderate relief and 94% complete relief 
(Sloman et al., 2006). In a population of limb and neck pain patients, a change of three 
points on the scale was required for a meaningful change (Stratford and Spadoni, 2001). 
The validity of verbal delivery of the NRS, for use in this study was important, as the 
measure was administered by phone by the PI at T4, as part of the six month follow-up 
testing battery. Administration of the box scale for pain was conducted in person with the 
participant at T2 and T3 in the physiotherapy department of Beaumont Hospital so the 
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participant was familiar with the measure being administered by phone at T4. A copy of the 
Box scale for pain is available as appendix 26.  
4.8.7 Linear Analogue Scale Assessment (LASA)  
The LASA is a brief quality of life measure that has been validated for used in the neuro-
oncology population (Locke et al., 2007). Specific domains include physical well-being (i.e., 
fatigue, activity level), emotional well-being (i.e., depression, anxiety, stress), spiritual well-
being (i.e., sense of meaning, relationship with God), and intellectual well-being (i.e., ability 
to think clearly, concentrate). An item for overall QOL is also included. The Likert scales run 
from 0 (as bad as it can be) to 10 (as good as it can be). Thus, higher ratings suggest higher 
QOL. The LASA was completed as part of the testing battery pre-operatively and at six 
months follow-up. Failure to include the LASA as a component of the testing battery at the 
other two testing time-points was aimed to reduce participant burden by collecting the 
quality of life data at the most appropriate time-points, to highlight the long-term quality of 
life, as a consequence of the surgery. A copy of the LASA is available as appendix 27.  
4.8.8 Tumour specific information  
Information relating to the tumour and the associated surgery was captured. Initial 
presenting information was gathered once consent was obtained and collected from the 
participant’s medical chart and the online computerised radiology system (PACS) in 
Beaumont Hospital. Information included, the exact location of the tumour, size, histology, 
presence of midline shift, presence of hydrocephalus, presence of mass effect, surgical 
procedure undertaken and extent of the surgical resection. Tumour size was determined by 
the maximum diameter of the tumour, in any one direction, as classified by the treating 
neuro-radiologist. Data relating to the surgical intervention and tumour histology was 
captured post-operatively, prior to the participant’s discharge from hospital. A record of 
need for future radiotherapy or chemotherapy was also captured. 
4.9 Statistical Analysis 
Data was analysed using STATA (version 13). Descriptive statistics, with graphical and 
tabulated data representation were utilised throughout the study. A narrative 
representation of study outcomes was also provided to monitor change over time in the 
cohort and the impact of surgery on outcomes.  
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The use of inferential statistics was restricted in the study to track changes over time due to 
the small cohort. Loss to follow-up and incomplete datasets further restricted choice of 
statistical analysis used. The limited number of study participants restricted the complexity 
of statistical analysis completed. Statistical analysis of the research data was completed in 
conjunction with a statistician. 
4.10 Conclusion 
Chapter four has categorized in detail the study methodology followed in the execution of 
this research project and the testing procedures utilised. The results of the study are 
presented in chapter five.    
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Chapter 5: Results 
5.1 Introduction  
The aim of the study was to establish the impact of surgery on balance, mobility, upper limb 
dexterity and dizziness in patient’s pre and post-surgery for the presence of a tumour of the 
posterior fossa. Secondary aims of the study included characterising the demographic and 
tumour profiles of the cohort of patients admitted to Beaumont Hospital for posterior fossa 
tumour surgery. The experimental hypothesis was that the subjects with posterior fossa 
tumours would demonstrate reduced balance, reduced gait speed, increased dizziness and 
reduced upper limb dexterity and quality of life post-operatively when compared with their 
pre-operative status. The null hypothesis for the research was that there would be no 
difference between pre and post- operative outcomes on assessment of balance, gait, 
dizziness, quality of life and upper limb dexterity.  
5.2 Participant recruitment  
Thirteen participants were recruited for involvement in this study. The recruitment process 
commenced on 8th February 2013, once ethical approval was received from Beaumont 
Hospital Ethics Committee, and concluded on 5th June 2014 once the desired recruitment 
sample size had been achieved. Consecutive patients admitted to the neurosurgical 
department of Beaumont Hospital for surgery due to the presence of a tumour located in 
the posterior fossa were considered for inclusion in the study. Inclusion was dependent on 
fulfilling the inclusion criteria and providing informed, written consent to participate in the 
research study. During the recruitment period, 46 individuals were admitted to Beaumont 
Hospital for a surgical procedure due to the presence of a tumour of the cerebellum, 
brainstem or fourth ventricle. These figures were sourced from the Beaumont Hospital HIPE 
(hospital inpatient enquiry) system that tracks and codes patient admissions to the hospital, 
based on diagnosis. Flow of participants through the study is demonstrated in figure 5a 
(overleaf). 
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Figure 5a Flow of participants through the study 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Individuals admitted to Beaumont Neurosurgical Department 
for excision of a posterior fossa tumour (n = 46) 
Individuals admitted for a neurosurgical procedure excluded 
from consideration for involvement (n = 2) 
Participants identified for potential inclusion (n= 44) 
31 participants excluded from the study 
Reasons for exclusion: 
Unable to consent  (n= 4) 
Previous Cerebral Surgery (n=  8) 
Not identified prior to Surgical intervention 
(n=2) 
Emergency transfer(n = 8) 
Previous radiotherapy (n = 1) 
Unable to stand for 20 seconds (n= 3) 
Refusal to participate (n= 2) 
Did not have a surgical intervention (n = 3) 
 
Included Participants (n= 13) 
Participants at T2 (n=9) 
Reason for follow-up loss:  
- Admission ITU (n=2) 
- Discharge home (n=1) 
- Excessive pain (n=1) 
 
Participants at T3 (n=8) 
Reason for follow-up loss: 
- Transfer care to another 
hospital (n=1) 
- Post-operative morbidity 
(n=2) 
- Adjuvant therapy (n=2) 
Participants at T4 (n=8) 
Reason for follow-up loss: 
- Death (n=3) 
- Post-operative 
morbidity (n=1) 
- Too unwell (n=1) 
Participants with full datasets at all three post-operative time-points (n = 6) 
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5.3 Description of the study group  
The study sample consisted of eight females (62%) and five males (38%). The mean age of 
the sample was 48.8 ± 15.7 years. Participant ages ranged from 21 years to 77 years. The 
female participants in the study had an average age of 49 years with males having an 
average age of 48.6 years. While both groups had the same average age, the male group of 
participants contained both the youngest and oldest participants (21 years and 77 years) 
recruited to the study. Of the recruited participants, all displayed a Glasgow Coma Scale 
score of 15/15 (100%), as measured by the treating nursing staff on the day of approach by 
the gatekeeper regarding potential inclusion. At admission to hospital twelve participants 
were independently mobile without the use of an aid (92.3%) and one participant used a 
zimmer-frame (7.7%), at baseline. Eleven participants were right hand dominant (84.6%) 
and two were left hand dominant (15.4%). The demographic data of the study participants 
are summarised in table 5a (below). 
 
Table 5a Demographic data of participants  
 
Variable       Subjects (n=13)  
        
 
Age (Mean and SD)      48.8 ± 15.7    
Gender (n)       8 Females    
        5 Males     
GCS at Admission (n)         GCS 15/15 = 13   
Mobility Status (n)      Independent = 12   
        Zimmer frame = 1 
Hand Dominance (n)      Right = 11   
        Left = 2 
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5.4 Excluded Participants 
During the period of recruitment 31 participants were excluded from inclusion in the study 
for varying reasons. The most common reason for exclusion from the study was due to a 
previous brain operation and eight subjects (25.8%) were excluded as a result. Four 
individuals (12.9%) were unable to provide consent, secondary to a low GCS, eight 
participants (25.8%) were transferred for surgery as a medical emergency thus were unable 
to engage in the recruitment process, one individual (3.2%) had previous radiotherapy to 
the brain, three participants (9.7%) were unable to stand for testing, two individuals (6.5%) 
refused to participate in the study, three individuals (9.7%) did not have a surgical 
intervention and two individuals (6.5%) were not identified early enough pre-surgery to 
complete the recruitment and testing process. The excluded participant data are 
summarised in figure 5a, page 74. 
5.5 Loss to follow-up 
Thirteen participants were recruited for inclusion in the research study. All participants 
completed the objective testing at T1, pre-operatively. One participant, (P6) did not return 
the subjective measures, DHI and LASA to the PI post completion and the data was not 
included. Follow-up with the participant (P6) regarding the pre-operative assessments was 
not possible due to significant post-operative morbidity which prevented subsequent 
testing.  
At T2, nine participants (69%) completed the testing protocol with four participants not 
included at this time-point. Two participants (16%) were admitted to ITU requiring 
intubation and ventilation, one participant (8%) was discharged home prior to completing 
the testing battery and one participant refused to engage with testing due to excessive post-
operative pain levels (8%). 
At T3, eight participants completed the testing protocol with five participants not included 
at this time-point. Two participants (16%) had significant post-operative morbidity and were 
unable to participate in testing. These two participants were the same two participants that 
had been admitted to ITU post-operatively. Two participants (16%) were receiving adjuvant 
chemotherapy or radiotherapy and were not eager to engage at that point and one 
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participant (8%) had his care transferred to local services in Galway and was unable to 
return to Dublin.  
At T4, eight participants completed the testing protocol with five participants not included 
as this time-point. Three participants (24%) were dead at six month follow-up, one 
participant (8%) had significant post-operative morbidity that prevented engagement and 
one participant (8%) was too unwell at six month follow-up to participate. The mortality and 
morbidity of the study cohort is presented in figure 5b (below). 
Table 5b Study Outcomes for mortality and morbidity 
 
Outcome      Time-point 
                  T1  T2  T3  T4 
 
Mortality     0  0  0  3 
Morbidity    0  2  2  2 
 
Footnote: Numbers equating to the number of individuals unable to complete testing at a 
particular time-point, due to death or significant morbidity 
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Table 5c Testing protocols completed by each participant during the research project 
 
Participant    T1  T2  T3  T4 
 
P1    √  √  √  × 
P2    √  √  √  √ 
P3    √  √  ×  √ 
P4    √  ×  ×  × 
P5    √  √  √  √ 
P6    √¶  ×  ×  × 
P7    √  ×  √  √ 
P8    √  ×  √  × 
P9    √  √  ×  × 
P10    √  √  √  √ 
P11    √  √  ×  ×   
P12    √  √  √  √ 
P13    √  √  √  √ 
 
√ = Completed testing battery 
× = Did not complete testing battery  
¶ = Did not complete LASA  
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5.6 Tumour Characteristics  
All participants included in the study subsequently had a surgical intervention secondary to 
a tumour in the posterior fossa of the cranium. Three tumours were located in the fourth 
ventricle, two in the cerebellar vermis, eight within the cerebellar hemispheres and none 
were within the brainstem. The size of the tumours varied from 2.5cm to 4.5cm and is 
illustrated in figure 5b (below).  
 
Figure 5b Bar graph of participant tumour size 
Eleven of the tumours were intra-axial and two were extra-axial. The histological 
classification of the tumours were metastatic carcinoma in seven patients (53.9%), one 
ependymoma (7.7%), one atypical choroid plexus papilloma (ACPP) (7.7%), two 
meningiomas (15.4%), one haemangioblastoma (7.7%) and one pilocytic astrocytoma 
(7.7%). According to the WHO classification of brain tumours, four tumours were grade one, 
two grade two tumours and seven grade four tumours. No tumour had a grade three WHO 
classification. Six of the tumours were of primary origin with seven tumours of secondary 
origin. Of the seven metastatic tumours, three had the primary location in the lung, two in 
the breast and one in each the colon and the ovaries. Seven participants required 
radiotherapy post surgery while six participants did not. Four participants required post-
operative chemotherapy. All participants had an MRI scan pre surgery and twelve 
participants had a CT scan. The tumour data of the study participants are summarized in 
table 5d (overleaf). 
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Table 5d Tumour parameters of participants 
 
Variable       Subjects (n= 13) %    
 
Size of Tumour (cm) Mean and SD    3.5 ± 0.7     
Location of Tumour      4th Ventricle = 3 (23.1%) 
       Cerebellar Vermis = 2 (15.4%) 
       Cerebellar Hemisphere = 8 (61.5%) 
Intra/extra axial tumour    Intra-axial = 11 (84.6%) 
       Extra-axial = 2 (15.4%)   
Histology of Tumour      Metastatic lesion = 7 (53.9%) 
       Ependymoma = 1 (7.7%) 
       ACPP = 1 (7.7%) 
       Meningioma = 2 (15.4%) 
       Haemangioblastoma = 1 (7.7%) 
       Pilocytic astrocytoma = 1 (7.7%) 
WHO Classification of Tumour    WHO Grade 1 = 4 (30.8%) 
       WHO Grade 2 = 2 (15.4%) 
       WHO Grade 3 = 0 (0%) 
       WHO Grade 4 = 7 (53.9%) 
Primary Tumour (n) %    6 (46.1%) 
Secondary Tumour (n) %    7 (53.9%) 
Requiring Post-op Radiotherapy    Yes = 7 (53.9%) 
       No = 6 (46.1%) 
Requiring Post-op Chemotherapy    Yes = 4 (30.8%) 
    No = 9 (69.2%)
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5.7 Surgical parameters of participants at baseline  
Eleven participants underwent a craniectomy procedure and two participants had 
craniotomies to expose the tumour. Nine participants had a total excision of the tumour 
while four had a sub-total excision. Nine participants required only one surgical procedure, 
two participants required two, one participant required three procedures and one 
participant required five surgeries. Two participants had the presence of midline shift on 
MRI scan and seven participants had mass effect on MRI scan. Eight participants had the 
presence of hydrocephalus on MRI scan. One individual required the insertion of a shunt 
and four participants required EVD insertion. Four participants developed post-operative 
haemorrhages. Four participants required admission to the intensive care unit post surgery.  
The intervention data of the study participants are summarized in table 5e (overleaf). 
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Table 5e Participant interventions  
 
Variable       Subjects (n=13) % 
 
Exposure Technique      Craniectomy = 11 (84.6%) 
       Craniotomy = 2 (15. 4%) 
Number of Surgical Interventions    One surgery = 9 (69.2%) 
       Two surgeries = 2 (15.4%) 
       Three surgeries = 1 (7.7%) 
       Four surgeries = 0 (0%) 
       Five surgeries = 1 (7.7%) 
Total Excision      Yes = 9 (69.2%) No = 4 (30.8%) 
Subtotal Excision     Yes = 4 (30.8%) No = (69.2%) 
Presence of Mass Effect    Yes = 7 (53.9%) No = 6 (46.1%) 
Presence of Midline Shift    Yes = 2 (15.4%) No = 11 (84.6%) 
Presence of Hydrocephalus    Yes = 8 (61.5%) No = 5 (38.5%) 
Requiring Shunt Insertion    Yes = 1 (7.7%)  No = 12 (92.3%) 
Requiring EVD Insertion    Yes = 4 (30.8%) No = 9 (69.2%) 
Post-operative Haemorrhage   Yes = 4 (30.8%) No = 9 (69.2%) 
Post-operative ITU admission   Yes = 4 (30.8%) No = 9 (69.2%) 
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5.8 Presenting Features  
Participants in the study reported several pre-surgical features of the tumour. Nine 
participants complained of headache on admission. Seven participants had nausea and five 
reported vomiting pre admission. Five participants had visual disturbances. Seven 
participants experienced dizziness. Two participants complained of vertigo. One participant 
had tinnitus. No participant experienced oscillopsia. All participants were GCS intact and all 
scored 15/15 at admission. At admission twelve participants were independently mobile 
with one participant using a zimmer frame. The presenting features of the study participants 
are summarized in table 5f (below). 
 
Table 5f Presenting features of participants  
 
Variable      Subjects (n = 13) % 
 
Headache    Yes: 9 (69.2%)  No: 4 (30.8%)  
Nausea     Yes: 7 (53.9%)  No: 6 (46.2%) 
Vomiting     Yes: 5 (38.5%)  No: 8 (61.5%)  
Visual Disturbance    Yes: 5 (38.5%)  No: 8 (61.5%) 
Dizziness    Yes: 7 (53.9%)  No: 6 (46.2%) 
Vertigo    Yes: 2 (15.4%)  No: 11 (84.6%)  
Tinnitus     Yes: 1 (7.7%)  No: 12 (92.3%) 
Oscillopsia     Yes: 0 (0%)  No: 13 (100%) 
Mobility Status    Independent: 12 (92.3%) 
     Zimmer frame: 1 (7.7%) 
GCS on Admission    15/15: 13 (100%) 
 
 
84 
 
5.9 Assessments   
This section catalogues the testing battery completed for each participant.  
5.9.1 Balance  
Outcome measure: Equitest (Computerized dynamic posturography) 
Computerized dynamic posturography (Equitest) testing was carried out with participants at 
three different stages during the course of the study and was the primary outcome measure 
of the study. The sensory organization test (SOT) was the test protocol utilised. Initial testing 
was prior to the participant undergoing a surgical intervention (T1), second testing was post-
operatively while the participant was an inpatient in the hospital (T2) and finally when the 
participant returned to the hospital for their clinic review at six weeks (T3). At T1, all 
thirteen participants had the testing completed. A mean composite score of 58.7 ± 16.2 was 
achieved with the minimum being 34 and the maximum 83.  
At T2 nine participants had the testing completed. A mean composite score of 61.3 ± 11.0 
was achieved at this point with the minimum result 49 and the maximum 86. Participants 
failed to engage in T2 Equitest data collection due to admission to ITU (n=2; 15.4%), 
discharge home prior to testing completion (n=1; 7.7%) and excessive pain levels limiting 
engagement (n=1; 7.7%).  
At T3 eight participants had the testing completed. A mean composite score of 68.1 ± 18.8 
was achieved with a minimum composite score of 29 and maximum score of 85. Participants 
failed to engage in T3 Equitest data collection due to follow-up care transferred to local 
services in Galway (n=1; 7.7%), inability to complete assessment due to post-operative 
morbidity (n=2; 15.4%) and on-going adjuvant therapy (radiation and chemotherapy) 
limiting participation (n=2, 15.4%). The SOT data for the three tested time-points is 
presented in table 5g (overleaf). 
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Table 5g SOT composite equilibrium data 
 
Time-point                       Composite Score    
                     (Mean and SD)  
One (Pre-operative) (n=13)           58.7 ± 16.2    
Two (Post-operative) (n=9)                 61.3 ± 11.0     
Three (Clinic Review – 6 weeks) (n=8)          68.1 ± 18.8  
 
 
 
 
 
Figure 5c All available SOT composite scores over T1, T2 and T3 for all participants 
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Figure 5d SOT composite data for participants with complete data sets at all time-points   
 
 
 
 
Figure 5e Pre and post-operative Composite SOT scores for participants with cerebellar 
tumours   
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5.9.2 Equitest: Condition Five and Six of the Sensory Organisation Test (SOT) 
Conditions five and six of the SOT challenge a person’s ability to use input from the 
vestibular system. The mean and standard deviation for condition five and six was 
calculated for each time-point. Table 5h below outlines the data from the two test 
conditions. The average number of falls experienced by the participants during testing of 
conditions five and six is also represented.  
 
Table 5h Condition five and six of the SOT  
 
SOT condition    Mean and SD    Number of Falls  
 
Condition Five  
 T1 (n=13)   25.8 ± 27.6   1.6 
 T2 (n=9)   20 ± 18.7   1.5  
T3 (n=8)   44.5 ± 30.2   0.9 
     
Condition Six  
 T1 (n=13)   35.7 ± 26.9   1.2   
 T2 (n=9)   39.3 ± 30.2   1.1   
T3 (n=8)   45.0 ± 31.6   1.0   
 
 
 
 
 
 
 
88 
 
 
 
 
Figure 5f Average equilibrium scores for each participant on condition 5 of the SOT  
Foot note: Reasons for missing data: P3 (T3) follow-up care transferred to another site, 
P4(T2, T3) Assessments limited by post-operative morbidity, P6(T2, T3) Assessments limited 
by post-operative morbidity, P7 (T2) Discharge from hospital prior to testing completion, P8 
(T2) Refusal to participate due to post-operative pain, P9 (T3) On-going adjuvant therapy 
(radiation and chemotherapy) limiting participation, P11(T3) On-going adjuvant therapy 
(radiation and chemotherapy) limiting participation.  
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Figure 5g Average equilibrium scores for each participant on condition 6 of the SOT 
Foot note: Reasons for missing data: P3 (T3) follow-up care transferred to another site, 
P4(T2, T3) Assessments limited by post-operative morbidity, P6(T2, T3) Assessments limited 
by post-operative morbidity, P7 (T2) Discharge from hospital prior to testing completion, P8 
(T2) Refusal to participate due to post-operative pain, P9 (T3) On-going adjuvant therapy 
(radiation and chemotherapy) limiting participation, P11(T3) On-going adjuvant therapy 
(radiation and chemotherapy) limiting participation.  
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Figure 5h Average equilibrium scores for participants with complete datasets on condition 
5 of the SOT 
 
 
 
 
 
Figure 5i Average equilibrium scores for participants with complete datasets on condition 
6 of the SOT 
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5.9.3 Gait  
Outcome measure: 10 metre walking tests at preferred and max gait speeds and with 
horizontal head turns.  
Walking speed was assessed using 10m walking tests. The walking tests were completed 
under three different conditions; self selected walking speed, maximum speed and self 
selected walking speed with included horizontal head turns. An average of the results of 
three trials was included for each participant, for analysis.  
At T1 all thirteen participants completed the testing, at T2 nine participants completed 
testing and at T3 eight participants completed the testing. The preferred gait speed data for 
the three tested time-points is presented in table 5i (below). 
 
Table 5i Preferred self-selected gait speed  
 
Time-point       Mean and SD (m/s)  
 
T1 (n=13)       1.3 ± 0.3    
T2 (n=9)       0.9 ± 0.4    
T3 (n=8)       1.3 ± 0.2 
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Figure 5.9.3.1 Graphical representation of preferred gait speed for all participants at all 
three time-points  
 
 
At T1 all thirteen participants completed the testing, at T2 nine participants completed 
testing and at T3 eight participants completed the testing. The maximum gait speed data for 
the three tested time-points is presented in table 5j (below). 
Table 5j Maximum Gait Speed  
 
Time point      Mean and SD (m/s) 
 
T1 (n=13)     1.7 ± 0.4     
T2 (n=9)     1.2 ±0 .4      
T3 (n=8)     1.5 ± 0.3      
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Figure 5k Graphical representation of maximum gait speed for all participants for all three 
time-points 
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At T1 all thirteen participants completed the testing, at T2 nine participants completed 
testing and at T3 eight participants completed the testing. Mean preferred walking speed 
with associated horizontal head turns is outlined in table 5k (below). 
 
Table 5k Gait speed with horizontal head turns  
 
Time-point     Mean and SD (m/s)  
 
T1       1.3 ± 0.3      
T2       0.9 ± 0.4      
T3      1.1 ± 0.5   
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Figure 5l Graphical representation of preferred gait speed with associated horizontal head 
turns for all three time-points  
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5.9.4 Upper Limb Dexterity 
Outcome measure: Nine Hole Peg Test (NHPT) 
Upper limb dexterity was measured using the NHPT and was completed for bilateral upper 
limbs. Eleven participants (85%) were right hand dominant and two participants were left 
hand dominant (15%). Completion of the NHPT for both upper limbs was carried out at T1, 
T2 and T3 for participants. Pre-operatively at T1 the average speed of completion of the test 
was 24.34 seconds, at T2 average speed was 23.35 seconds and at T3 average speed was 
24.30 seconds for the right upper limb. For the left upper limb at T1 the average speed of 
completion was 28.24 seconds, at T2 average speed was 25.46 seconds and at T3 average 
speed was 25.90 seconds. All thirteen participants completed the NHPT at T1, nine 
completed testing at T2 and eight participants completed testing at T3.  
 
Table 5l Right Upper Limb Dexterity 
 
Time point       Mean and SD (secs)  
 
T1       24.3 ± 13.7     
T2        23.4 ± 4.2     
T3        24.3 ± 14.5  
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Figure 5m Right upper limb NHPT score in seconds for each participant at all three time-
points  
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Table 5m Left Upper Limb Dexterity 
 
Time point       Mean and SD (secs)  
 
T1        28.2 ± 21.0     
T2        25.5 ± 5.6   
T3        25.9 ± 12.3  
 
 
 
 
Figure 5n Left upper limb NHPT score in seconds for each participant at all three time-
points  
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Ten participants (77%) were diagnosed with a tumour of the cerebellum. Eight participants 
(62%) had an intramedullary lesion of the cerebellum and two had an extra-medullary lesion 
(15%). Eight of the participants had the tumour occur within the cerebellar hemispheres and 
two occurred within the vermis. The mean age of the participants with tumours of the 
cerebellum was 54 ± 13.35 years. Figure 5o represents the mean completion times of the 
NHPT for all participants with a cerebellar tumour. Data for the right upper limb is 
represented.  
 
 
 
Figure 5o Mean NHPT completion times at T1, T2 and T3 for participants with cerebellar 
tumours (n=10)  
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5.9.5 Dizziness 
Outcome measure: Dizziness handicap inventory 
Dizziness of the participants was captured by using the Dizziness Handicap Inventory, a 
measure of self-perceived dizziness. This measure was completed at all four time-points in 
the study. At T1, pre-operatively all thirteen participants completed the DHI, at T2 nine 
participants completed the DHI, at T3 eight participants completed the DHI and at T4 seven 
completed the DHI.  
 
Table 5n Dizziness handicap inventory  
 
Time point       Mean and SD     
 
T1 (n= 13)      21.2 ± 22.9    
T2 (n= 9)      32.2 ± 30.1     
T3 (n= 8)      24.3 ± 28.9     
T4 (n= 7)      25.1 ± 26.6  
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Figure 5p DHI scores for all participants at all time-points 
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5.9.6 Post-operative pain  
Outcome Measure: Box scale for pain   
The Box scale for pain was used to capture a subjective measure of the participant’s post-
operative pain. This measure was completed at T2, T3 and T4 to capture post-operative pain 
that may impact on ability to participate with physical outcome measures.  At T2, 10 
participants completed the box scale for pain, eight participants completed the box scale at 
T3 and eight at T4. One participant refused to engage in T2 testing due to reported 
significant post-operative pain.  
 
Table 5o Box Scale for Pain   
 
Time point      Mean and SD      
 
T2 (n=10)      3.1 ± 2.6    
T3 (n=8)      0.3 ± 0.7     
T4 (n=8)      0.5 ± 1.1 
 
 
 
 
 
 
 
 
 
 
 
103 
 
 
 
 
Figure 5q Post-operative surgical site wound pain as captured on the Box scale for pain 
Footnote: Rating scale for pain ranging from zero to ten     
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5.9.7 Quality of Life 
Outcome Measure:  Linear Analogue Scale Assessment    
The LASA scale was completed for measurement of the participant’s perception of quality of 
life in five different domains. They included overall quality of life, intellectual wellbeing, 
physical wellbeing, emotional wellbeing and spiritual wellbeing. Twelve participants 
completed the measures at T1 and eight completed the T4 measures. The LASA values for 
pre-operative testing are outlined in table 5p (below). 
 Table 5p LASA scores at T1 and T4 
 
Quality of Life Variables              Mean and SD 
              T1       T4    
 
Overall quality of life      7.3 ± 2.5 7.1 ± 2.2   
Intellectual well-being    7.6 ± 2.1 7.9 ± 2.0   
Physical well-being     7.9 ± 2.4 6.9 ± 2.5  
Emotional well-being     7.3 ± 1.6 7.3 ± 1.4   
Spiritual well-being     8.3 ± 2.4 8.3 ± 1.6  
 
 
 
  
 
 
 
 
 
 
105 
 
5.10 Inpatient Days 
The number of days each participant was an inpatient in Beaumont Hospital was captured. 
The mean number of days in hospital was 19.8, with the minimum number of days five and 
the maximum number of days 81. 
 
Table 5q Inpatient Days  
 
       Mean and SD      
 
Inpatient Days (n=13)    19.8 ± 21.6     
 
 
Figure 5r (below) is a graphical representation of the correlation between the size of a 
participant’s tumour and the association with number of inpatient days in Beaumont 
Hospital. A non-linear relationship between the size of the tumour and the number of 
inpatient days is depicted.  
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Chapter 6: Discussion  
6.1 Introduction  
The primary aim of this research study was to characterise balance, gait, dizziness, upper 
limb dexterity and quality of life in patients, pre and post posterior fossa tumour surgery. 
The secondary aim was to evaluate the demographic and tumour characteristics of the 
included participants. The experimental hypothesis was that subjects with posterior fossa 
tumours would demonstrate reduced balance, reduced gait speed, increased dizziness and 
reduced upper limb dexterity and quality of life post-operatively when compared with their 
pre-operative status. The results of the research study showed a small increase in the 
primary endpoint, composite equilibrium score on the SOT of computerized dynamic 
posturography post-operatively, which does not support the study hypothesis. A reduction 
in gait speed for all testing conditions, a reduction in nine hole peg test completion speed 
and an increase in post-operative dizziness were also identified, supporting the study 
hypothesis in relation to secondary endpoints. 
6.2 Description of the study group  
The cohort of recruited participants in this research study consisted of eight females and 
five males, who demonstrated a similarity in the inter-gender age profiles. The majority of 
research currently available in relation to posterior fossa tumours has contained paediatric 
cohorts. The propensity for investigation of this topic in children relates to the high 
occurrence rate of paediatric posterior fossa tumours (Zakrzewski et al., 2003), high risk of 
malignancy (Park et al., 1983) and the associated morbidity (Cochrane et al., 1994). The 
limited research currently available in the adult population, profiling the impact of surgery 
and the resultant impairments, makes this a novel piece of neuro-oncology research in the 
adult population.   
This research study classified an adult as an individual over the age of 18 years and only 
adult participants were recruited for inclusion and participation. Within the catalogue of 
adult research, discrepancies exist in relation to the classification age of adults. In a profile 
of medullablastoma patients, a common posterior fossa tumour diagnosis, those over the 
age of fourteen were classified as adults (Kumar et al., 2015), while Menon et al (2008) 
classified an adult as being  over the age of 16. A large volume of literature is available that 
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classifies participants as those over the age of 18 (Greenberg et al., 2001) but  care must be 
taken when making comparisons between the research populations given the discrepancies 
that exist between presentation, management, histology and prognosis of this complex 
population, based on age.   
6.3 Presenting Features 
A large variety of presenting features were evident in the study cohort. Headache 
historically has been classified as one of the most frequently occurring features of a brain 
tumour (Buckner et al., 2007) and was present in nine of the study participants (69.2%), at 
first presentation to a medical facility. According to the international classification of 
headache disorders (2013), brain tumour related headache has a tendency to present worst 
in the morning, be aggravated by coughing and be progressive in nature.  In a study 
investigating the characteristics of headaches in brain tumour patients, Schankin et al (2007) 
found headaches to be a presenting feature in 60% of their participants, with only one study 
participant (2%), experiencing headache as their sole feature at presentation. Seventy-one 
per cent of the participants diagnosed with an infra-tentorial tumour experienced headache, 
which is similar to the occurrence rate of tumour related headache in this study. In a study 
reviewing the presenting characteristics of patients with posterior fossa 
haemangioblastomas, 64% presented with head pain classified as being related to changes 
in intracranial pressure or more localised occipital pain (Jeffreys, 1975). Jeffreys (1975) 
included the data of five spinal haemangioblastoma patients in their study, which may 
account for the slightly lower occurrence of headache, as spinal pathology would not be 
routinely associated with the presence of headache. The low incidence of independently 
occurring headache highlights the importance of careful evaluation of patients, to ensure 
associated features are recognised to assist in the diagnosis of those at risk of a sinister 
diagnosis.  
Brain tumour histology can influence the potential of experiencing tumour related 
headache. In this study, cerebellar metastases (METS) was the most frequently occurring 
histology type, with 71% of those diagnosed with a metastatic tumour in the cerebellum 
experiencing headaches (n = 7; 54%). Schankin et al (2007) did not identify any clinical 
significance between the diagnosis of a metastatic lesion and the increased incidence of 
headache but they did find diagnosis of a meningioma was associated with a trend towards 
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increased presence of headache (P = 0.06). Only two individuals (14.7%) in this study were 
diagnosed with a meningioma and both had headache as a presenting feature. Comparison 
of presenting features between the two study cohorts is difficult as Schankin et al (2007) did 
not restrict inclusion, based on cerebral location of the tumour. This study included only 
individuals with a tumour in the posterior fossa and as a result a trend cannot be 
formulated, based on the small cohort numbers and variations in presentation. In a profile 
of 109 patients with cerebellar metastases, 38% experienced severe headache attributed to 
consequences of raised intracranial pressure secondary to hydrocephalus (Yoshida and 
Takahashi, 2009). A similar incidence was noted by Lassman and DeAngelis (2003) who 
found headache in 31% of a cohort of 1,013 patients diagnosed with cerebral metastatic 
lesions. The discrepancy between the higher rate of headache associated with the presence 
of a cerebellar metastases in this study, may be attributed to the overall small sample size 
and the limited number of cerebellar metastases diagnosis, on which to formulate 
conclusions.  
In individuals diagnosed with a brain tumour, presenting features tend to occur in clusters, 
with independent presenting features being rare. These features are often the consequence 
of raised intracranial pressure and are considered a common side-effect of a tumour of the 
posterior fossa. In the posterior fossa, headache associated with elevated intracranial 
pressure often presents with vomiting. In this study, four participants (31%) presented with 
both headache and vomiting on initial medical review, while three participants (21%) 
showed no signs of headache or vomiting as part of their presenting features. The presence 
of a vomiting centre has been catalogued in the “area postrema in the floor of the caudal 
part of the fourth ventricle” (Baker and Bernat, 1985). Tumours occurring in this region of 
the brain have been shown to impair appetite and cause nausea (Abecassis et al., 2013). 
Projectile patterns of vomiting have also been linked to involvement of the pons and the 
cerebellar peduncles (Baker and Bernat, 1985). In this study, five participants (38%) had 
features of headache and vomiting at presentation and four were diagnosed with metastatic 
lesions, all occurring in the cerebellum and one atypical choroid plexus papilloma of the 
fourth ventricle. In a profile of 111 patients with brain tumours, researchers found the 
presence of altered neurological exam, nausea, vomiting or a change in previous headache 
pattern generally indicative for the presence of a brain tumour (Forsyth & Posner, 2003). 
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While this study sample remains too small to extrapolate robust conclusions on the 
correlation of headache and vomiting, in this population it raises the question of a potential 
correlation that could be further explored, in the future, with a larger patient cohort. 
6.4 Tumour Characteristics 
A secondary aim of this research study was to investigate the tumour characteristics of the 
included participants. Within the posterior fossa, metastatic lesions remain the most 
commonly occurring tumour type in adult populations, with 53% of the participants in this 
study being diagnosed with metastatic lesions. The profile of metastatic primary tumour 
location within this study mirrors that of international research (Aragon-Ching and Zujewski, 
2007, Nguyen et al., 2009). Lung cancer remains the most frequent, primary tumour that 
metastasises to the brain and breast cancer represents the second (Gavrilovic and Posner, 
2005). In this study three participants were being treated for a secondary metastatic lesion 
to the cerebellum, resulting from a lung primary (23%) and two with a breast primary (15%). 
One male participant had a colorectal primary (7.7%) and one female participant an ovarian 
primary (7.7%). An American study investigating occurrence rates of metastatic lesions as a 
consequence of diagnosis with a primary tumour in the year 2007, found a 6% future risk 
rate, for development of a metastatic brain lesion (Davis et al., 2012). Of the population to 
develop metastatic lesions, 19.9% originated from a lung primary, 5.1% from a breast 
primary, 2.3% from colorectal primaries and 0.5% from an ovarian primary. In a Swedish 
population study, similar trends were identified in a retrospective review of oncology data 
between the years 1987 and 2006 (Smedby et al., 2009). In both sexes, lung primaries were 
the most frequent site to metastasise to the brain, 44% in males and 33% in females. Breast 
primaries accounted for 33% of the primaries in females. The Irish neuro-oncology annual 
report for 2012 (Neuro-oncology annual report, 2012), reviewed metastatic lesion 
occurrence rates and the associated primary regions. Lung primaries across both sexes, 
accounted for 38% of lesions and breast primaries 19%. While this study mirrors the overall 
international trends in primary tumour sites that metastasize to the brain, the small number 
of participants in the study and variations in histology, prevents the formulation of robust 
conclusions.  
While metastatic lesions were the most commonly occurring tumour histology in this study, 
other tumour histology types were also diagnosed in the research cohort. Two participants 
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were diagnosed with cerebellar meningiomas (14.4%). Both meningiomas provided 
compressive forces onto the cerebellar hemispheres of the involved participants, which 
caused the associated features that resulted in presentation to the medical facility. 
Optimum management of meningiomas is total surgical resection but in the posterior fossa 
access to the lesion can be complicated, due to the proximity to vascular and neurological 
tissues and the slow growing nature of this tumour type (Jung et al., 2014). In a review of 
158 patients admitted to a Korean institution for the management of an infra-tentorial 
meningioma, Jung et al (2014) highlighted an 81% gross total resection rate in their 
population. Both participants (14.4%) in this research study had sub-total excisions of their 
tumours. Failure to excise the tumour in its entirety requires consideration of 
supplementary treatments such as radiation therapy (Barbaro et al., 1987). Neither of the 
participants in this study received adjuvant radiation in conjunction with the surgical 
procedure, even though full resection of the tumour was not achieved.   
One participant (7.7%) was diagnosed with an atypical choroid plexus papilloma. Choroid 
plexus tumours (CPT) are rare, slow growing tumours that arise from the choroid plexus and 
are mainly of benign histology. They form less than 1% of adult brain tumours with their 
primary adult location occurring in the fourth ventricle or cerebello-pontine angle (CPA) 
(Turkoglu et al., 2014). Atypical choroid plexus papilloma (ACPP) is classified as a choroid 
plexus tumour displaying some characteristics of malignancy (Gopal et al., 2008), but 
definite classification criteria remain vague. In this research study one participant was 
diagnosed with an ACPP, WHO tumour classification Grade two (Louis et al., 2007). Given 
the propensity of this tumour to develop within the ventricular system it is often causative 
of hydrocephalus (Turkoglu et al., 2014). While this study participant was not diagnosed 
with pre-operative hydrocephalus, peri-surgical clot formation resulted in hydrocephalus 
development, leading to two subsequent surgeries to decompress the brain. The patient 
died 63 days post-surgically and had significant morbidity which limited post-operative 
testing. The vascular nature of this tumour heightens the risk of haemorrhage associated 
with surgical excision. In a profile of 26 patients undergoing surgery for the presence of a 
CPT, a mortality rate of 15% (4/26) was identified (McGirr et al., 1988). However, the deaths 
within the cohort were in individuals who received surgery prior to 1950, limiting the ability 
to draw comparison, based on neurosurgical advancement over several decades. A recent 
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review conducted in the USA, looked at surgical outcomes in a cohort of 24 individuals with 
ages ranging from six months to 55 years, diagnosed with CPPs (Safaee et al., 2013). This 
study mirrored findings of more historical series looking at CPPs, with a noted higher age in 
individuals with infra-tentorial lesions (p=0.002). Two patients (8%) were diagnosed with 
atypical CPPs, further highlighting the rarity of this tumour type.  
One participant (7.7%) was diagnosed with a cerebellar haemangioblastoma. While 
considered a rare tumour, accounting for 1.5-2% of all CNS tumours, 7-12% occurs within 
the adult posterior fossa (Resche et al., 1993). The highly vascular nature of this tumour 
complicates surgical management due to the high risk of bleeding, often requiring 
embolisation of the lesion prior to excision (Seong Eom et al., 2011). This participant did not 
require an embolisation prior to excision, which may be due to the cerebellar location of 
their lesion. Within the literature, the maximum merit of embolisation has been recognised 
in lesions occurring within the brainstem (Tampieri et al., 1993). The surgical resection of 
haemangioblastomas is the internationally accepted best management approach and is 
generally curative in this tumour type (Tomasello and La Torre, 2014). The participant within 
this study had a gross total resection of their tumour and did not require any follow-up 
therapy. The participant’s peri-operative course was complicated by the development of a 
pseudomeningocele, secondary to a CSF leak. In a profile of complications associated with 
posterior fossa surgical techniques, CSF leak was observed in 10% of the participants who 
underwent a posterior fossa excision secondary to a cerebellar lesion (Dubey et al., 2009). 
While 11 patients (2%) of the cohort of 500 participants were diagnosed with a cerebellar 
haemangioblastoma, the authors did not sub-analyse the number of haemangioblastoma 
patients who developed CSF leak, limiting the ability to calculate the associated risk of CSF 
leak in haemangioblastoma excision, within the cohort. Given the high association of this 
tumour type with the diagnosis of VHL syndrome, the participant underwent testing while 
an inpatient. The testing was negative for VHL, indicating a diagnosis of sporadic 
haemangioblastoma.   
One participant (7.7%) was diagnosed with a pilocytic astrocytoma. Pilocytic astrocytoma 
(PA) is a WHO grade one tumour, most commonly occurring in the paediatric population, 
with an incidence in adults of 0.1 cases per 100,000 person-years, in those over the age of 
45 years (Johnson et al., 2012). Considered a very rare brain tumour in adults, little evidence 
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is available in relation to the clinical course of this tumour in the adult population. In a large 
series of 127 adult PA patients, 50 of the included cohort had their tumour occurring within 
the posterior fossa, highlighting 39% localisation within the PF (Theeler et al., 2014). The 
median age profile of the cohort was 30 years, with the majority of participants aged 
between 18 and 39 years. The participant within this study, diagnosed with a PA was 21 
years, the youngest participant enrolled within the study, supporting the age profiling of this 
tumour as outlined by Theeler et al (2014). In a SEER (Surveillance, Epidemiology, and End 
Results) study, of over three thousand adult and paediatric cases, researchers looked at the 
associated hazard risk of a PA diagnosis across the lifespan (Johnson et al., 2012). A positive 
correlation between increasing age and associated risk was identified, with the oldest age 
category of 60+ identified as having the poorest survival. The relative survival associated 
with the age category (20 – 39 years) that the participant (21 years) from this study 
corresponded with, identified an observed survival of 93% at 24 months and 89.5% at 60 
months. Associated risk with location of the tumour was significantly worse in the adult 
population for all locations except the cerebellum. This study participant’s tumour was 
localised within the fourth ventricle. Peri-operative complications resulted in the participant 
having an intra-operative infarct, which complicated recovery and resulted in significant 
post-operative morbidity.  
The differing histological diagnosis obtained by each of the participants has been discussed 
and highlights the impact location, histology, and demographic variables can have on 
outcome. The characteristics of the tumour remain only one factor that influences the 
outcomes of this population of patients.  
6.5 Balance   
The role of computerised dynamic posturography (CDP) in the assessment of equilibrium 
and balance has been widely investigated. Two fundamental goals of CDP have been 
identified (Jacobson et al., 1993) including differentiation between central and peripheral 
causes of imbalance and to enable appropriate management of patient symptoms by 
maximising function and limiting the negative impact of the disability. The latter is 
particularly important in patients with imbalance due to a central lesion, given the potential 
of a progressive and life threatening clinical course.  
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Within this study, initial testing of the participants pre-operatively at T1, identified a 
composite equilibrium score of 58.7 ± 16.2 points. A large degree of variability between 
participants is highlighted with the large standard deviation, indicating variability in relation 
to participant’s presenting balance and equilibrium. This composite score shows a marked 
deficit in equilibrium when compared with normal data. In a study comparing SOT 
equilibrium scores across three ages categories, young (25.2 ± 5.6 years), middle age (50.9 ± 
5.7 years) and the elderly (67.4 ± 5.3 years), with this study, a significantly lower composite 
equilibrium score was attained by the elderly (67.6 ± 6.5 points) when compared with both 
the young (76.3 ± 5.7 points) and middle-aged (69.9 ± 5.8 points) norms (Liaw et al., 2009). 
The mean age of the participants in this study was 48.8 ± 15.7 years, indicating most 
similarity in age with the middle age-group. A notably decreased composite equilibrium is 
evident in this population (58.7 ± 16.2) when compared with the middle aged norms (69.9 ± 
5.8) from the study by Liaw et al (2009). In a study that compared results of CDP and 
electronystagmography in individuals with peripheral, central or mixed central and 
peripheral vestibular deficits, a higher prevalence of abnormality was detected in the 
participants with central involvement (Keim, 1993). These two studies identify both age and 
central diagnosis as potential contributors to reduced equilibrium scores when compared 
with normative data.  
The SOT was completed at three time-points during the research study; pre-operatively (T1), 
post-operatively (T2) and at six weeks follow-up (T3). The composite scores obtained for the 
cohort was 58.7 ± 16.2 at T1,  61.3 ± 11.0 at T2 and 68.1 ± 18.8 at T3. Previous researchers 
have identified an eight point change in the SOT composite score as a clinically meaningful 
change (Wrisley et al., 2007). On comparison of the composite scores obtained between T1 
and T2 and T2 and T3, an eight point change in equilibrium was not obtained. However, the 
average composite score obtained between T1 and T3 demonstrated a ten point change in 
score, highlighting a clinically significant increase in equilibrium, as measured by the SOT at 
six weeks post-operatively. The hypothesis of the study predicted a reduction in the 
composite equilibrium scores obtained post-operatively when compared with the pre-
operative measurements. However, there was a minor improvement noted in post-
operative equilibrium which does not support the proposed hypothesis. This improvement 
however is not clinically significant when compared with previously established minimal 
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detectable changes on the SOT (Wrisley et al., 2007). The results of comparison of pre and 
post-operative SOT scores should be regarded with caution due to differences in the cohorts 
tested over the two time-points. Only nine participants completed testing post-operatively 
as compared with pre-operative. The main body of research utilising CDP and the SOT to 
track changes in balance and equilibrium over time has been in vestibular rehabilitation to 
evaluate rehabilitation protocols (Meldrum et al., 2015, Pavlou et al., 2004). Within these 
studies the cohorts are often composed of participants with vestibular deficits resulting 
from either a peripheral or central lesion. No study is available that has used the SOT to 
track the impact of a neurosurgical procedure on associated function or outcome. This 
highlights the novelty of this research. As no pre-existing research is available in this 
population, it is impossible to draw direct comparison. As previously identified, the 
normative data that is currently available for SOT composite scores has classified the data 
according to age categories (Liaw et al., 2009). Due to the limited number of participants in 
this study, sub-classification of the SOT equilibrium based on age, is impossible.   
Within this study ten participants (77%) were diagnosed with a tumour of the cerebellum. 
Balance deficits associated with cerebellar dysfunction include increased postural sway and 
an increased potential to fall with the eyes open or shut (Thach and Bastian, 2004). The SOT 
data collected, relating to the cerebellar participants was distracted from the overall data 
sample and separate analysis was completed. All ten participants completed the testing pre-
operatively. The mean composite equilibrium score obtained was 54.1 ± 15.7 points. 
Analysis of the whole sample revealed a composite that was four points higher (58.7 ± 16.2), 
indicating when both the participants with cerebellar and fourth ventricle tumours were 
collectively analysed, balance function was marginally improved, indicating involvement of 
the cerebellum had a higher contribution to decreased stability. Only three participants 
(23%) were diagnosed with fourth ventricle tumours in this study. While involvement of the 
fourth ventricle has the potential to impair balance due to changes in intra-cranial pressure 
and associated hydrocephalus (Shoman and Longridge, 2007), no participants within this 
study population were diagnosed with hydrocephalus on MRI scan at admission. A study 
investigating the impact of infra-tentorial lesions on falls and postural stability in a cohort of 
Multiple Sclerosis patients, found that increased falls frequency and reduced static balance 
was associated with lesions located in the brainstem and middle cerebellar peduncle 
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(Prosperini et al., 2011), but reduced equilibrium as a result of CNS damage cannot be 
restricted and localised in its entirety to the exact location of the lesion (Prosperini et al., 
2014). While the lesions were located within the cerebellum or the fourth ventricle, the 
adaptive potential of the tumour due to mechanical and chemical adaptions involved in 
oncological processes, may have contributed to changes within the tumour surrounding 
environment, contributing to changes in stability (Blouw et al., 2003). While the 
pathogenesis of Multiple Sclerosis and brain tumours would differ significantly, both disease 
processes result in space occupying lesions that could cause compressive, destructive 
changes to brain tissues.   
Condition five and six of the SOT in this study were independently analysed, to determine 
the participant equilibrium on condition five and six and the associated number of falls that 
occurred under these testing conditions. As previously outlined condition five tests 
participants under conditions with eyes closed and unstable platform, while condition six 
has unstable platform with a sway referenced visual surround. Both the testing conditions 
aim to distort visual and somatosensory information, with greater deficits on these testing 
conditions being noted in individuals with deficits of the vestibular system (Di Fabio, 1995). 
This results in increased reliance on the vestibular system to compensate for the absence or 
distortion of the visual and somatosensory stimuli on these conditions. The scores obtained 
reveal reduced equilibrium post-operatively when compared with pre-operative scores and 
a significant improvement noted by six weeks. A similar trend was noted in the scores 
obtained for condition six. While a similar pattern in the equilibrium scores across both 
testing conditions is evident, condition five reveals a greater degree of dysfunction on 
testing in the pre and post-operative timeframes compared with condition six. Condition 
five of the SOT is believed to provide the most comprehensive assessment of vestibular 
function on the SOT (Jacobson et al., 1993). The cerebellum acts as the “adaptive processor” 
in the monitoring and adjustment of vestibular input through inhibitory modulation, when 
required, secondary to dysfunction (Khan and Chang, 2013). The localisation of the tumours 
within the cerebellum of ten participants correlates with the associated vestibular deficits, 
as highlighted by the dysfunction on condition five and six due to the significant role of the 
cerebellum in modulating vestibular inputs (Herdman, 2007).    
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6.6 Gait  
Mobility testing within the study utilised the 10m walk test under three different conditions, 
self-selected walking speed, maximal walking speed and self-selected walking speed with 
associated horizontal head turns. Walking speed has become a frequently measured 
outcome in research due to its ease of administration and grading and its ability to predict 
outcomes such as future health status (Fritz and Lusardi, 2009). Preferred walking speed 
gives a representation of the individual’s preferential speed at which to mobilise and 
maximum walking speed is the maximum speed at which an individual can ambulate safely 
(Steffen et al., 2002). Mobility with associated horizontal head turns was also included in the 
gait testing protocol due to increased difficulties with gait and balance associated with head 
movement in individuals with vestibular deficits (Marchetti et al., 2008). 
Normal gait speed is documented as ranging from 1.2 – 1.4 m/s, which accounts for 
variations in age, gender, and anthropometrics (Fritz and Lusardi, 2009). On review of the 
data collected for the study participants, preoperatively (1.3 ± 0.3 m/s) and at six week 
follow-up (1.3 ± 0.2 m/s), the gait speeds fall within normal ranges. Gait speed immediately 
post-operatively (0.9 ± 0.4), was outside the range of normal gait speed. This reduction in 
measured gait speed supports the study hypothesis in which a reduction in gait speed was 
anticipated, as a direct consequence of the surgery. The findings also highlight the return to 
pre-surgical walking speed, by the participants, at six weeks post-surgery. The influence of 
the cerebellum on gait speed and the potential impact of the surgery directly on the 
cerebellum (Hoogkamer et al., 2015), supports the noted changes in preferred gait speed 
over time in this cohort.  
Maximal gait speeds were collected for the participants, as sensory perturbations have been 
shown to have a higher impact on gait performance, of healthy subjects, when they walk 
slowly and less impact when they walk fast (Jahn et al., 2001). A noted deterioration in 
maximal gait speed was measured post-operatively (1.2 ± 0.4 m/s), with an associated 
improvement in maximal gait speed at six weeks (1.5 ± 0.3 m/s). In a TBI population, a 
change of 0.25 m/s was considered a clinically meaningful change in maximal gait speed 
(Van Loo et al., 2004). When compared with the pre-surgical, maximal gait speed (1.7 ± 0.4), 
a clinically significant reduced gait speed is evident immediately post-operatively but not at 
six weeks. Improvements between T2 and T3 were also clinically significant. When 
117 
 
extracting conclusions regarding clinically significant differences in maximal gait speed, the 
differences in the research populations need to be considered. The noted trend in maximal 
gait speed changes over the study time-points, supports the study hypothesis.  
In a comprehensive study investigating gait speed, based on gender and decade of life, the 
researchers identified a decrease in gait speed with associated age, and maximal walking 
speeds showed a more significant decline with age than preferred, self-selected speeds 
(Bohannon, 1997), in keeping with the results of this study. Direct comparison of both 
studies is not possible due to variants in the study data collection methods and analysis. In a 
review of normative self -selected walking speed data, male speeds of 1.18-1.34m/s were 
identified in a sample of varying age from ten to 79 years (Oberg et al., 1993). While the 
study contains paediatric cases and a slightly older category of patients, the large age range 
may account for flexibility in interpretation. The male preferred gait speed in the male 
cohort of this study fell within the normative rage as identified by Oberg et al (1993). For 
females the self-selected speed was 1.10 – 1.29 m/s. Within this study the mean female 
speed falls within this range. A variation in the age categorization of these studies, when 
compared with this study, prevents direct comparison but observations can be extracted.  
6.7 Upper Limb Dexterity  
Co-ordination has been defined as “synchronous, spatially coherent movement of two 
effectors” (Miall et al., 2001), with upper limb dexterity defined as “the fine voluntary 
movements used to manipulate small objects during a specific task, as measured by the 
time to complete the task” (Wang et al., 2011). The cerebellum has been shown to be 
involved in the modulation of upper limb dexterous movements with the characteristics of 
cerebellar incoordination including hypermetria, dyssynergia, and kinetic tremor (Haggard 
et al., 1994). The use of the NHPT as a measure of upper limb dexterity in this research 
study complies with the primary aim of the National Health Institute by using a brief and 
uniform measure in assessing neurological function. 
There were no significant differences in time taken to complete the NHPT across assessment 
points. Eleven participants (85%) were right handed and discussion will focus on right upper 
limb dexterity. While there is a minor deterioration in the speed noted immediately post-
operatively, a reduced standard deviation highlights greater homogeneity across the testing 
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scores obtained. Normative data, in relation to speed of execution of the NHPT is available.  
A study of 340 MS patients, that investigated measurement options for determining the 
severity of upper limb tremor and ataxia, included a control group of 140 normal 
participants, to establish normative NHPT data (Erasmus et al., 2001). Dominant hand speed 
in the control group was 17.81 seconds and non-dominant was 18.49 seconds. A greater 
than five second difference in execution of the task exists between the participants of this 
study, at all time-points and the pre-determined adult norms.  In a study that looked at 
establishing normative data for adults, using a commercially available NHPT kit, the authors 
found a high correlation between age and performance of the NHPT (males: right hand = 
0.908, left hand = 0.918; females: right hand = 0.890, left hand = 0.896) (Oxford Grice et al., 
2003). Data was not analysed according to hand dominance but collectively analysed as left 
and right side. Within the study, left hand dominance accounted for less than 10% of the 
population and the researchers deemed this adequately low to negate the need to analyse 
the data based on dominance. This study had two participants with left hand dominance, 
accounting for 14.7% of the study population. A large-scale epidemiological study 
investigated the NHPT across a wide range of American participants, aged between three 
and 85 years in an effort to establish age related normative data for the NHPT across the 
American population (Wang et al., 2015). In a sample of 3,936 participants, the researchers 
identified a non-linear relationship between dexterity and age and found adults aged 18 to 
30 years demonstrating the shortest mean completion time of 19 seconds, while adults 
aged 70 to 85 demonstrated the slowest completion time, 24.9 seconds. The small number 
of participants in this study makes sub-analysis based on gender and age difficult due to the 
restricted volume of data available and as a result direct comparison of the NHPT results in 
this study must be observed with caution.  
The location of the tumours within the posterior fossa in this population of participants was 
anticipated to impact on the ability to execute upper limb dexterous activities. Eight 
participants (62%) had their tumour located within the cerebellum, while two of the 
participants (15%) had the tumour located extra-axially and provided a compressive force 
on the cerebellar tissues. Researchers have identified functional localizations of the 
cerebellum and as a result knowledge of the location of the tumour can be linked to 
anticipated deficits, based on location (Witter and De Zeeuw, 2015). Limb movements are 
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believed to be controlled by the dentate nucleus, the interpositus nucleus, the intermediate 
cerebellar cortex and the lateral cerebellar cortex, implying that disruption to tissue in these 
areas would impact on upper limb motor control (Manto et al., 2012). Lang and Bastian 
(2002) investigated the involvement of the cerebellum in making a practiced movement 
more automatic, in a cohort of cerebellar damaged participants and found a reduction in 
the number of tasks completed, slower hand speed and degradation of the performance 
with a dual task component when compared to healthy controls. While a notable 
improvement in the task quality was noted with practice, the cerebellar group showed a 
more modest gain. The task for completion within their study was the formulation of a 
figure of eight task with the upper limb, while maintaining upright stance. The task was 
considered a novel activity ensuring that both the control and cerebellar group would have 
no prior practice, of such a task. The same would be assumed with the use of the NHPT 
within our research study, as it would be anticipated that the participants would have had 
limited exposure to the test prior to involvement in the study. On comparison of mean 
NHPT scores over the three testing timeframes of the participants with cerebellar tumours 
(n=10), a reduction in speed of execution was noted immediately post-operatively (T1, 25.6 
secs; T2, 23.1 secs, T3, 25.0 secs).  Pre-existing data outlining clinically significant changes in 
NHPT execution time is not available on which to draw comparisons. The study hypothesis 
anticipated a decrease in the speed of completion of the NHPT post-operatively due to the 
impact of anticipated surgical trauma. The observed improvement may be explained in part 
by the immediate decompressive impact of surgery on the cerebellum, relieving associated 
pressure and reducing symptoms (Gopalakrishnan et al., 2014). 
6.8 Dizziness 
Dizziness is viewed as a complex neurologic symptom that indicates an imbalance in the 
perception of balance (Stanton et al., 2007). Within the literature four differing types of 
dizziness are frequently discussed; vertigo, presyncope, disequilibrium, and nonspecific 
dizziness (Newman-Toker et al., 2007). Vertigo is linked to vestibular symptoms, presyncope 
with cardiovascular compromise, disequilibrium with neurological presentations and 
nonspecific dizziness associated with psychiatric or metabolic disorders. Central causes of 
dizziness are believed to account for a quarter of all cases of dizziness and tumours are a 
frequent contributor to central dizziness (Karatas, 2008).  
120 
 
Within this study, dizziness as a pre-operative presenting feature was captured in the 
participants due to the potential of dizziness occurring as a presenting feature in this 
population of patients. Seven participants (54%) had dizziness at presentation. This rate of 
dizziness as a presenting feature is much higher than identified in a profile of 20 cerebellar 
haemangioblastoma patients in which no patient presented with dizziness (Liao and Huang, 
2014). Association of dizziness solely with malignant lesions of the posterior fossa is not 
supported in the literature. In a case report of an individual with solitary fibrous lesion of 
the fourth ventricle, dizziness was one of the initial presenting features of this benign lesion 
(Montano et al., 2010). Of the three participants (23%) who had their lesion located in the 
fourth ventricle, all three experienced dizziness as a feature at presentation. The potential 
for ventricular lesions to impact on CSF flow and ultimately intracranial pressure could have 
contributed to the dizziness experienced by the participants with fourth ventricle lesions 
(Johnson et al., 2006). This highlights the potential, that dizziness as a pre-operative feature 
of posterior fossa tumours could be influenced by both the location and histology of the 
tumour.  
The Dizziness Handicap Inventory, a self-report measure of vestibular disease was utilised in 
this study to monitor the self-perceived disabling features of dizziness, pre and post-
operatively (Mutlu and Serbetcioglu, 2013). An eleven point difference is reported between 
scores pre and immediately post-operatively. This highlights the increase in perceived 
dizziness, between pre and post-operative testing and supports the hypothesis that the 
surgical intervention would result in increased levels of dizziness in the participants. While a 
deterioration in self-perceived dizziness levels is noted, an eleven point change signifies that 
surgery did not cause an 18 point, significantly meaningful change in self-perceived dizziness 
as measured by the DHI (Jacobson and Newman, 1990).  
DHI scores at T4 (25.1 ± 26.6) show a slight increase when compared with those measured 
at T3 (24.3 ± 28.9). With an increasing timeframe since surgery, a continued reduction in 
self-perceived dizziness would be anticipated. The increase in dizziness at T4 may be a result 
of the evolution of the metastatic lesions diagnosed within the cohort. At T4, DHI data for 
four of the participants (31% study participants) with metastatic lesions was captured. 
Metastatic lesions are commonly associated with vasogenic oedema and this in turn plays a 
pivotal role in enhancing the compressive forces of the tumour (Strugar et al., 1994). The 
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potential progression of these terminal tumours, with regrowth since the decompressive 
surgery, may have contributed to the increase in perceived dizziness at six months.  
6.9 Post-operative pain 
In the current study, pain severity as gathered using the numeric rating scale, the box scale 
for pain, highlighted the most significant post-operative pain experienced by participants 
was in the initial post-operative testing period (T2) (3.1 ± 2.6). This initial testing timeframe 
was determined, as outlined within the methodology as the earliest post-operative period in 
which the participant felt able to undertake the testing battery and was deemed 
appropriate by the treating neurosurgeon. Previous research, which has looked at post-
operative pain trends in a neurosurgical population, found that reported pain and requests 
for pain medication, decreased successively over days one, three and five, postoperatively 
in those receiving burr hole craniotomy surgery (Klimek et al., 2006). This research study 
also noted a downward trend in post-operative pain levels between T2 (3.1 ± 2.6) and T3 
(0.3 ± 0.7). This trend would be anticipated with post-operative natural healing, given that 
T3 assessments were completed at approximately six weeks post the surgical intervention.  
Kilmek et al (2006) looked at associated post-operative pain in 13 differing neurosurgical 
procedures. Craniotomy surgery was revealed to have the second lowest associated post-
surgical pain levels of all the interventions investigated. However there are significant 
differences between the study populations in both studies. Given the tumour locations 
being investigated in this study, surgical access was restricted to infra-tentorial approaches. 
Surgical access requiring a sub-occipital or infra-temporal approach has been shown to 
result in higher post-operative pain levels (Jellish et al., 2006). Noted increased pain levels in 
individuals undergoing surgical procedures that had sub-occipital or retro-sigmoid access 
routes suggest that potential trauma to major muscle groups may contribute to the higher 
pain levels in this population (De Benedittis et al., 1996).  
The potential for post-operative pain levels to impact on objective testing was a concern, 
given the associated risk with this surgical intervention, however only one participant (8%) 
refused to engage in the T2 testing procedures secondary to post-operative pain. The box 
scale for pain was not completed as a result but it can be assumed that pain levels would be 
classified as moderate or severe, given its impact on post-operative engagement in the 
research protocol. T2 mean participant scores (3.1 ± 2.6) are classified as moderate pain 
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severity on a numeric rating scale as determined by previous researchers (Gerbershagen et 
al., 2011).  This post-operative complication, coupled with the associated stress of awaiting 
a histology result, highlights the complexity of recruiting and researching in this population 
of patients in the acute phase.  
A noted minor, non-clinically significant increase in reported pain scores was evident 
between T3 and T4 (T3; 0.3 ± 0.7; T4; 0.5 ± 1.1). As previously outlined an expected decrease 
in pain levels would be anticipated in the increasing timeframe from the original surgery. T4 
box scale testing was completed by the PI over the phone. While emphasis was placed on 
pain and how it related to the original post-operative wound, responses may have been 
provided in relation to a more global concept of pain, which the participant may have been 
experiencing at that time.  Headache pain has been documented as more of a post-surgical 
issue than surgery site pain in individuals undergoing craniotomy surgery (Klimek et al., 
2006) and may have influenced T4 pain results. 
Several factors have been associated with influencing levels of perceived post-operative 
pain including age, sex, expected incision size and surgical procedure (Kalkman et al., 2003). 
In an orthopaedic study, Thomas et al (1998) identified pre-operative pain levels as a 
statistically significant predictor of post-operative pain. While the study cohorts differed 
considerably, it highlights the potential impact pre-surgical headache may have had on post-
operative pain outcomes. Nine participants (69%) experienced headache as one of their 
presenting features. The testing battery did not include a measure to capture this perceived 
pre-operative pain but may have provided useful information regarding post-operative 
perception of pain.  
6.10 Quality of Life (QOL)  
QOL, often termed health related quality of life (HRQOL), measures the impact of disease 
and the associated treatments on an individual’s perceived QOL (Dirven et al., 2014). 
Individual’s own health status and that of their families and friends has been identified as an 
important factor in people’s lives, with the ability to impact on QOL (Bowling, 1995).  
Limited curative treatment options and associated treatment morbidity, places increased 
emphasis on the need for appropriate HRQOL brain tumour measures, to assist with 
evaluation of the risks and benefits in brain tumour management options (van den Bent et 
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al., 2005). Within the literature, HRQOL has become increasingly recognised as a secondary 
endpoint in evaluation of brain tumour treatments, in randomized controlled trials (Mauer 
et al., 2008).  Within this study all participants (100%), underwent at least one surgical 
intervention with seven participants (53.9%) requiring post-surgical radiotherapy and four 
participants (30.8%) requiring chemotherapy, highlighting the potential risk within this 
population, of developing negative consequences of treatment, which could impact on 
HRQOL. 
QOL has become an umbrella term, that encompasses several key components that are 
viewed as integral to the concept of QOL, including physical functioning, health status, 
perceptions, life conditions, behaviours, happiness, lifestyle and associated symptoms 
(Moons et al., 2006) The LASA, linear analogue scale assessment, was used as a measure of 
HRQOL in this study, pre-operatively at T1 and post-operatively at T4. The LASA is a brief 
measure that is easily administered and has been shown to be a valid measure of HRQOL, in 
oncology populations (Locke et al., 2007). The LASA captured five of the common features 
of quality of life, as outlined in the literature (Carr and Higginson, 2001), including overall 
quality of life, intellectual well-being, spiritual well-being, emotional well-being and physical 
well-being, pre and post-operatively. 
On comparison of the pre and post-surgery QOL data, only one component, physical well-
being, showed a one point or greater change in score, pre and post-operatively. Fatigue in 
brain tumour patients, has been shown to have 40-50% more of a negative impact when 
compared with general oncology patients (Cormie et al., 2015). Increased levels of fatigue, 
combined with the trauma of surgery and psychological distress of coping with a brain 
tumour, may enhance fatigue levels, ultimately having a negative impact on physical ability. 
In a study investigating the impact of laparoscopic surgery on perceived postoperative 
fatigue, cardiovascular function, neuro-muscular performance and nutrition rather than 
psychological factors had the greatest impact on fatigue levels, post-surgery (Christensen et 
al., 1986). This supports the findings of this study as spiritual, emotional and intellectual 
well-being, as measured by the LASA showed negligible change, pre and post-operatively, at 
six months. Failure to complete the LASA immediately post-operatively and at six weeks 
follow-up may have resulted in the loss of valuable participant related data. 
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6.11 Loss to follow-up 
The nature of the cohort of participants under investigation in this study highlighted a 
considerable challenge in the ability to monitor and complete follow-up assessments 
according to the study protocol follow-up timeframes. The rarity of the condition and rigid 
inclusion and exclusion criteria, restricted the volume of potentially available participants 
which were recruited to this study. While this rigidity in the protocol resulted in small 
numbers of included participants (n=13) being identified, it provides a novel insight into a 
complex neuro-oncology population which has received very limited research attention to 
date.   
Difficulty in the recruitment of participants to healthcare research has become a concern 
that has resulted in a large degree of effort being employed to assist with identifying the 
barriers to participation. Several key factors have been identified as determinants in 
willingness to partake in research including experience of illness in a friend or family 
member, middle-aged, prior experience of inclusion in medical research, supported use of 
human subjects in research  and belief in ethnic diversity in medical research (Trauth et al., 
2000). It has been estimated that in cancer research only 2% of potentially eligible adult 
patients consent to participate in medical research (Tejeda et al., 1996). Only two 
individuals (6%) refused to participate in the study which is in direct contradiction with the 
participation rates as put forward by Tejeda et al (1996). As previously outlined education 
regarding healthcare and the disease process plays a role in participation in research. While 
previous exposure to the healthcare system may have assisted with initial recruitment of 
these participants, the terminal diagnosis created several issues with loss to follow up and 
subsequently missing data. During the course of this study three participants (24%) had died 
by the final testing time-point and two participants had significant morbidity which 
prevented testing (16%).  
Loss to follow-up is a major concern in brain tumour research trials (Newberry et al., 2010) 
and is mirrored in other major populations of research such as TBI (Carroll et al., 2004). 
Within research, several barriers to the research process have been identified in studies 
recruiting vulnerable populations such as dying patients. In a study in which the main study 
population was home hospice patients the main barriers identified were attrition and poor 
compliance. No difficulties were identified in the initial recruitment of the population 
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highlighting a willingness of dying patients to participate in research (Dobratz, 2003). While 
that population of patients were aware of their terminal diagnosis, within this study tumour 
histology and diagnosis would only have been discovered post-operatively and subsequently 
post-recruitment and would not have been a factor of influence in original recruitment. In a 
longitudinal study of palliative cancer and HIV patients, within a sample of 38 cancer 
patients, only 13% of the recruited sample completed the testing protocol (Sherman et al., 
2005). 57% of their data was incomplete due to death and illness which restricted 
participation. In this study incomplete data is an issue at several time-points throughout the 
study. At T4 no outcomes are collected for five participants (38%) due to death, morbidity or 
illness. The discrepancy in retention at follow-up is attributable to the fact this study only 
had a six month follow-up compared with two years in the Sherman et al (2005) study.    
6.12 Mortality 
The overall mortality of the study was 23% (3/13) with three participants having died by the 
final testing timeframe (6 months). Mortality associated with surgical procedures carried 
out on the posterior fossa is believed to have a higher rate of mortality and significant 
morbidity when compared with supra-tentorial procedures (Dubey et al., 2009). In a study 
of 500 patients who underwent posterior fossa surgeries for a variety of diagnosis, CSF 
leaks, meningitis, wound infection, cranial nerve palsies, cerebellar oedema, hydrocephalus 
and death were identified as complications that are more frequently observed in infra-
tentorial surgical techniques, when compared with supra-tentorial surgery (Dubey et al., 
2009). The complication rate within their cohort equated to 31.8% of all surgeries, 
highlighting the associated risk with posterior fossa surgical approaches.   
Two of the participants that died were diagnosed with a metastatic lesion of the brain, with 
the primary location for both occurring in the lung. Survival with diagnosis of a metastatic 
brain lesion is considered low, with the median expected survival timeframe generally 
months rather than years (Gavrilovic and Posner, 2005). Metastatic lesions to the CNS, 
originating from a lung primary have been speculated to adhere to the “Seed and Soil 
hypothesis” (Fidler, 2003) as well as dependence on blood flow to assist with transport and 
subsequently, invasion of the brain tissues (Weiss, 1992). The Seed and Soil hypothesis 
postulates that the tumour cells (seeds), derived from the primary lesion are transported to 
and find optimum conditions in the brain tissue, to undergo rapid proliferation (Fidler, 
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2003).  The aggressive nature of metastatic lesions of primary lung origin and the associated 
poor survival of a metastatic lesion to the brain is highlighted in this study by the death of 
two participants within the six month follow-up timeframe.  
One participant (7%), diagnosed with an atypical choroid plexus papilloma died within the 
six month follow-up of the study. Although the histological parameters of the tumour are 
consistent with a WHO grade two histology, the vascular nature of the lesion and the site of 
origin within the fourth ventricle increases the complexity of access during surgery and the 
risk of bleeding. In a surgical series of 26 patients with choroid plexus papilloma, two 
patients undergoing gross total resection died peri-operatively (McGirr et al., 1988). While 
the participant in this study also underwent a gross total resection, comparison of the 
surgical outcomes across the two studies is impossible due to limited information 
documented by McGirr et al (1988) in relation to the peri-surgical complications resulting in 
death. The participant in this study required two subsequent surgeries due to the 
development of hydrocephalus secondary to a clot formation post-operatively. The surgical 
risk associated with the development of hydrocephalus and haemorrhage in this tumour 
type has been supported in surgical series in the literature (Boyd and Steinbok, 1987), with 
increased morbidity associated with a posterior fossa location of the tumour (Barbosa et al., 
2001).  
6.13 Health Care Utilization 
The societal burden of treating and managing patients diagnosed with brain tumours, has a 
significant impact on economies, governments, health systems and individuals (Raizer et al., 
2014). In a comprehensive European review of the economic impact of varying brain 
pathologies, brain tumours were identified as one of the most costly diseases of the brain to 
treat, with an average spend of approximately €26,000 per patient, in 2010 (Olesen et al., 
2012). On analysis of the Irish data within the study, the predicted total cost of brain tumour 
treatment in Ireland was in excess of €7.5 million, in 2010 (Olesen et al., 2012).  
In a review of brain tumour surgical activity within the Republic of Ireland in 2012, 680 
intracranial surgeries were completed for primary and secondary brain tumours within Irish 
neurosurgical centres. Beaumont Hospital executed 552 of the cerebral neuro-oncology 
surgical interventions, equating to 73% of all the surgeries completed in the country for 
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adults requiring a surgical intervention due to the presence of a brain tumour (Neuro-
oncology annual report, 2012). In 2012, 2,073 neurosurgical procedures were completed in 
Beaumont Hospital, making brain tumour surgery, 27% of the adult neurosurgical caseload 
(Beaumont Hospital Annual Report, 2012). 
The breakdown of specific surgical and medical modalities, utilised in management of brain 
tumour patients, has had limited research to date, making cost analysis of the components 
of brain tumour patient care difficult. In a Swedish study of brain tumour management 
costs, the number of acute inpatient neurosurgical bed days utilised, based on 1996 data, 
were 11,687, at a cost of 7.8 million US dollars (Blomqvist et al., 2000). This equates to $667, 
per bed, per day. The cost of a neurosurgical bed, per day in Beaumont Hospital, during the 
duration of the study was €286, per bed, per day (Beaumont Hospital Finance Report, 2015). 
Costings, for an intensive therapy unit (ITU) bed, per day were €1873 (General Intensive 
Care and Richmond Intensive Care Audit, 2014).  257 neurosurgical bed days were utilised 
by the study cohort, 221 days in ward based beds and 36 in ITU. This equates to a total cost 
of €130,634, to maintain the study participants in acute neurosurgical beds, in Beaumont 
Hospital, over the study duration.   
The average length of stay, across all departments of Beaumont Hospital, in 2012 was 9.9 
days (Beaumont Hospital Annual Report, 2012) and 9.25 days in 2013 (Beaumont Hospital 
annual report, 2013). Within this study, the average length of stay of the participants, in an 
acute neurosurgical bed, was 19.8 ± 21.6 days. This figure is higher than the LOS, for a 
population of brain tumour patients undergoing a craniotomy for brain tumour, in an 
academic teaching hospital in Maryland, USA (Long et al., 2003). The average LOS was 9.9 
days, considerably shorter than that seen in the study participants. The discrepancy may be 
due to the differences between the health service delivery systems in Ireland and the USA 
and the localisation of all tumours in this study within the posterior fossa. While a modest 
trend in decreased average length of stay (LOS) is notable between the years 2012 and 2013 
for the hospital, participants of this study had considerably longer LOS. While total average 
LOS for the hospital over the duration of the study is not available, the longer length of stay 
in this cohort, when compared with previous hospital averages, reflects the complexity of 
the diagnosis. Potential morbidity associated with diagnosis of a brain tumour (Mukand et 
al., 2001) and increased speciality MDT involvement, may contribute to this increased 
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demand on inpatient resources from this population of patients (Guilfoyle et al., 2011). Best 
practice in the management of brain tumour patients supports a multidisciplinary team 
approach to manage the diverse and complex needs of the brain tumour patient, which 
ultimately leads to longer hospital stays to allow the patient access to required services and 
reduce the burden of further travel to the hospital, post discharge (Eichler and Loeffler, 
2007). 
The protocol and testing battery completed as part of this study was conducted in full by the 
PI, a senior neurosurgical physiotherapist. The estimated timeframe for completion of each 
testing procedure was one hour. The protocol outlined four timeframes for the testing of 
each participant, with an associated four hours of senior therapist time, equating to 52 
hours of dedicated time to the participants as part of the protocol. Based on the cost of a 
senior physiotherapy salary per hour, implementation of this research protocol cost 
approximately €1,800, in physiotherapy time resources. Given the complexity of the 
presenting features and risk of surgical morbidity, careful and comprehensive examination 
of this population is essential to provide optimum care. The implementation of a testing 
battery for this population, based on the study protocol could potentially reduce service 
cost. Early identification of surgery associated deficits would allow for optimally timed, 
rehabilitation interventions, with the potential to reduce the number of inpatient bed days 
required, reducing overall cost to the hospital and ultimately, the Health Service Executive 
(HSE).  
6.14 Limitations 
Several limitations were encountered during the course of this research study and have 
been mentioned and discussed throughout this chapter. This section will give a summary of 
the main limitations experienced.  
The population of brain tumour patients being investigated were considered a rare cohort, 
with the potential numbers available to recruit to the study expected to be small. This 
proved to be the case, with only thirteen participants being recruited for participation. The 
small sample size limits the ability to extract robust conclusions in relation to the results of 
the study. While the numbers are small, a valuable catalogue of data relating to this 
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complex cohort is now available, profiling the impact of surgery on a variety of tumour 
associated impairments.  
Access to potential participants was often identified as a barrier to recruitment. A large 
volume of potential participants that presented to Beaumont Hospital were transferred 
under emergency procedures and received surgery prior to consideration for inclusion. The 
imminent surgery of these patients highlights the potentially critical nature of those with a 
posterior fossa tumour. This study protocol aimed to gather data on more functionally able 
participants, which formed a small subset of this population, based on excluded data. Care 
must be heeded on the extrapolation of patterns in relation to this population of patients, 
as more critical cases may never have had the potential for inclusion.  
Measurement variability was an issue throughout the research project. Variations in relation 
to patient access, post-operative complications and morbidity prevented standardisation of 
the testing protocol. Several participants failed to complete the full testing procedure due to 
morbidity and mortality. While every effort was made to standardise the testing procedure, 
the acute and critical nature of this population limited protocol execution. These 
methodological limitations however, provided valuable data in relation to the complexities 
in management and researching this population.  
The data gathered excluded tumours originating in the internal auditory meatus. This is a 
common site of origin for vestibular schwannomas. This tumour type has a tendency to 
grow and migrate out into the cerebello-pontine angle and can cause compressive force on 
the cerebellum and brainstem. Technically classified as a posterior fossa lesion, presentation 
and surgical management of this tumour type differs significantly to those discussed in this 
study. Exclusion of participants with this tumour type from potential inclusion, limits the 
conclusions that be extracted, in relation to all posterior fossa tumours that occurred in an 
eighteen month period, in Beaumont Hospital. 
Within this research study the objective testing battery, incorporating the Equitest, 10m 
walking tests and NHPT was not completed at the six month follow-up. This component of 
the protocol was designed to reduce the burden on the participants as travel back to 
Beaumont Hospital would not be required. As attendance in Beaumont was not guaranteed 
at this stage of the participants neurosurgical management and the potential of medical 
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deterioration at six months a phone follow-up to administer the subjective outcome 
measures was deemed appropriate to monitor patient status. While completion of the full 
testing battery at six months would have provided useful data, increased participant burden 
resulted in its exclusion from the finalised protocol.  
The quality of life data, using the LASA scale, was only completed by the participants pre-
operatively and at six months follow-up. Exclusion of the scale as a component of the testing 
battery at Tp two and three was to reduce participant burden but may have provided useful 
information in relation to peri-operative QOL in this population.  
The data captured in relation to the physiotherapy involvement in this population of 
patients did not capture the rehabilitation techniques utilised to treat the study 
participants, post-operatively. Analysis of the treatments provided would have enhanced 
the catalogue of data available in relation to this cohort. The lack of data collection in 
relation to the rehabilitation provided to the study participants was based on logistical 
limitations including time restrictions and study execution on a part-time basis. 
Retrospective analysis of the rehabilitation techniques used could be undertaken as a 
second stage research project in the future, to further enhance the catalogue of data in 
relation to this population.  
Loss to follow-up of participants was a major limitation of this study and resulted in reduced 
levels of data available for analysis. Given the small initial cohort numbers, this loss of 
follow-up data diluted the results obtained and the ability to extrapolate more robust 
conclusions. While loss of data is a limitation of the study, the morbidity and mortality 
resulting in incomplete datasets cannot be ignored as a very relevant feature of this 
population of neuro-oncology patients. 
The small volume of participants recruited to the study also limited the type of statistical 
analysis that could be utilised in the study. The statistical analysis in the study has been 
based solely on descriptive statistics. To adequately analyse the impact of surgery on 
balance, gait, upper limb dexterity and dizziness in this population, a larger population of 
patients, recruited over a longer period of time would be required, to allow for the use of 
inferential statistics.  
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6.15 Considerations for Future Research 
During the period of recruitment for the research study, thirty-one participants were 
excluded from the study for a variety of reasons. Difficulty in the recruitment of participants 
to healthcare research has become a concern that has resulted in a large degree of research 
being conducted to assist with identifying the barriers to participation. Several key factors 
have been identified as determinants in willingness to partake in research, including 
experience of illness in a friend or family member, being middle-aged, prior experience of 
inclusion in medical research, supported use of human subjects in research  and belief in 
ethnic diversity in medical research (Trauth et al., 2000). Misconceptions, fear, and a lack of 
appropriate information are also believed to limit participation in clinical research 
(Lawrence, 1990). It has been estimated that in cancer research, only 2% of potentially 
eligible adult patients consent to participate in medical research (Tejeda et al., 1996). 
Careful consideration of the pre-existing barriers to research and in particular cancer 
research, would assist with the establishment of research protocols that would 
accommodate maximum recruitment, in future brain tumour studies.  
The limited research available in this cohort and the difficulties identified in recruitment, 
make optimal protocol design for research in this population difficult. The limited catalogue 
of available research in this population highlights the need for further investigation in this 
cohort. This research study provides preliminary data on a rare population but several 
potential difficulties in the implementation of a second stage study exist. In chapter four, 
the significant lack of quality evidence evaluating rehabilitation in this population was 
identified. The conclusions drawn in the systematic review highlighted the need for further 
research to be completed to enhance the pre-existing catalogue. Small observational studies 
evaluating a particular rehabilitation approach might be more appropriate, in the initial 
phase. The use of smaller observation studies would enhance the available research 
catalogue available in relation to this population on which to structure more robust 
protocols. Components of the testing battery used in this prospective study could be used as 
the framework for a methodology, evaluating particular rehabilitation approaches.  
Prospective evaluation of treatment approaches for use in this population would 
consolidate the catalogue of evidence available in relation to surgery and rehabilitation in 
this population of patients. 
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Chapter 7: Conclusion 
The primary aim of this study was to investigate the impact of a surgical intervention on 
balance, gait, upper limb dexterity and dizziness in patients with posterior fossa tumours. 
The study hypothesis proposed a noted decrease in balance, walking speed, upper limb 
dexterity and an increase in dizziness, post-operatively, when compared with their pre-
operative status. The results obtained for the primary outcome, equilibrium and balance, 
did not support the hypothesis, with a noted improvement in balance and equilibrium post-
operatively. While a modest improvement was observed immediately post-operatively, it 
was not considered a clinically significant improvement. A clinically significant improvement 
was noted in balance and equilibrium by six weeks follow-up, when compared with pre-
operative status. Results of the secondary outcomes, gait speed, upper limb dexterity and 
self-reported dizziness, supported the study hypothesis, showing a decline in function post-
operatively. For each of the 10m walk testing conditions, a deterioration in function was 
noted post-operatively, with a significant improvement in gait speed captured by the six 
week follow-up. A similar pattern was noted for the NHPT when executed for the right 
upper limb but by six week follow-up, left upper limb dexterity had not improved when 
compared with the post-operative results. Participants self-perceived dizziness levels 
improved by six week review, with a very minor deterioration noted by six month follow-up. 
At both six weeks and six months post-operatively, self-perceived dizziness had not returned 
to pre-operative status. The results of the testing battery utilised in this study highlight the 
impairments associated with a tumour of this region of the brain and the comprehensive 
assessment that should be conducted as part of routine care on which to formulate 
adequate and comprehensive treatment programmes.  
The secondary aims of the study were to profile participant and tumour characteristics of 
the study participants. The profile presented of the included participants, provided 
confirmation of the rarity of the condition under investigation, the risk of malignancy 
associated with a tumour of this portion of the brain and the associated mortality and 
morbidity. The study has provided a profile of the characteristics associated with a tumour 
of this portion of the brain and will assist physiotherapists with pattern recognition and 
symptomology, on which to formulate clinical decisions.  
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In an era of health care volatility, with a demand for cost-effectiveness and consumer 
satisfaction, physiotherapists along with all members of the multi-disciplinary team, need to 
support clinical decisions with evidence based research. This research study has provided 
novel, comprehensive research into a neuro-oncological population that has received 
limited research to date. As previously outlined, with increasing numbers of patients 
presenting with tumours in this location of the brain, this research will provide a framework 
for physiotherapists, on which to formulate assessments and rehabilitation programmes to 
maximise recovery and function.  
Implementation of future research studies in this population needs to consider the 
morbidity and mortality associated with diagnosis of a posterior fossa tumour, as identified 
in this study. The results of this study highlighted the impact of surgery on outcome and 
provides novel information regarding the devastating physical consequences of the 
diagnosis and associated surgery. Future research direction involving this population should 
consider the exploration of qualitative research methods to explore patient perceptions of 
rehabilitation and physiotherapy confidence in the management of this complex population. 
Further insight into the patient’s perspective could assist with the tailoring of meaningful 
future quantitative protocols and will potentially assist with participant recruitment and 
reduce attrition.  
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Records identified through 
database searching 
(n = 3,815) 
Additional records identified 
through other sources 
(n = 17) 
Records after duplicates removed 
(n =3,624) 
Records screened 
(n = 3,624) 
Records excluded 
(n = 3587) 
Full-text articles assessed 
for eligibility 
(n = 37) 
Full-text articles excluded, 
with reasons (n = 32): 
 Tumour location 
not specific to the 
posterior fossa 
 A period of 
rehabilitation not 
provided to the 
subjects 
 
Studies included in 
qualitative synthesis  
(n = 5) 
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Appendix 10: Summary of studies included in systematic review entitled “Rehabilitation 
practices in the treatment of patients with tumours of the posterior fossa 
Study  Participants: 
n, sex, mean 
age  
Study 
Design 
Participant 
Characteristics 
Intervention  Duration of 
intervention  
Outcome 
Measures  
 
Ada et al, 
2009 
Australia 
 
 
One 5 year 
old female 
 
Single-
case 
design  
 
Had undergone 
full surgical 
resection for a 
low grade, large 
cerebellar 
pilocytic 
astrocytoma 3.5 
years previous 
 
Tracking task that 
required the 
participant to track 
the movements of 
a pseudo-random 
target on the 
computer screen 
using elbow joint 
flexion and 
extension 
 
 
 
12 
Intervention 
sessions of ten 
minutes 
duration  
 
Finger nose test 
for upper limb 
dexterity 
 
Nine hole peg 
test. Activity 
was recorded by 
speed and 
smoothness of 
movement on a 
10 point VAS   
scale  
 
 
Betker et 
al, 2006 
Canada 
 
 
Case 1. 20 
year old Case 
2. 58 year 
old 
 
Case3. 41 
year old 
 
 
Case 
study  
 
Case 1. Cerebellar 
tumour excision 
 
 
 
Case 2.  Right CVA  
 
 
Case 3. Closed TBI  
 
 
 
Centre of pressure 
(COP) controlled 
video game based 
exercise system  
 
No conventional 
balance 
rehabilitation  
 
8 x 45 minute 
sessions over 
three weeks  
 
Number of falls, 
range of COP 
excursion and 
COP path length  
 
 
Cremer, 
1998 
USA  
 
 
 
One 15 year 
old male  
 
 
Case 
study 
 
 
Post Posterior 
fossa 
medullablastoma 
excision with 
associated 
chemotherapy 
and radiotherapy   
 
 
 
MDT involvement 
but specific 
interventions not 
documented  
 
 
Received 
physiotherapy 
and 
occupational 
therapy input 
but 
programme is 
not outlined  
 
 
Nil Documented  
 
Gill-body 
et al, 
1997 
USA 
 
 
 
Case 1. 36 
year old 
female 
 
 
 
 
 
 
 
Case 
report  
 
Case 1. 7 months 
post excision of a 
recurrent 
cerebellar vermis 
pilocytic 
astrocytoma   
 
 
 
 
Customized 
rehabilitation 
programmes for 
both patients that 
focused on 
balance, gait and 
gaze stability 
exercises to 
improve functional 
 
Case 1. The 
patient had a 
weekly 30-45 
minute 
physiotherapy 
session with a 
30-40 minute 
HEP 
completed 
 
Dynamic 
posturography, 
dizziness 
handicap 
inventory (DHI), 
gait parameters 
including 
velocity, base of 
support, double 
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Case 2. 48 
year old 
male  
 
 
 
 
Case2. 
Cerebrotendinous 
xanthamatosis 
(CX) and diffuse 
cerebellar 
atrophy 
ability once daily, 5 
days a week 
for 6 weeks 
 
Case2. The 
patient had 
weekly 30 
minute 
physiotherapy 
sessions with a 
30 minute HEP 
completed 
once daily, 4 
times a week 
for 6 weeks  
limb stance 
time, dynamic 
gait index 
 
 
 
 
 
   
 
Karakaya 
et al, 
2000 
Turkey  
 
 
7 females 
and 13 males 
with 
posterior 
fossa 
tumours 
 
8 females 
and 12 males 
with 
cerebello-
pontine 
angle 
tumours   
 
Single 
case 
design 
 
20 subjects with 
posterior fossa 
tumours 
 
 
 
 
20 subjects with 
cerebello-pontine 
angle tumours 
 
Frenkel exercise, 
Proprioceptive 
neuromuscular 
facilitation (PNF), 
Training for 
dysmetria and 
disdiadochokinesia, 
balance, mobility 
and stairs 
rehabilitation  
 
Intervention 
five times 
weekly for two 
weeks  
 
Mokken’s 4 
point rating 
system to 
evaluate 
balance, 
customized 
evaluation of 
gait and limb 
ataxia 
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Appendix 13: Patient Information Leaflet  
 
Patient Information Leaflet  
 
 
Study title: “The impact of surgery on balance, gait, upper limb dexterity and 
dizziness in patients with posterior fossa tumours” 
 
 
Principal investigator’s name:   Kareena Malone 
 
Principal investigator’s title:    Senior Physiotherapist in Neurosurgery 
 
Telephone number of principal investigator:  (01) 8092526; (01) 8092535 
 
 
You are being invited to take part in a clinical research study to be carried out at Beaumont 
Hospital.  
 
Before you decide whether or not you wish to take part, you should read the information 
provided below carefully and, if you wish, discuss it with your family, friends or GP (doctor).  
Take time to ask questions – don’t feel rushed and don’t feel under pressure to make a 
quick decision. 
 
You should clearly understand the risks and benefits of taking part in this study so that you 
can make a decision that is right for you. This process is known as ‘Informed Consent’.  
 
You don't have to take part in this study. If you decide not to take part it won’t affect your 
future medical or physiotherapy care. 
 
You can change your mind about taking part in the study any time you like.  Even if the study 
has started, you can still opt out.  You don't have to give us a reason.  If you do opt out, rest 
assured it won't affect the quality of treatment you get in the future.  
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Why is this study being done? 
 
 Beaumont Hospital is the neurosurgical centre of Ireland and patients are routinely 
admitted for brain tumour surgery. The posterior portion of the skull houses the brainstem 
and cerebellum, two portions of the brain involved in the control of balance and walking. 
These tumours are also associated with causing dizziness. When a patient requires removal 
of a tumour from one of these portions of the brain, problems with the persons walking and 
balance can potentially occur.  
This study will assess walking, balance and dizziness in the patients before and after surgery 
to see if they are having any problems with these tasks. It will also allow the testers to see 
how the different types of tumour and their different locations impact on the patients 
walking and balance. 
 
 
Who is organising and funding this study? 
 
Kareena Malone, a Senior Physiotherapist in Beaumont Hospital is carrying out this study. 
Her supervisors are Mr Stephen McNally, Consultant neurosurgeon in Beaumont Hospital 
and Dr Rose Galvin and Ms. Dara Meldrum, lecturers in the School of Physiotherapy, Royal 
College of Surgeons (RCSI), Dublin. The study is part of a Masters Degree through research 
in RCSI. As requested the following section was deleted from the leaflet (version 2) 
 
Why am I being asked to take part? 
 
You are being asked to take part in this study because you have been admitted to Beaumont 
Hospital for surgery due to a tumour in the posterior portion of your brain.  All patients 
admitted for this surgery over a one year period will be asked to take part in the study. 
 
 
How will the study be carried out? 
 
The study will start in December 2012 and will continue until approximately June 2014.  
A person who volunteers for the study will have an assessment carried out before surgery, 
after surgery as an inpatient, at 6 weeks after surgery, on the same day as your clinic review 
and a telephone follow-up at 6 months. All testing will be carried out in Beaumont Hospital. 
At the end of the assessment all results will be explained to you. 
 
 
What will happen to me if I agree to take part? 
 
If you agree to take part in the study you will have an assessment carried out before your 
surgery in the physiotherapy department of Beaumont Hospital. An appointment will be 
arranged for a time that suits you. It is best to wear comfortable clothing for the 
assessments. You will undergo an assessment of your walking, using a marked out walkway 
that will take 5 minutes. You will also undergo a computerised assessment of your balance 
using a system called the Equitest which will take a further 15 minutes. A test to look at the 
control of movement in your hands and arms will be carried out that will take approximately 
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5 minutes and finally you will complete 2 questionnaires looking at your quality of life and 
symptoms of dizziness. 
After your surgery when you are well enough to recommence physiotherapy, the 
assessments will be repeated during your stay in hospital and then again at 6 weeks post 
discharge on the same day as your clinic appointment. The walking and balance tests will be 
repeated at these times and also the questionnaires. 
At 6 months post discharge from Beaumont I will contact you by phone and repeat the 2 
questionnaires over the phone.  
At the end of the assessments Kareena Malone will explain all the results to you.  
 
What other treatments are available to me? 
 
If you decide not to take part in the study you will receive your medical and physiotherapy 
care as normal. Refusal to be part of the study will not impact on the care you receive. 
 
What are the benefits? 
 
By taking part in the study you will benefit from detailed assessments, by a physiotherapist 
before and after surgery. You will receive appropriate advice based on the assessments. Any 
balance or walking issues you may be having will be picked up by the assessments. The 
impact of dizziness on your quality of life will also be looked at. By finding these deficits you 
can be treated more effectively and referred onto the appropriate services, as required 
 
 
What are the risks? 
 
Although you will be supervised at all times by an experienced physiotherapist, in a safe 
environment, there is a very small risk that you may sustain a fall as the assessments test 
your balance. To decrease the risk you can use your normal walking aid as required. You will 
be closely supervised throughout the testing by the assessor (Kareena Malone).  
Neck pain may also occur due to the post-op wound. We will minimise this risk by carefully 
assessing your pain (Deletion). There is also a small risk of dizziness due to the type of 
assessments but should you become dizzy I will stop testing.  Your level of tiredness will 
also be monitored throughout testing to prevent you feeling too tired after the tests.  
 
What if something goes wrong when I’m taking part in this study? 
 
If you experience any problems as a result of participating in this study Kareena Malone will 
be responsible for dealing with these problems and will discuss them with your consultant 
and his team if required. 
  
Will it cost me anything to take part? 
 
There is a time commitment required to complete the assessments that are part of this 
study. However, these assessments will be arranged during your stay in hospital or during 
your follow up clinic visit.  
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Is the study confidential? 
 
The main investigator (Kareena Malone) will look at your medical chart and online scan to 
gather the required information. Your GP and consultant will be informed of your taking 
part in the study. All of your information will be coded for protection. Your coded 
information will be saved on encrypted USB keys for five years after which time it will be 
destroyed according to the Beaumont policy 
 
Where can I get further information? 
 
If you have any further questions about the study or if you want to opt out of the study, you 
can rest assured it won't affect the quality of treatment you get in the future.   
If you need any further information now or at any time in the future, please contact:  
 
 
Name: Kareena Malone  
Address: Physiotherapy Department, Beaumont Hospital, Beaumont Road, Dublin 9   
 
Phone No: (01) 8092526; (01) 8092535 
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Appendix 14: Participant Consent Form  
 
Patient Consent Form 
 
 
Study title:  “The Impact of surgery on balance, gait, upper limb dexterity and 
dizziness in patients with posterior fossa tumours” 
 
I have read and understood the Information Leaflet about this research 
project.  The information has been fully explained to me and I have been 
able to ask questions, all of which have been answered to my satisfaction. 
Yes  No  
I understand that I don’t have to take part in this study and that I can opt 
out at any time.  I understand that I don’t have to give a reason for opting 
out and I understand that opting out won’t affect my future 
physiotherapy treatment or medical care. 
Yes  No  
I am aware of the potential risks of this research study. Yes  No  
I give permission for my GP to be informed of my involvement in this 
research study 
Yes  No  
I give permission for my Consultant to be informed of my involvement in 
this research study 
Yes  No  
I give permission for researchers to look at my medical records to get 
information.  I have been assured that information about me will be kept 
private and confidential. 
Yes  No  
I have been given a copy of the Information Leaflet and this completed 
consent form for my records. 
Yes  No  
I give permission to be contacted by telephone post discharge Yes  No  
Storage and future use of information: 
I give my permission for information collected about me to be stored or 
electronically processed for the purpose of scientific research and to be 
used in related studies or other studies in the future but only if the 
research is approved by a Research Ethics Committee. 
Yes  No  
  
 |   |  
------------------------------------------------------------------------------------------------------------------------- 
Patient Name (Block Capitals) | Patient Signature | Date 
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To be completed by the Principal Investigator or nominee.  
 
I, the undersigned, have taken the time to fully explain to the above patient the nature and 
purpose of this study in a way that they could understand. I have explained the risks 
involved as well as the possible benefits. I have invited them to ask questions on any aspect 
of the study that concerned them. 
 
 
 |   |  | 
--------------------------------------------------------------------------------------------------------------------------
--Name (Block Capitals) | Qualifications | Signature | Date 
 
 
3 copies to be made: 1 for patient, 1 for PI and 1 for hospital records. 
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Appendix 15: Consultant letter of participant involvement in study 
 
Physiotherapy Department, 
Beaumont Hospital, 
Beaumont Road, 
Dublin 9. 
 
Xx/xx/xxxx 
 
Re: “The impact of surgery on balance, gait, upper limb dexterity and dizziness in 
patients with posterior fossa tumours” 
 
 
Dear Mr_________________, 
 
I am writing in relation to a study that I am conducting in Beaumont Hospital physiotherapy 
department as part of an MSc by research, investigating the impact on balance and gait post 
posterior fossa tumour surgery. ____________________ was recruited to the study during 
their inpatient stay in Beaumont Hospital.  
 
The project is being supervised by Mr. Stephen McNally, Consultant Neurosurgeon, 
Beaumont Hospital, Dr. Rose Galvin, School of Physiotherapy, Royal College of Surgeons 
and Ms. Dara Meldrum, School of physiotherapy, Royal College of Surgeons.  
 
Participation in the study involves a pre-operative assessment that looks at balance, gait and 
dizziness. Post operatively the assessments are repeated during the inpatient stay, at the 6 
week neurosurgical clinic review and a phone follow-up at 6 months.  All objective 
assessments will be completed by the principal investigator, Kareena Malone, in the 
physiotherapy department of Beaumont Hospital.  
 
If you have any queries please don’t hesitate to contact me to discuss them further. I can be 
contacted on (01) 8092535 
 
Yours sincerely, 
 
___________________________________________ 
Kareena Malone, Senior Physiotherapist in Neurosurgery, Beaumont Hospital 
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Physiotherapy Department, 
Beaumont Hospital, 
Beaumont Road, 
Dublin 9. 
 
Xx/xx/xxxx 
 
Re: “The impact of surgery on balance, gait, upper limb dexterity and dizziness in 
patients with posterior fossa tumours” 
 
 
Dear Dr_________________ 
 
I am writing in relation to a study that I am conducting in Beaumont Hospital physiotherapy 
department investigating the impact on balance and gait post posterior fossa tumour surgery. 
____________________ was recruited to the study during their inpatient stay in Beaumont 
Hospital.  
 
The project is being supervised by Mr. Stephen McNally, Consultant Neurosurgeon, 
Beaumont Hospital and Dr. Rose Galvin and Dara Meldrum based in the School of 
Physiotherapy, Royal College of Surgeons. 
 
Participation in the study involves a pre-operative assessment that looks at balance, gait and 
dizziness. Post operatively the assessments are repeated during the inpatient stay, at the 6 
week neurosurgical clinic review and a phone follow-up at 6 months.  All objective 
assessments will be completed by the principal investigator, Kareena Malone, in the 
physiotherapy department of Beaumont Hospital.  
 
If you have any queries please don’t hesitate to contact me to discuss them further. I can be 
contacted on (01) 8092535 
 
Yours sincerely, 
 
 
Kareena Malone, Senior Physiotherapist in Neurosurgery, Beaumont Hospital 
 
 
                              Appendix 16: GP information letter  
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Data Collection Sheet                                                                                                      
 
Patient Name                                                                                   
Sex   
Age   
Height   
Weight   
MRI/CT         MRI                                                                                   CT 
Location  of SOL   
Size of SOL  
Histology   
Mass Effect          
Midline Shift          
Surgical procedure  
Total Excision           
Subtotal Excision           
For Chemotherapy           
For Radiotherapy           
Headache   
Nausea   
Vomitting   
Visual Deficit   
GCS on admission   
Dizziness           
Hydrocephalus  
Vertigo   
Tinnitus  
Oscillopsia  
Mobility Aid   
Days post op for 
initial assessment  
 
Days post op for 
clinic assessment  
 
Number of 
inpatient days  
 
ITU Admission   
Subject Reference Number  
Appendix 17: Data collection sheet  
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Appendix 18: Testing protocol at varying time-points 
 
Outcome Measure   T1  T2  T3  T4 
 
CDP     √  √  √   
10m Walks   √  √  √   
NHPT    √  √  √  
DHI    √  √  √  √ 
LASA    √      √ 
Box Scale      √  √  √ 
Demographics  √ 
Tumour Data   √  √ 
Length of Stay       √ 
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Appendix 19: Checklist for T1 
Testing Checklist T1 
 
 
 
Written and Verbal consent Obtained 
 
 
Copy of written consent to participant 
 
 
Copy of written consent placed in Med chart 
 
 
T1 assessment time scheduled 
 
 
Testing procedure explained to participant 
 
 
10m walk tests completed  
 
 
LASA Completed  
 
 
NHPT Completed 
 
 
DHI Completed  
 
 
Equitest Completed  
 
 
Tumour Parameters obtained  
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Appendix 20: Checklist for T2 
Testing Checklist T2  
 
 
Physiotherapy referral received from team 
 
 
Postoperative tumour data obtained 
 
 
T2 assessment time scheduled 
 
 
Testing procedure explained to participant 
 
 
10m walk Completed  
 
 
LASA Completed  
 
 
Box Pain completed  
 
 
NHPT Completed 
 
 
DHI Completed  
 
 
Equitest Completed  
 
Confirm phone contact will be made re clinic 
appointment 
 
 
Liase with secretaries re clinic appointment 
 
 
Refer to CPT if required 
 
 
 
 
 
 
 
 
 
 
 
195 
 
Appendix 21: Checklist for T3 
Testing Checklist T3 
 
 
 
Phone patient on day of clinic to ensure 
attendance 
 
 
Testing procedure explained to participant 
 
 
10m walk Completed  
 
 
Box Pain completed  
 
 
NHPT Completed 
 
 
DHI Completed  
 
 
Equitest Completed  
 
 
Refer to CPT if required 
 
 
Advise re phone contact at 6 months  
 
 
Forward letter to the GP  
 
 
Forward letter to consultant 
 
 
Insert date in diary for phone followup 
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Appendix 22: Checklist for T4 
Testing Checklist T4  
 
 
DHI completed 
 
 
LASA Completed  
 
 
Box scale completed  
 
 
Refer to CPT if required 
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Appendix 23: 10m Walk test protocol 
 
10m Walking Test Protocol 
The testing protocol used for the 10m walk tests was that outlined by Peters et al, 2013. 
Walking speed was assessed at participants' self-selected walking speed, fastest walking 
speed and self -selected walking speed with horizontal head turns using the 10-Meter Walk 
Test. 
Distances were provided at the beginning and end of the timed walkway (5m) to allow 
participants space to accelerate/decelerate outside the data collection area to help reduce 
gait variability.  
Each participant completed 3 consecutive trials for each walking test, for a total of 9 walking 
trials. 
Order of administration of the 3 different walking conditions was self-selected, fast and self-
selected with horizontal head turns, to allow participants an opportunity to familiarise 
themselves with the task, starting with those considered the easier tasks. 
Participants were instructed to “walk at your comfortable, normal pace” until they reached 
the end of the marked path for the self-selected speed. 
Participants were instructed to “walk as fast as you can but ensure you feel steady and safe” 
until they reached the end of the marked path for the fastest walking speed. 
Participants were instructed to “walk at your comfortable speed and turn your head from 
side to side, as fast as you can while keeping your balance” until they reached the end of the 
marked path for the walking trials with horizontal head turns. 
The PI measured walking time with a stopwatch, starting the stopwatch as soon as the 
participant's lead leg (or assistive device) crossed the first marker and stopping it when the 
participant's lead leg (or assistive device) crossed the second marker.  
The PI performed all stopwatch measurements to prevent introducing inter-rater variability.  
Participants were provided rest breaks as needed throughout the testing session.  
Averages were obtained for the three trials, for each condition tested 
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Appendix 24: NHPT testing protocol  
 
Nine Hole Peg Test Protocol 
The protocol was implemented based on the original protocol outlined by Mathiowetz et al, 
1985. 
The NHPT test consisted of a plastic console with a shallow round dish to contain the pegs 
on one end of the console and the nine-hole peg-board on the opposite end.  
Each participant was asked to centre the pegboard directly in front of him or her, oriented 
such that the shallow dish was on the participant’s dominant hand side and the peg holes on 
the non-dominant side. 
The participant was instructed to “place each of the nine pegs in the nine holes and once all 
nine pegs are in the holes, take them out, one at the time”.  
Participants were given the opportunity for a brief practice test prior to the actual test and 
were then tested using their dominant hand first, followed by their non-dominant hand. 
The tests were timed, with a stopwatch, from the moment the participant touched the first 
peg until the moment the last peg hit the dish. 
 
The test was then repeated for the non-dominant hand using the same testing method, with 
the pegboard rotated such that the dish was in front of the non-dominant hand.  
 
All participants were tested using this procedure. 
 
In the event that the participant dropped a peg or the trial was interrupted in any way, the 
PI cued the participant to stop and a new trial was initiated. 
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Appendix 26: Box scale for pain  
 
Box Scale for Pain  
 
 
 
Each number (e.g. 0–10) is written in a box and patients are asked: 
"If a zero (0) means 'no pain' and a ten (10) means 'pain as bad as it could be', on this scale 
of 0–10, what is your level of pain? Put an "X" through that number.”13 
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Linear Analogue self-assessment 
 
Adapted from the protocol used by Locke et al, 2007 
 
Directions: Please circle the number (0-10) best reflecting your response to the following 
that best describes your feelings during the past week, including today. 
 
1. How would you rate your physical well-being over the past week? 
This question refers to such things as fatigue, activity, etc. 
 
0         1         2         3         4         5         6         7         8         9         10 
As bad as                                                                                           As good as 
it can be                                                                                               it can be 
 
 
2. How would you rate your emotional well-being over the past week? 
This question refers to such things as depression, anxiety, stress, etc. 
 
0         1         2         3         4         5         6         7         8         9         10 
As bad as                                                                                          As good as 
it can be                                                                                             it can be 
 
 
3. How would you rate your spiritual well-being over the past week? 
This question refers to such things as a sense of meaning and purpose, relationship with 
God, etc. 
 
0         1         2         3         4         5         6         7         8         9         10 
As bad as                                                                                          As good as 
it can be                                                                                              it can be 
 
 
4. How would you rate your intellectual well-being over the past week? 
This question refers to such things as the ability to think clearly, to concentrate, to 
remember, etc. 
 
0         1         2         3         4         5         6         7         8         9         10 
As bad as                                                                                          As good as 
it can be                                                                                             it can be 
 
 
5. How would you rate your overall well-being over the past week? 
 
0         1         2         3         4         5         6         7          8         9         10 
 
As bad as                                                                                          As good as 
it can be                                                                                             it can be 
Appendix 27: Linear Analogue Scale Assessment (LASA) 
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Appendix 28: Data collection spread-sheet  
 
 
 
 
 
 
 
 
 
 
 
Intra-axial  Extra-axial Midline Shift Mass Effect Histology  WHO Grade  
No. of 
Surgeries  
1 2 2 1 1 4 2 
1 2 2 2 2 2 1 
1 2 2 1 1 4 1 
1 2 2 2 3 2 3 
2 1 2 1 4 1 1 
1 2 2 2 6 1 5 
2 1 1 1 4 1 1 
1 2 2 2 1 4 1 
1 2 2 1 1 4 1 
1 2 2 2 1 4 1 
1 2 2 1 1 4 1 
1 2 2 2 5 1 2 
1 2 1 1 1 4 1 
 
 
 
 
 
 
 
 
 
 
       
ID Sex Age Height  MRI  CT 
SOL 
Location SOL Size_cm  
PT001 2 59 171 1 1 4 3.5 
PT002 2 34 159 1 1 2 3.4 
PT003 1 56 174 1 1 4 3.7 
PT004 1 40 173 1 1 2 2.5 
PT005 2 69 164 1 1 4 4 
PT006 1 21 171 1 1 2 4.3 
PT007 2 44 170 1 1 4 3.2 
PT008 1 49 177 1 2 4 2.5 
PT009 2 39 160 1 1 3 2.5 
PT010 2 62 159 1 1 3 3 
PT011 1 77 175 1 1 4 4 
PT012 2 51 160 1 1 4 4.5 
PT013 2 34 160 1 1 4 3.9 
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Exposure  Total Ex Subtotal Ex Chemo RTX Headache  Nausea  Vomiting  
1 1 2 1 1 2 2 2 
1 1 2 2 2 2 1 2 
2 1 2 2 1 1 1 2 
2 1 2 2 2 1 1 1 
1 2 1 2 2 2 2 2 
1 1 2 2 2 1 2 2 
1 2 1 2 2 1 2 2 
1 1 2 1 1 1 2 2 
1 1 2 1 1 1 1 1 
1 2 1 1 1 2 1 1 
1 2 1 2 1 1 1 1 
1 1 2 2 2 1 2 2 
1 1 2 2 1 1 1 1 
 
Visual Disturbance  Adm_GCS Dizziness Hydrocephalus EVD Shunt Haemorrhage  Vertigo  
2 1 2 1 2 2 1 2 
2 1 1 1 1 2 1 1 
2 1 1 2 2 2 2 2 
2 1 1 2 1 2 1 1 
2 1 2 2 2 2 2 2 
1 1 1 1 1 1 1 2 
1 1 2 2 2 2 2 2 
1 1 2 1 2 2 2 2 
1 1 2 1 2 2 2 2 
1 1 1 2 2 2 2 2 
2 1 1 1 2 2 2 2 
2 1 1 1 1 2 2 2 
2 1 2 1 2 2 2 2 
 
Tinnitus  Oscillopsia Mobility aid Aid type  ITU admin DaysITU Secondary PrimaryLOC 
2 2 2 5 1 3 1 1 
1 2 2 5 1 1 2 6 
2 2 2 5 2 0 1 4 
2 2 2 5 1 14 2 6 
2 2 2 5 2 0 2 6 
2 2 2 5 1 18 2 6 
2 2 2 5 2 0 2 6 
2 2 2 5 2 0 1 5 
2 2 2 5 2 0 1 5 
2 2 1 2 2 0 1 2 
2 2 2 5 2 0 1 5 
2 2 2 5 2 0 2 6 
2 2 2 5 2 0 1 1 
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Mortality 
T1 
Mortality 
T2 
Mortality 
T3 Mortality T4 
Morbidity 
T1 
Morbidity 
T2 
Morbidity 
T3 
Morbidity 
T4 
2 2 2 2 2 2 2 2 
2 2 2 2 2 2 2 2 
2 2 2 2 2 2 2 2 
2 2 2 1 2 1 1 3 
2 2 2 2 2 2 2 2 
2 2 2 2 2 1 1 1 
2 2 2 2 2 2 2 2 
2 2 2 1 2 2 2 3 
2 2 2 1 2 2 2 3 
2 2 2 2 2 2 2 2 
2 2 2 2 2 2 2 1 
2 2 2 2 2 2 2 2 
2 2 2 2 2 2 2 2 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
   
Inpt Days  ET_TP1_Comp ET_TP2_Comp ET_TP3_Comp ET_Cond5_T1_Av NoFalls_Cond5_T1 
15 44 49 74 0 3 
36 77 57 79 64 0 
7 67 67 
 
49 0 
41 75 
  
64 0 
8 71 62 68 45 0 
81 70 
  
38 1 
7 61 
 
77 0 3 
5 41 
 
29 17 2 
6 47 64 
 
0 3 
12 42 61 52 0 3 
15 34 50 
 
0 3 
16 51 56 81 0 3 
8 83 86 85 59 0 
 
 
 
 
 
 
206 
 
ET_Cond5_T2_Av NoFalls_Cond5_T2 ET_Cond5_T3_Av NoFalls_Cond5_T3 ET_Cond6_T1_Av 
22 1 63 0 16 
0 3 65 0 58 
24 1 
  
42 
    
54 
41 0 31 1 46 
    
50 
  
56 0 64 
  
0 3 0 
37 1 
  
18 
0 3 0 3 0 
9 2 
  
0 
0 3 70 0 34 
47 0 71 0 82 
 
Gait Speed_T1_Preferred m/sec Gait Speed_T2_Preferred m/sec Gait Speed_T3_Preferred m/sec 
1.54 0.72 1.38 
1.18 0.31 1.07 
1.44 1.58 
 1.55 
  1.24 1.11 1.38 
1.43 
  1.66 
 
1.56 
0.87 
 
0.84 
1.17 0.46 
 1.03 0.93 1.37 
0.91 0.98 
 1.6 1.36 1.45 
1.41 1.43 1.38 
 
Gait Speed_T1_Max m/sec Gait Speed_T2_Max m/sec Gait Speed_T3_Max m/sec 
1.93 1.09 1.84 
1.53 0.4 1.09 
1.7 1.74 
 2.06 
  1.53 1.3 1.62 
2.7 
  1.9 
 
1.75 
1.25 
 
1.11 
1.5 0.71 
 1.28 1.18 1.53 
1.4 1.34 
 1.7 1.5 1.64 
1.84 1.48 1.66 
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DHI_Comp_1 DHI_Comp_2 DHI_Comp_3 DHI_Comp_4 
LASA_1_1 Overall 
QOL  
LASA_2_1 
Mental 
6 40 20 20 5 8 
6 72 64 56 9 10 
2 2 
 
58 8 8 
32 
   
7 5 
0 4 0 0 10 10 
0 
     2 
 
0 0 10 10 
68 
 
58 
 
4 5 
32 66 
  
2 4 
50 64 52 42 8 8 
14 36 
  
8 8 
50 0 0 0 7 7 
14 6 0 0 10 10 
Gait Speed_T1_HT m/sec Gait Speed_T2_HT m/sec 
Gait Speed_T3_HT 
m/sec 
1.62 0.86 1.4 
1.32 0.26 0.59 
1.5 1.5 
 1.64 
  1.32 1.19 1.38 
1.57 
  1.49 
 
1.7 
1.04 
 
0 
0.71 0.46 
 0.88 0.86 1.18 
1.09 1.1 
 1.41 1.06 1.34 
1.7 1.22 1.3 
 
 
 
 
 
 
   
LASA_3-1 Physical  
LASA_4_1 
Emotional  LASA_6_1 Spiritual  
LASA_1_4 Overall 
QOL  LASA_2_4 Mental  
8 8 6 7 7 
10 9 10 5 6 
5 8 8 4 7 
6 7 10 
  10 8 10 7 10 
     10 7 10 10 8 
3 5 2 
  10 4 10 
  8 8 9 6 5 
9 7 8 
  6 7 7 10 10 
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LASA_3_4 Physical  LASA_4_4 Emotional  LASA_6_4 Spiritual  Box_2 Box_3 Box_4 HandDom 
7 7 7 3 0 0 1 
4 6 8 1 2 0 1 
3 7 6 3 
 
1 2 
      
1 
7 6 7 5 0 3 1 
      
2 
10 8 10 
 
0 0 1 
   
8 0 
 
1 
   
3 
  
1 
6 6 10 0 0 0 1 
   
6 
  
1 
10 10 10 0 0 0 1 
8 8 8 2 0 0 1 
 
 
NHPT_1_R_secs NHPT_1_L_secs NHPT_2_R_secs NHPT_2_L_secs NHPT_3_R_secs NHPT_3_L_secs 
D/c 
Destination  
18.95 29.08 24.53 34.69 14.94 36.19 1 
22.09 20.17 25.71 27.16 19.52 20.38 1 
26.63 28.53 25.12 28.14 
  
1 
20.87 21.84 
    
3 
20.59 20 22.69 21.83 21.81 19.78 1 
17.75 17.64 
    
3 
16.51 16.63 
  
17.34 18.19 1 
68 97 
  
59.26 52.45 3 
21.13 25.2 23.5 25.5 
  
3 
28.8 23.56 30.88 32.25 24.77 22.76 1 
22.4 27.2 22.84 21.72 
  
1 
17.46 20.3 18.87 18.23 16.59 16.31 1 
15.33 20.09 16.09 19.64 20.18 21.2 1 
 
 
 
 
  
10 10 10 8 10 
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Appendix 29: Data Codebook  
Variable Name Response Options Codes  Units  
Age  
   Sex  Male  Male = 1 
 
 
Female  Female = 2  
 Height 
  
cm 
CT Yes Yes = 1 
 
 
No  No = 2  
 MRI  Yes Yes = 1 
 
 
No  No = 2  
 
    Histology  Mets Mets = 1 
 
 
Ependymoma Ependymoma = 2 
 
 
Atypical choroid plexus papilloma  Atypical Choroid Plexus Papilloma = 3 
 
 
Meningioma  Meningioma = 4 
 
 
Haemangioblastoma Haemangioblastoma = 5  
 
 
Pilocytic Astrocytoma Pilocytic Astrocytoma = 6 
 Who Classification  WHO 1 WHO 1 = 1 
 
 
WHO 2 WHO 2 =2  
 
 
WHO 3  WHO 3 = 3  
 
 
WHO 4 WHO 4 = 4  
 Number of surgeries  1 Surgery  1 Surgery = 1  
 
 
2 Surgeries  2 Surgeries = 2  
 
 
3 Surgeries  3 Surgeries = 3  
 
 
4 Surgeries  4 Surgeries = 4  
 
 
5 Surgeries  5 Surgeries = 5  
 Surgery to expose Tumour  Craniectomy  Craniectomy = 1  
 
 
Craniotomy  Craniotomy = 2  
 Total Excision  Yes  Yes = 1 
 
 
No  No = 2  
 Subtotal Excision  Yes  Yes = 1 
 
 
No  No = 2  
 Supplementary Surgery  Haematoma Evacuation  Haematoma Evacuation = 1  
 
 
Shunt Insertion  Shunt Insertion = 2  
 
 
EVD insertion  EVD = 3 
 
 
Nil  Nil = 4  
 Chemotherapy Yes  Yes = 1 
 
 
No  No = 2  
 Radiotherapy Yes Yes = 1 
 
 
No  No = 2  
 Headache Yes Yes = 1 
 
 
No  No = 2  
 Nausea Yes Yes = 1 
 
 
No  No = 2  
 Vomiting Yes Yes = 1 
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No  No = 2  
 Visual Disturbance Yes Yes = 1 
 
 
No  No = 2  
 GCS  GCS 15 GCS 15 = 1 
 
 
GCS 14 GCS 14 = 2  
 
 
GCS 13 GCS 13 = 3  
 
 
GCS 12  GCS 12 = 4  
 
 
GCS 11  GCS 11 = 5  
 
 
GCS 10 GCS 10 = 6  
 
 
GCS 9 GCS 9 = 7  
 
 
GCS 8  GCS 8 = 8 
 
 
GCS 7  GCS 7 = 9  
 
 
GCS 6  GCS 6 = 10 
 
 
GCS 5  GCS 5 = 11 
 
 
GCS 4  GCS 4 = 12  
 
 
GCS 3  GCS 3 = 13  
 Dizziness  Yes Yes = 1 
 
 
No  No = 2  
 Hydrocephalus  Yes Yes = 1 
 
 
No  No = 2  
 EVD Yes Yes = 1 
 
 
No  No = 2  
 Shunt Insertion  Yes Yes = 1 
 
 
No  No = 2  
 Haemorrhage  Yes Yes = 1 
 
 
No  No = 2  
 Vertigo Yes Yes = 1 
 
 
No  No = 2  
 Tinnitus  Yes Yes = 1 
 
 
No  No = 2  
 Oscillopsia Yes Yes = 1 
 
 
No  No = 2  
 Mobility Aid  Yes  Yes = 1 
 
 
No  No = 2  
 Type of mobility aid  Walking stick  Walking stick = 1  
 
 
Zimmer frame  Zimmer frame = 2  
 
 
1 crutch  1 crutch = 3  
 
 
2 crutches  2 crutches = 4  
 
 
Independent  Independent = 5  
 Number of days to assessment  
  ITU admission  Yes Yes = 1 
 
 
No  No = 2  
 Secondary lesion Yes Yes = 1 
 
 
No  No = 2  
 Primary lesion Breast Breast = 1  
 
 
Ovary  Ovary = 2  
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Liver  Liver = 3  
 
 
Colon Colon = 4  
 
 
Lung  Lung = 5  
 
 
Not applicable  NA = 6  
 Dizziness  Yes  Yes = 1 
 
 
No  No = 2  
 
 
Sometimes  Sometimes = 3  
 Midline Shift  Yes  Yes = 1 
 
 
No  No = 2  
 Mass Effect Yes Yes = 1 
 
 
No No = 2  
 Location of Tumour Brainstem  Brainstem = 1  
 
 
4th Ventricle  4th Ventricle =2 
 
 
Cerebellar vermis Cerebellar Vermis = 3  
 
 
Cerebellar Cortex  Cerebellar Cortex = 4  
 Hand Dominance  Right  Right = 1  
 
 
Left  Left = 2  
 Status at 6 months Independent  Independent = 1 
 
 
Mobile with an aid  Aid = 2  
 
 
Mobile with assistance of one person  One person = 3  
 
 
Mobile with assistance of two persons  Two people = 4  
 
 
Wheelchair Mobiliser  Wheelchair = 5  
 
 
Confined to bed  Bed = 6  
 
 
RIP  RIP = 7  
 Current Chemo Yes Yes = 1 
 
 
No  No = 2  
 Current Rtx  Yes  Yes = 1 
 
 
No No = 2  
 GCS  GCS 15 GCS 15 = 1 
 
 
GCS 14 GCS 14 = 2  
 
 
GCS 13 GCS 13 = 3  
 
 
GCS 12  GCS 12 = 4  
 
 
GCS 11  GCS 11 = 5  
 
 
GCS 10 GCS 10 = 6  
 
 
GCS 9 GCS 9 = 7  
 
 
GCS 8  GCS 8 = 8 
 
 
GCS 7  GCS 7 = 9  
 
 
GCS 6  GCS 6 = 10 
 
 
GCS 5  GCS 5 = 11 
 
 
GCS 4  GCS 4 = 12  
 
 
GCS 3  GCS 3 = 13  
 
 
RIP  RIP = 14 
 D/c destination  Home Home = 1  
 
 
Convalescence  Convalescence = 2  
 
 
Referring Hospital  Referring Hospital = 3 
 Mortality  Dead  Dead = 1  
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Alive  Alive = 2  
 Significant Morbidity  Significant Morbidity  Yes = 1 
 
 
No significant Morbidity  No = 2  
 
 
Dead  Dead =3 
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Appendix 30: STATA Output 
 
 
Gender (Male= 1; Female = 2) 
 
 
Age  
 
 
 GCS at admission  
 
 
Coding structure used to code GCS, indicating all participants at recruitment had GCS 15. 
Taken from Excel codebook  
      Total           13      100.00
                                                
          2            8       61.54      100.00
          1            5       38.46       38.46
                                                
        Sex        Freq.     Percent        Cum.
. tab Sex
         Age          13    48.84615    15.66762         21         77
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. summarize Age
      Total           13      100.00
                                                
          1           13      100.00      100.00
                                                
    Adm_GCS        Freq.     Percent        Cum.
GCS GCS 15 GCS 15 = 1
GCS 14 GCS 14 = 2 
GCS 13 GCS 13 = 3 
GCS 12 GCS 12 = 4 
GCS 11 GCS 11 = 5 
GCS 10 GCS 10 = 6 
GCS 9 GCS 9 = 7 
GCS 8 GCS 8 = 8
GCS 7 GCS 7 = 9 
GCS 6 GCS 6 = 10
GCS 5 GCS 5 = 11
GCS 4 GCS 4 = 12 
GCS 3 GCS 3 = 13 
214 
 
 
 
Use of Mobility Aid (Yes = 1; No = 2) 
 
 
Mobility Aid type 
 
 
Coding structure used to code for mobility aid use pre admission, indicating one participant used a 
zimmer-frame pre admission, 12 participants mobilised independently. Taken from Excel codebook 
 
 
Hand Dominance (Right = 1; Left = 2) 
 
 
 
      Total           13      100.00
                                                
          2           12       92.31      100.00
          1            1        7.69        7.69
                                                
        aid        Freq.     Percent        Cum.
   Mobility  
      Total           13      100.00
                                                
          5           12       92.31      100.00
          2            1        7.69        7.69
                                                
  Aid type         Freq.     Percent        Cum.
Type of mobility aid Walking stick Walking stick = 1 
Zimmer frame Zimmer frame = 2 
1 crutch 1 crutch = 3 
2 crutches 2 crutches = 4 
Independent Independent = 5 
      Total           13      100.00
                                                
          2            2       15.38      100.00
          1           11       84.62       84.62
                                                
    HandDom        Freq.     Percent        Cum.
. tab HandDom
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Tumour size (cm) 
 
 Tumour Location  
 
 
Coding structure for location of brain tumour within Posterior fossa. Taken from Excel codebook  
 
 
 Intra-axial lesion (Yes = 1; No = 2) 
 
 
  SOLSize_cm          13    3.461538     .687433        2.5        4.5
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. summarize SOLSize_cm
. 
      Total           13      100.00
                                                
          4            8       61.54      100.00
          3            2       15.38       38.46
          2            3       23.08       23.08
                                                
   Location        Freq.     Percent        Cum.
        SOL  
. tab SOLLocation
Location of Tumour Brainstem Brainstem = 1 
4th Ventricle 4th Ventricle =2
Cerebellar vermis Cerebellar Vermis = 3 
Cerebellar Cortex Cerebellar Cortex = 4 
      Total           13      100.00
                                                
          2            2       15.38      100.00
          1           11       84.62       84.62
                                                
Intra-axial        Freq.     Percent        Cum.
. tab Intraaxial
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 Extra-axial lesion (Yes = 1; No = 2) 
 
 
 Histology  
 
 
Coding structure used for tumour histology. Taken from Excel codebook  
 
 
 WHO classification  
 
      Total           13      100.00
                                                
          2           11       84.62      100.00
          1            2       15.38       15.38
                                                
Extra-axial        Freq.     Percent        Cum.
. tab Extraaxial
      Total           13      100.00
                                                
          6            1        7.69      100.00
          5            1        7.69       92.31
          4            2       15.38       84.62
          3            1        7.69       69.23
          2            1        7.69       61.54
          1            7       53.85       53.85
                                                
 Histology         Freq.     Percent        Cum.
. tab Histology
Histology Mets Mets = 1
Ependymoma Ependymoma = 2
Atypical chorioid plexus papilloma Atypical Choroid Plexus Papilloma = 3
Meningioma Meningioma = 4
Haemangioblastoma Haemangioblastoma = 5 
Pilocytic Astrocytoma Pilocytic Astrocytoma = 6
      Total           13      100.00
                                                
          4            7       53.85      100.00
          2            2       15.38       46.15
          1            4       30.77       30.77
                                                
 WHO Grade         Freq.     Percent        Cum.
. tab WHOGrade
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 Coding structure used for WHO tumour classification. Taken from Excel codebook  
 
 
 Secondary tumour (Yes = 1; No = 2) 
 
 
 Location of Primary lesions  
 
 
Location of primary lesion in participants diagnosed with a secondary lesion. Data from Excel 
codebook 
 
Requiring post-operative chemotherapy (Yes = 1; No = 2) 
Who Classification WHO 1 WHO 1 = 1
WHO 2 WHO 2 =2 
WHO 3 WHO 3 = 3 
WHO 4 WHO 4 = 4 
      Total           13      100.00
                                                
          2            6       46.15      100.00
          1            7       53.85       53.85
                                                
  Secondary        Freq.     Percent        Cum.
. tab Secondary
         1           2          1          1          3          0           7 
                                                                              
Histology            1          2          4          5          6       Total
                                   PrimaryLOC
tab Histology PrimaryLOC
Primary lesion Breast Breast = 1 
Ovary Ovary = 2 
Liver Liver = 3 
Colon Colon = 4 
Lung Lung = 5 
Not applicable NA = 6 
      Total           13      100.00
                                                
          2            9       69.23      100.00
          1            4       30.77       30.77
                                                
      Chemo        Freq.     Percent        Cum.
. tab Chemo
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Requiring post-operative radiotherapy (Yes = 1; No = 2) 
 
 
MRI  
 
 
 CT (Yes=1; No=2) 
 
 Number of surgical procedures  
 
      Total           13      100.00
                                                
          2            6       46.15      100.00
          1            7       53.85       53.85
                                                
        RTX        Freq.     Percent        Cum.
. tab RTX
      Total           13      100.00
                                                
          1           13      100.00      100.00
                                                
       MRI         Freq.     Percent        Cum.
. tab MRI
      Total           13      100.00
                                                
          2            1        7.69      100.00
          1           12       92.31       92.31
                                                
         CT        Freq.     Percent        Cum.
. tab CT
      Total           13      100.00
                                                
          5            1        7.69      100.00
          3            1        7.69       92.31
          2            2       15.38       84.62
          1            9       69.23       69.23
                                                
  Sugeries         Freq.     Percent        Cum.
     No. of  
. tab NoofSugeries
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Number of surgical interventions participants underwent while a neurosurgical inpatient. Data from 
Excel codebook  
 
 
Surgical Exposure technique  
 
 
 Coding structure for surgical technique used to expose tumour. Data from Excel codebook  
 
 
 
 Total Excision (Yes = 1; No = 2) 
 
 
Number of surgeries 1 Surgery 1 Surgery = 1 
2 Surgeries 2 Surgeries = 2 
3 Surgeries 3 Surgeries = 3 
4 Surgeries 4 Surgeries = 4 
5 Surgeries 5 Surgeries = 5 
Surgery to expose Tumour Craniectomy Craniectomy = 1 
Craniotomy Craniotomy = 2 
      Total           13      100.00
                                                
          2            4       30.77      100.00
          1            9       69.23       69.23
                                                
   Total Ex        Freq.     Percent        Cum.
. tab TotalEx
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 Subtotal Excision (Yes = 1; No = 2) 
 
 
 Presence of mass effect on scan (Yes = 1; No = 2) 
 
 
Presence of midline shift on scan (Yes = 1; No = 2) 
 
 
 Presence of hydrocephalus on scan (Yes = 1; No = 2) 
      Total           13      100.00
                                                
          2            9       69.23      100.00
          1            4       30.77       30.77
                                                
Subtotal Ex        Freq.     Percent        Cum.
. tab SubtotalEx
      Total           13      100.00
                                                
          2            6       46.15      100.00
          1            7       53.85       53.85
                                                
Mass Effect        Freq.     Percent        Cum.
. tab MassEffect
      Total           13      100.00
                                                
          2           11       84.62      100.00
          1            2       15.38       15.38
                                                
      Shift        Freq.     Percent        Cum.
    Midline  
. tab MidlineShift
      Total           13      100.00
                                                
          2            5       38.46      100.00
          1            8       61.54       61.54
                                                
         us        Freq.     Percent        Cum.
Hydrocephal  
. tab Hydrocephalus
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Requiring insertion of an EVD (Yes = 1; No = 2) 
 
 
Requiring insertion of a shunt (Yes = 1; No = 2) 
 
 
Developed a haemorrhage post-operatively (Yes = 1; No = 2) 
 
 
 Pre-operative headache (Yes = 1; No = 2) 
      Total           13      100.00
                                                
          2            9       69.23      100.00
          1            4       30.77       30.77
                                                
        EVD        Freq.     Percent        Cum.
. tab EVD
      Total           13      100.00
                                                
          2           12       92.31      100.00
          1            1        7.69        7.69
                                                
      Shunt        Freq.     Percent        Cum.
. tab Shunt
      Total           13      100.00
                                                
          2            9       69.23      100.00
          1            4       30.77       30.77
                                                
Haemorrhage        Freq.     Percent        Cum.
. tab Haemorrhage
      Total           13      100.00
                                                
          2            4       30.77      100.00
          1            9       69.23       69.23
                                                
  Headache         Freq.     Percent        Cum.
. tab Headache
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Requiring admission to intensive care post-operatively (Yes = 1; No = 2) 
 
 
 Pre-operative nausea (Yes = 1; No = 2) 
 
 
 Pre-operative vomiting (Yes = 1; No = 2) 
 
 
Pre-operative visual disturbance (Yes = 1; No = 2)  
      Total           13      100.00
                                                
          2            9       69.23      100.00
          1            4       30.77       30.77
                                                
  ITU admin        Freq.     Percent        Cum.
. tab ITUadmin
      Total           13      100.00
                                                
          2            6       46.15      100.00
          1            7       53.85       53.85
                                                
    Nausea         Freq.     Percent        Cum.
. tab Nausea
      Total           13      100.00
                                                
          2            8       61.54      100.00
          1            5       38.46       38.46
                                                
 Vomitting         Freq.     Percent        Cum.
. tab Vomitting
      Total           13      100.00
                                                
          2            8       61.54      100.00
          1            5       38.46       38.46
                                                
Disturbance        Freq.     Percent        Cum.
     Visual  
. tab VisualDisturbance
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 Pre-operative dizziness (Yes = 1; No = 2) 
 
 
 Pre-operative vertigo (Yes= 1; No = 2) 
 
 
 Pre-operative tinnitus (Yes = 1; No =2) 
 
 
 Pre-operative oscillopsia (Yes = 1; No = 2) 
      Total           13      100.00
                                                
          2            6       46.15      100.00
          1            7       53.85       53.85
                                                
  Dizziness        Freq.     Percent        Cum.
. tab Dizziness
      Total           13      100.00
                                                
          2           11       84.62      100.00
          1            2       15.38       15.38
                                                
   Vertigo         Freq.     Percent        Cum.
. tab Vertigo
      Total           13      100.00
                                                
          2           12       92.31      100.00
          1            1        7.69        7.69
                                                
  Tinnitus         Freq.     Percent        Cum.
. tab Tinnitus
      Total           13      100.00
                                                
          2           13      100.00      100.00
                                                
Oscillopsia        Freq.     Percent        Cum.
. tab Oscillopsia
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 Mobility aid use pre-morbid (Yes = 1; No = 2) 
 
 
Type of aid use  
 
 
 Type of mobility aid used pre-morbid. Data taken from Excel codebook  
 
 Equitest data for Time points one, two and three  
 
 
      Total           13      100.00
                                                
          2           12       92.31      100.00
          1            1        7.69        7.69
                                                
        aid        Freq.     Percent        Cum.
   Mobility  
. tab Mobilityaid
      Total           13      100.00
                                                
          5           12       92.31      100.00
          2            1        7.69        7.69
                                                
  Aid type         Freq.     Percent        Cum.
. tab Aidtype
Type of mobility aid Walking stick Walking stick = 1 
Zimmer frame Zimmer frame = 2 
1 crutch 1 crutch = 3 
2 crutches 2 crutches = 4 
Independent Independent = 5 
. 
 ET_TP3_Comp           8      68.125    18.79542         29         85
 ET_TP2_Comp           9    61.33333    11.04536         49         86
 ET_TP1_Comp          13    58.69231    16.22439         34         83
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum ET_TP1_Comp ET_TP2_Comp ET_TP3_Comp
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 Average score on condition five of SOT at timepoint one, two and three 
 
 
 Average number of falls on condition five of the SOT at time-point one, two and three  
 
 
 Average score on condition six of SOT at timepoint one, two and three 
 
 
 Average number of falls on condition six of the SOT at time-point one, two and three 
 
 
ET_C~5_T3_Av           8        44.5    30.21353          0         71
ET_C~5_T2_Av           9          20    18.70829          0         47
ET_C~5_T1_Av          13    25.84615    27.60992          0         64
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum ET_Cond5_T1_Av ET_Cond5_T2_Av ET_Cond5_T3_Av
NoFalls~5_T3           8        .875    1.356203          0          3
NoFalls~5_T2           9    1.555556    1.236033          0          3
NoFalls~5_T1          13    1.615385    1.445595          0          3
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum NoFalls_Cond5_T1 NoFalls_Cond5_T2 NoFalls_Cond5_T3
ET_C~6_T3_Av           8          45    31.59114          0         81
ET_C~6_T2_Av           9    39.33333    30.28614          0         85
ET_C~6_T1_Av          13    35.69231    26.85574          0         82
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum ET_Cond6_T1_Av ET_Cond6_T2_Av ET_Cond6_T3_Av
NoFalls~6_T3           8           1    1.309307          0          3
NoFalls~6_T2           9    1.111111    1.269296          0          3
NoFalls~6_T1          13    1.153846    1.281025          0          3
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum NoFalls_Cond6_T1 NoFalls_Cond6_T2 NoFalls_Cond6_T3
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Equitest data for T1, T2 and T3 for cerebellar tumour participants  
 
 
 SOT composite data for participants with complete SOT data sets  
 
 
 Preferred Gait Speed at time-points one, two and three  
 
 
Data for maximum walking speed  
 
 
 ET_TP3_Comp           7    66.57143    19.73877         29         85
 ET_TP2_Comp           8      61.875     11.6795         49         86
 ET_TP1_Comp          10        54.1    15.70173         34         83
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum ET_TP1_Comp ET_TP2_Comp ET_TP3_Comp
 ET_TP3_Comp           6    73.16667    11.92337         52         85
 ET_TP2_Comp           6    61.83333    12.70302         49         86
 ET_TP1_Comp           6    61.33333    17.82882         42         83
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum ET_TP1_Comp ET_TP2_Comp ET_TP3_Comp
GaitSpeed_..           8     1.30375    .2325595        .84       1.56
GaitSpeed_..           9    .9866667    .4348563        .31       1.58
GaitSpeed_..          13        1.31    .2632806        .87       1.66
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
Ga~3_Maxmsec           8        1.53    .2807134       1.09       1.84
Ga~2_Maxmsec           9    1.193333     .415602         .4       1.74
Ga~1_Maxmsec          13    1.716923    .3878441       1.25        2.7
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum GaitSpeed_T1_Maxmsec GaitSpeed_T2_Maxmsec GaitSpeed_T3_Maxmsec
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Walking speeds with head turns  
 
 
 Nine Home Peg Test Data for the right upper limb  
 
 
 Nine Hole Peg Test Data for Left upper limb  
 
 
Summary statistics for NHPT, for participants with cerebellar tumours  
 
Summary statistics of age in participants with cerebellar tumours  
Gai~3_HTmsec           8     1.11125    .5479165          0        1.7
Gai~2_HTmsec           9    .9455556    .3872696        .26        1.5
Gai~1_HTmsec          13        1.33    .3115017        .71        1.7
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum GaitSpeed_T1_HTmsec GaitSpeed_T2_HTmsec GaitSpeed_T3_HTmsec
NHPT_3_R_s~s           8    24.30125    14.46148      14.94      59.26
NHPT_2_R_s~s           9    23.35889     4.18765      16.09      30.88
NHPT_1_R_s~s          13    24.34692    13.65915      15.33         68
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum NHPT_1_R_secs NHPT_2_R_secs NHPT_3_R_secs
NHPT_3_L_s~s           8     25.9075    12.31766      16.31      52.45
NHPT_2_L_s~s           9    25.46222     5.64226      18.23      34.69
NHPT_1_L_s~s          13    28.24923    21.03876      16.63         97
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum NHPT_1_L_secs NHPT_2_L_secs NHPT_3_L_secs
NHPT_3_R_s~s           7    24.98429    15.48017      14.94      59.26
NHPT_2_R_s~s           8      23.065     4.37644      16.09      30.88
NHPT_1_R_s~s          10       25.58    15.50255      15.33         68
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum NHPT_1_R_secs NHPT_2_R_secs NHPT_3_R_secs
         Age          10          54    13.35831         34         77
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum Age
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 Dizziness Handicap Inventory  
 
 
 Box scale for Pain  
 
 
Summary statistics for 5 participants with complete data sets for box scale for pain  
 
LASA quality of life measure for overall QOL, mental, physical, emotional and spiritual wellbeing at 
time-point one, preoperatively  
  DHI_Comp_4           7    25.14286    26.57962          0         58
  DHI_Comp_3           8       24.25    28.93219          0         64
  DHI_Comp_2           9    32.22222     30.0906          0         72
  DHI_Comp_1          13    21.23077    22.88432          0         68
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum DHI_Comp_1 DHI_Comp_2 DHI_Comp_3 DHI_Comp_4
       Box_4           8          .5    1.069045          0          3
       Box_3           8         .25    .7071068          0          2
       Box_2          10         3.1    2.601282          0          8
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum Box_2 Box_3 Box_4
       Box_4           5          .6    1.341641          0          3
       Box_3           5          .4    .8944272          0          2
       Box_2           5         1.6    2.073644          0          5
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum Box_2 Box_3 Box_4
LASA_6_1Sp~l          12    8.333333    2.424621          2         10
LASA_4_1Em~l          12    7.333333     1.61433          4         10
LASA_31Phy~l          12    7.916667    2.391589          3         10
LASA_2_1Me~l          12        7.75    2.137331          4         10
LASA_1_1Ov~L          12    7.333333    2.534609          2         10
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum LASA_1_1OverallQOL LASA_2_1MentalIntellectual LASA_31Physical LASA_4_1Emotional LASA_6_1Spiritual
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Summary statistics for 5 participants with complete data sets for overall QOL, mental, physical, 
emotional and spiritual wellbeing at T1, preoperatively 
 
 
LASA quality of life measure for overall QOL, mental, physical, emotional and spiritual wellbeing at 
time-point four, 6 months post-operatively  
 
 
Summary statistics for 5 participants with complete data sets for overall QOL, mental, physical, 
emotional and spiritual wellbeing at T4, postoperatively 
 
 
Duration of Inpatient stay  
LASA_6_1Sp~l           5         9.2     1.30384          7         10
LASA_4_1Em~l           5         8.4    1.140175          7         10
LASA_31Phy~l           5         8.8    1.788854          6         10
LASA_2_1Me~l           5           9    1.414214          7         10
LASA_1_1Ov~L           5         8.8     1.30384          7         10
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum LASA_1_1OverallQOL LASA_2_1MentalIntellectual LASA_31Physical LASA_4_1Emotional LASA_6_1Spiritual
LASA_6_4Sp~l           8        8.25    1.581139          6         10
LASA_4_4Em~l           8        7.25     1.38873          6         10
LASA_3_4Ph~l           8       6.875    2.531939          3         10
LASA_2_4Me~l           8       7.875     1.95941          5         10
LASA_1_4Ov~L           8       7.125    2.167124          4         10
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
sum LASA_1_4OverallQOL LASA_2_4Mental LASA_3_4Physical LASA_4_4Emotional LASA_6_4Spiritual
LASA_6_4Sp~l           5         8.6    1.341641          7         10
LASA_4_4Em~l           5         7.2    1.788854          6         10
LASA_3_4Ph~l           5           7    2.236068          4         10
LASA_2_4Me~l           5         8.2     2.48998          5         10
LASA_1_4Ov~L           5         7.2    1.923538          5         10
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum LASA_1_4OverallQOL LASA_2_4Mental LASA_3_4Physical LASA_4_4Emotional LASA_6_4Spiritual
    InptDays          13    19.76923    21.59149          5         81
                                                                      
    Variable         Obs        Mean    Std. Dev.       Min        Max
. sum InptDays
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 Excluded participants  
 
 
 Coding structure for excluded participants taken from Excel codebook  
 
 
 
 
 
 
 
 
 
 
      Total           31      100.00
                                                
          8            3        9.68      100.00
          7            2        6.45       90.32
          6            3        9.68       83.87
          5            1        3.23       74.19
          4            8       25.81       70.97
          3            2        6.45       45.16
          2            8       25.81       38.71
          1            4       12.90       12.90
                                                
 Exclusion         Freq.     Percent        Cum.
 Reason for  
. tab ReasonforExclusion
Codebook for Excluded Participants 
Unable to consent = 1 
Previous Cerebral Surgery = 2 
Not identified prior to Surgical intercvention = 3
Emergency transfer = 4
Previous RTX = 5 
Unable to stand for 20 seconds = 6
Refusal to participate = 7
Did not have a surgical intervention = 8 
